WEBSTER FINANCIAL CORP, 10-Q filed on 8/11/2025
Quarterly Report
v3.25.2
Cover Page - shares
 6 Months Ended
Jun. 30, 2025
Aug. 08, 2025
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2025  
Document Transition Report false  
Entity File Number 001-31486  
Entity Registrant Name WEBSTER FINANCIAL CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 06-1187536  
Entity Address, Address Line One 200 Elm Street  
Entity Address, City or Town Stamford  
Entity Address, State or Province CT  
Entity Address, Postal Zip Code 06902  
City Area Code 203  
Local Phone Number 578-2202  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   166,188,648
Entity Central Index Key 0000801337  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2025  
Common Class A    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, par value $0.01 per share  
Trading Symbol WBS  
Security Exchange Name NYSE  
Preferred Stock Series F Issued    
Entity Information [Line Items]    
Title of 12(b) Security Depositary Shares, each representing 1/1000th interest in a share  
Trading Symbol WBS-PrF  
Security Exchange Name NYSE  
Preferred Stock Series G Issued    
Entity Information [Line Items]    
Title of 12(b) Security Depositary Shares, each representing 1/40th interest in a share  
Trading Symbol WBS-PrG  
Security Exchange Name NYSE  
v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets:    
Cash and due from banks $ 425,349 $ 388,060
Interest-bearing deposits 2,568,570 1,686,374
Fair Value [1] 9,620,354 9,006,600
Investment securities held-to-maturity, net of allowance for credit losses [2] 8,192,720 8,444,191
Loans held for sale [3] 278,409 27,634
Loans and leases 53,671,959 52,505,168
Allowance for credit losses on loans and leases (722,046) (689,566)
Loans and leases, net 52,949,913 51,815,602
Federal Home Loan Bank and Federal Reserve Bank stock 370,272 321,343
Deferred tax assets, net 252,442 316,856
Premises and equipment, net 422,774 406,963
Goodwill 2,868,068 2,868,068
Other intangible assets, net 315,971 334,301
Cash surrender value of life insurance policies 1,262,311 1,251,622
Accrued interest receivable and other assets 2,387,117 2,157,459
Total assets 81,914,270 79,025,073
Deposits:    
Non-interest-bearing 10,345,761 10,316,501
Interest-bearing 55,968,664 54,436,579
Total deposits 66,314,425 64,753,080
Securities sold under agreements to repurchase and federal funds purchased (2) 372,806 344,168
Federal Home Loan Bank advances 3,339,914 2,110,108
Long-term debt 905,634 909,185
Accrued expenses and other liabilities 1,643,874 1,775,318
Total liabilities 72,576,653 69,891,859
Stockholders’ equity:    
Common stock 1,828 1,828
Paid-in capital 6,155,132 6,181,475
Retained earnings 4,100,350 3,759,158
Treasury stock, at cost—15,694,782 and 11,386,920 shares (765,410) (536,843)
Accumulated other comprehensive (loss), net of tax (438,262) (556,383)
Total stockholders’ equity 9,337,617 9,133,214
Total liabilities and stockholders’ equity 81,914,270 79,025,073
Preferred Stock Series F Issued    
Stockholders’ equity:    
Preferred stock 145,037 145,037
Preferred Stock Series G Issued    
Stockholders’ equity:    
Preferred stock $ 138,942 $ 138,942
[1] Investment securities available-for-sale had an amortized cost basis of $10,189,481 at June 30, 2025, and $9,720,415 at December 31, 2024.
[2] Investment securities held-to-maturity had a fair value of $7,291,244 at June 30, 2025, and $7,453,123 and at December 31, 2024.
[3] Total loans held for sale includes residential mortgage loans valued under the fair value option of $75 at June 30, 2025, and $297 at December 31, 2024.
v3.25.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Allowance for Credit Losses $ 102 $ 171
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 3,000,000 3,000,000
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, shares issued (in shares) 182,778,045 182,778,045
Common Stock, Shares, Outstanding 167,083,263 171,391,125
Amortized cost $ 10,189,481 $ 9,720,415
Fair Value 7,291,244 7,453,123
Originated loans held for sale $ 75 $ 297
Preferred Stock Series F Issued    
Preferred stock, shares issued (in shares) 6,000 6,000
Preferred stock, shares outstanding (in shares) 6,000 6,000
Preferred Stock Series G Issued    
Preferred stock, shares issued (in shares) 135,000 135,000
Preferred stock, shares outstanding (in shares) 135,000 135,000
v3.25.2
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Interest Income:        
Interest and fees on loans and leases $ 775,203 $ 798,097 $ 1,530,320 $ 1,590,142
Taxable interest on investment securities 190,600 150,588 377,715 285,659
Non-taxable interest on investment securities 7,166 10,239 14,520 22,753
Loans held for sale 7 5,593 22 5,675
Other interest and dividends 27,611 11,769 51,497 23,907
Total interest income 1,000,587 976,286 1,974,074 1,928,136
Interest Expense:        
Deposits 339,738 361,263 666,121 697,234
Securities sold under agreements to repurchase and federal funds purchased 218 1,114 1,894 3,222
Federal Home Loan Bank advances 29,825 33,727 53,414 71,094
Long-term debt 9,624 7,885 19,271 16,550
Total interest expense 379,405 403,989 740,700 788,100
Net interest income 621,182 572,297 1,233,374 1,140,036
Provision for credit losses 46,500 59,000 124,000 104,500
Net interest income after provision for credit losses 574,682 513,297 1,109,374 1,035,536
Non-interest Income:        
Deposit service fees 40,934 41,027 79,829 83,616
Loan and lease related fees 17,657 19,334 35,278 39,101
Wealth and investment services 7,779 8,556 15,568 16,480
Cash surrender value of life insurance policies 9,172 6,359 17,164 12,305
Gain (loss) on sale of investment securities, net 0 (49,915) 220 (59,741)
Other income 19,115 16,937 39,204 49,890
Total non-interest income 94,657 42,298 187,263 141,651
Non-interest Expense:        
Compensation and benefits 199,930 186,850 398,575 375,390
Occupancy 19,337 15,103 39,054 34,542
Technology and equipment 45,932 45,303 93,651 91,139
Intangible assets amortization 9,093 8,716 18,330 17,910
Marketing 5,171 4,107 9,198 8,388
Professional and outside services 18,394 14,066 35,620 27,047
Deposit insurance 15,061 15,065 31,406 39,288
Other expense 32,796 36,811 63,524 68,240
Total non-interest expense 345,714 326,021 689,358 661,944
Income before income taxes 323,625 229,574 607,279 515,243
Income tax expense 64,777 47,941 121,514 117,287
Net income 258,848 181,633 485,765 397,956
Preferred stock dividends 4,162 4,162 8,325 8,325
Income allocated to participating securities 2,991 1,977 5,361 4,090
Net income applicable to common stockholders $ 251,695 $ 175,494 $ 472,079 $ 385,541
Earnings per common share:        
Basic (in dollars per share) $ 1.52 $ 1.03 $ 2.82 $ 2.27
Diluted (in dollars per share) $ 1.52 $ 1.03 $ 2.81 $ 2.26
v3.25.2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Statement of Comprehensive Income [Abstract]        
Net income $ 258,848 $ 181,633 $ 485,765 $ 397,956
Other comprehensive income (loss), net of tax:        
Investment securities available-for-sale 8,858 (9,809) 105,439 (46,080)
Derivative financial instruments 2,004 (1,610) 12,128 (31,599)
Defined benefit pension and other postretirement benefit plans 277 (379) 554 351
Total 11,139 (11,798) 118,121 (77,328)
Comprehensive income $ 269,987 $ 169,835 $ 603,886 $ 320,628
v3.25.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock Series F Issued
Preferred Stock Series G Issued
Preferred Stock
Common Stock
Paid-In Capital
Retained Earnings
Retained Earnings
Preferred Stock Series F Issued
Retained Earnings
Preferred Stock Series G Issued
Treasury Stock, at cost
Accumulated Other Comprehensive (Loss), Net of Tax
Balance, beginning of period at Dec. 31, 2023 $ 8,689,996     $ 283,979 $ 1,828 $ 6,179,753 $ 3,282,530     $ (507,523) $ (550,571)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 397,956           397,956        
Other comprehensive income (loss), net of tax (77,328)                   (77,328)
Common stock dividends and equivalents (137,810)           (137,810)        
Preferred stock dividends   $ (3,938) $ (4,387)         $ (3,938) $ (4,387)    
Stock-based compensation 27,193         (26,467)       53,660  
Common shares acquired from stock compensation plan activity (16,619)                 (16,619)  
Common stock repurchase program (65,795)                 (65,795)  
Balance, end of period at Jun. 30, 2024 8,809,268     283,979 1,828 6,153,286 3,534,351     (536,277) (627,899)
Balance, beginning of period at Mar. 31, 2024 8,747,498     283,979 1,828 6,138,935 3,425,701     (486,844) (616,101)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 181,633           181,633        
Other comprehensive income (loss), net of tax (11,798)                   (11,798)
Common stock dividends and equivalents (68,821)           (68,821)        
Preferred stock dividends   (1,969) (2,193)         (1,969) (2,193)    
Stock-based compensation 13,433         14,351       (918)  
Common shares acquired from stock compensation plan activity (3,123)                 (3,123)  
Common stock repurchase program (45,392)                 (45,392)  
Balance, end of period at Jun. 30, 2024 8,809,268     283,979 1,828 6,153,286 3,534,351     (536,277) (627,899)
Balance, beginning of period at Dec. 31, 2024 9,133,214     283,979 1,828 6,181,475 3,759,158     (536,843) (556,383)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 485,765           485,765        
Other comprehensive income (loss), net of tax 118,121                   118,121
Common stock dividends and equivalents (136,248)           (136,248)        
Preferred stock dividends   (3,938) (4,387)         (3,938) (4,387)    
Stock-based compensation 29,132         (26,343)       55,475  
Common shares acquired from stock compensation plan activity (22,190)                 (22,190)  
Common stock repurchase program (261,852)                 (261,852)  
Balance, end of period at Jun. 30, 2025 9,337,617     283,979 1,828 6,155,132 4,100,350     (765,410) (438,262)
Balance, beginning of period at Mar. 31, 2025 9,204,154     283,979 1,828 6,140,885 3,913,169     (686,306) (449,401)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 258,848           258,848        
Other comprehensive income (loss), net of tax 11,139                   11,139
Common stock dividends and equivalents (67,505)           (67,505)        
Preferred stock dividends   $ (1,969) $ (2,193)         $ (1,969) $ (2,193)    
Stock-based compensation 15,121         14,247       874  
Common shares acquired from stock compensation plan activity (408)                 (408)  
Common stock repurchase program (79,570)                 (79,570)  
Balance, end of period at Jun. 30, 2025 $ 9,337,617     $ 283,979 $ 1,828 $ 6,155,132 $ 4,100,350     $ (765,410) $ (438,262)
v3.25.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) (Parenthetical) - $ / shares
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Common stock dividends/equivalents (in dollars per share) $ 0.40 $ 0.40 $ 0.80 $ 0.80
Preferred Stock Series F Issued        
Preferred stock dividends (in dollars per share) 328.125 328.125 656.25 656.25
Preferred Stock Series G Issued        
Preferred stock dividends (in dollars per share) $ 16.25 $ 16.25 $ 32.50 $ 32.50
v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating Activities:    
Net income $ 485,765 $ 397,956
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for credit losses 124,000 104,500
Deferred income tax expense 19,669 7,908
Stock-based compensation 29,132 27,193
Depreciation and amortization of property and equipment and intangible assets 36,327 36,510
Net (accretion) and amortization of interest-earning assets and borrowings (80,485) (32,845)
Amortization of low-income housing tax credit investments 66,672 42,249
Reduction of ROU lease assets 15,520 16,522
Net (gain) loss on sale of investment securities (220) 59,741
Originations of loans held for sale (4,781) (31,259)
Proceeds from sale of loans held for sale 5,025 5,770
Net (gain) on sale of mortgage servicing rights 0 (11,655)
(Increase) in cash surrender value of life insurance policies (17,164) (12,305)
(Gain) from life insurance policies (1,492) (8,560)
(Gain) on sale of alternative investments (5,748) 0
Other operating activities, net (2,927) (10,061)
Net (increase) decrease in derivative contract assets and liabilities (147,889) 39,768
Net (increase) decrease in prepaid expenses and other assets (76,566) 241,426
Net (decrease) in accrued expenses and other liabilities (79,034) (405,186)
Net cash provided by operating activities 365,804 467,672
Investing Activities:    
Purchases of available-for-sale securities (1,017,967) (654,675)
Proceeds from principal payments, maturities, and calls of available-for-sale securities 564,454 425,929
Proceeds from sale of available-for-sale securities 14,880 1,253,332
Purchases of held-to-maturity securities 0 (1,732,829)
Proceeds from principal payments, maturities, and calls of held-to-maturity securities 283,335 189,273
Net (increase) in Federal Home Loan Bank and Federal Reserve Bank stock (48,929) (21,381)
Alternative investments (capital calls), net of returns of capital (141,398) (8,533)
Proceeds from sales of alternative investments 9,536 0
Net (increase) in loans (1,561,321) (1,223,546)
Proceeds from sale of loans not originated for sale 80,938 92,664
Proceeds from sale of mortgage servicing rights 0 18,310
Proceeds from sale of foreclosed properties and repossessed assets 261 1,490
Proceeds from sale of property and equipment 2,323 3,820
Purchases of property and equipment (21,533) (13,483)
Proceeds from life insurance policies 8,591 12,541
Net cash paid for acquisition of Ametros 0 (359,460)
Net cash (used for) investing activities (1,826,830) (2,016,548)
Financing Activities:    
Net increase in deposits 1,559,263 1,502,372
Net increase in Federal Home Loan Bank advances 1,229,806 449,825
Net increase (decrease) in securities sold under agreements to repurchase and federal funds purchased 28,638 (218,863)
Repayment of long-term debt 0 (132,550)
Payment of contingent consideration (11,241) (4,050)
Dividends paid to common stockholders (135,839) (137,654)
Dividends paid to preferred stockholders (8,325) (8,325)
Common stock repurchase program (259,601) (65,402)
Common shares acquired related to stock compensation plan activity (22,190) (16,619)
Net cash provided by financing activities 2,380,511 1,368,734
Net increase (decrease) in cash and cash equivalents 919,485 (180,142)
Cash and cash equivalents, beginning of period 2,074,434 1,715,795
Cash and cash equivalents, end of period $ 2,993,919 $ 1,535,653
v3.25.2
Basis of Presentation and Accounting Standards Updates
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Accounting Standards Updates Basis of Presentation and Accounting Standards Updates
Basis of Presentation
The unaudited Condensed Consolidated Financial Statements of the Company have been prepared in accordance with GAAP for interim financial information and Article 10 of Regulation S-X. Certain information and footnote disclosures required by GAAP for complete financial statements have been omitted or condensed. Therefore, the Condensed Consolidated Financial Statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The Company’s financial condition, results of operations, and cash flows, for the three and six months ended June 30, 2025, as compared to 2024, are not necessarily indicative of the future results that may be attained for the entire year or other interim periods.
In the opinion of management, all necessary adjustments have been reflected to present fairly the financial position, results of operations, and cash flows for the reporting periods presented. Intercompany transactions and balances have been eliminated in consolidation. Assets under administration or assets under management that the Company holds or manages in a fiduciary or agency capacity for customers are not included in the Condensed Consolidated Financial Statements.
Certain prior period amounts disclosed in Note 9: Accumulated Other Comprehensive (Loss), Net of Tax have been reclassified to conform to the current period presentation. These reclassifications did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
Use of Estimates
The preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Supplemental Cash Flow Information
The following table summarizes supplemental disclosures of cash flow information and non-cash investing and financing activities:
Six months ended June 30,
(In thousands)20252024
Supplemental disclosure of cash flow information:
Interest paid$765,626 $811,338 
Income taxes paid53,100 84,450 
Non-cash investing and financing activities:
Transfer of loans held for investment to foreclosed properties and repossessed assets$3,967 $1,925 
Transfer of returned finance lease equipment to assets held for sale579 2,316 
Transfer of loans held for investment to loans held for sale317,172 333,483 
ROU lease assets obtained in exchange for operating lease liabilities28,437 8,259 
Approved commitments to fund LIHTC investments 99,054 212,041 
Acquisition of Ametros:
Tangible assets acquired$— $256,957 
Goodwill and other intangible assets— 417,085 
Liabilities assumed (1)
— 299,507 
Forgiveness of long-term debt— 12,875 
Pre-existing equity interest— 2,200 
(1)Reflects the sum of the $293.7 million of liabilities assumed from Ametros and the $5.8 million liability assumed for the Seller’s transaction expenses, which was included as part of the purchase price consideration and paid by the Company at closing.
Relevant Accounting Standards Issued But Not Yet Adopted
ASU No. 2023-09—Income Taxes (Topic 740)—Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU No. 2023-09—Income Taxes (Topic 740)—Improvements to Income Tax Disclosures, to provide more transparency about income tax information through improvements to income tax disclosures, primarily related to the rate reconciliation and income taxes paid information. Specifically, the amendments in this Update require disclosure of: (i) a tabular reconciliation, using both percentages and reporting currency amounts, with prescribed categories that are required to be disclosed, and the separate disclosure and disaggregation of prescribed reconciling items with an effect equal to 5% or more of the amount determined by multiplying pre-tax income from continuing operations by the application statutory rate; (ii) a qualitative description of the states and local jurisdictions that make up the majority (greater than 50%) of the effect of the state and local income taxes; and (iii) the amount of income taxes paid, net of refunds received, disaggregated by federal, state, and foreign taxes and by individual jurisdictions that comprise 5% or more of total income taxes paid, net of refunds received. The amendments in this Update also include certain other amendments to improve the effectiveness of income tax disclosures.
The Update is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. The Company is currently evaluating this guidance, which it will adopt in the fourth quarter of 2025, to determine the impact on its income tax disclosures.
ASU No. 2024-03—Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures
(Subtopic 220-40): Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires entities to disclose specified information about certain costs and expenses in the notes to financial statements at each interim and annual reporting period, including the amounts of: (a) purchases of inventory, (b) employee compensation, (c) depreciation, (d) intangible asset amortization, and (e) depletion included in each relevant expense caption. For the employee compensation category, bank holding companies may continue to present compensation expense on the face of the income statement in accordance with Regulation S-X Rule 210.9-04. A qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively are also required to be disclosed. In addition, entities must disclose the total amount of selling expenses and, in annual reporting periods, their definition of selling expenses.
The Update is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The amendments may be applied on either a prospective or retrospective basis. The Company is currently evaluating this guidance to determine the impact on its non-interest expense disclosures; however, the impact is not expected to be material.
v3.25.2
Business Developments
 6 Months Ended
Jun. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Business Developments Business Developments
Ametros Acquisition
On January 24, 2024, the Bank acquired all of the equity interest in Ametros from Long Ridge Capital Management (the “Seller”). Ametros is a custodian and administrator of medical funds from insurance claim settlements that helps individuals manage their ongoing medical care through its CareGuard service and proprietary technology platform. The acquisition provided the Bank with a fast-growing source of low-cost and long-duration deposits, new sources of non-interest income, and enhanced its employee benefit and healthcare financial services expertise.
The acquisition was accounted for as a business combination. Accordingly, the total purchase price, which included cash paid of $359.7 million, the forgiveness of $12.9 million in long-term debt, and the assumption of a $5.8 million liability for the Seller’s transaction expenses, has been allocated to the identifiable assets acquired and liabilities assumed based on their acquisition-date fair values, as summarized in the following table:
(In thousands)Fair Value
Purchase price consideration$378,424 
Assets:
Cash and due from banks310 
Premises and equipment
1,078 
Other intangible assets188,900 
Deferred tax assets, net(35,889)
Other assets:
Funds held in escrow288,167 
Accounts receivable 2,435 
Prepaid expenses1,166 
Total other assets291,768 
Total assets acquired$446,167 
Liabilities:
Interest-bearing deposits (1)
(20,622)
Other liabilities:
Accounts payable 684 
Accrued expenses4,270 
Deferred revenue20,391 
Members’ funds288,167 
Operating lease liabilities838 
Total other liabilities314,350 
Total liabilities assumed$293,728 
Net assets acquired152,439 
Pre-existing equity interest (2)
$2,200 
Goodwill$228,185 
(1)The $20.6 million reflects the amount held in Ametros’ operating cash account at the Bank on January 24, 2024. Upon acquisition, such cash and the Bank’s corresponding deposit liability owed to Ametros were eliminated in consolidation, which resulted in a decrease to interest-bearing deposits for the Bank and the Bank’s legal title to the funds being held in such operating cash account.
(2)Prior to the acquisition date, the Company had a 0.6% equity interest in Ametros. The consideration transferred reflects the purchase price for the remaining 99.4% of the business. Upon acquisition, the Company recognized a $1.5 million gain in Other income on the accompanying Condensed Consolidated Statement of Income, which represents the difference between the cost basis and estimated acquisition-date fair value of the Company’s pre-existing equity interest in Ametros.
The Company’s valuations of the assets acquired and liabilities assumed in the Ametros acquisition were considered final as of December 31, 2024. There were no adjustments to fair value estimates recognized during the measurement period. The $228.2 million of goodwill represents future economic benefits arising from acquiring Ametros, primarily due to its strong market position and its assembled workforce, and is not deductible for tax purposes. Information regarding the allocation of goodwill to the Company’s reportable segments can be found within Note 15: Segment Reporting.
The Company incurred $3.1 million of professional and outside services expenses related to the acquisition of Ametros during the first quarter of 2024. The revenue and earnings related to the Ametros business since the acquisition date are included in the Company’s Condensed Consolidated Statements of Income for both the three and six months ended June 30, 2025, and 2024, respectively, and were not material.
The following is a description of the valuation methodologies used to estimate the fair values of the significant assets acquired and liabilities assumed:
Other intangible assets. The Company identified and recognized a $182.8 million core deposit intangible asset and a $6.1 million trade name intangible asset. A core deposit intangible asset represents the value of relationships with deposit customers. The fair value of the core deposit intangible asset was estimated using a net cost savings method, a form of discounted cash flow methodology, which gave appropriate consideration to expected client attrition rates and other applicable adjustments to the projected deposit balance, the interest cost and net maintenance cost associated with the client deposit base, an alternative cost of funds, and a discount rate that was used to discount the future economic benefits of the core deposit intangible asset to present value. The core deposit intangible asset is being amortized on an accelerated basis over an estimated useful life of 25 years, which is the period over which the estimated economic benefits are estimated to be received. The fair value of the trade name intangible asset for the Ametros brand was estimated using a relief-from-royalty methodology, which models the cost savings from owning the brand rather than licensing it from a third party. The trade name intangible asset is being amortized on a straight-line basis over an estimated useful life of 5 years.
Funds held in escrow and Members’ funds. Funds held in escrow represent amounts held in interest-bearing checking accounts at insured depository institutions other than the Bank for the purpose of providing post-settlement medical administration services on a respective member’s behalf. Members’ funds is the corresponding liability to the Funds held in escrow. Given that these amounts can be withdrawn and/or directed for use on demand, as long as in accordance with the terms of the settlement agreement, their carrying amount is a reasonable estimate of fair value.
Sale of Mortgage Servicing Rights
On February 12, 2024, the Company sold the majority of its mortgage servicing portfolio, which comprised 9,184 individual residential mortgage loans with an aggregate UPB of $1.4 billion. In connection with the sale, the Company received net cash proceeds of $18.4 million and derecognized $6.7 million of mortgage servicing rights. The resulting $11.7 million net gain on sale of mortgage servicing rights is included in Other income on the Condensed Consolidated Statements of Income and in Consumer Banking for segment reporting purposes.
Joint Venture with Marathon Asset Management
On July 19, 2024, the Company, through its subsidiary, MW Advisor Holding, LLC, entered into an agreement with Marathon Asset Management and formed a private credit joint venture, which will deliver direct lending solutions for sponsor-backed middle market companies across the country.
On June 30, 2025, the Company identified the individual loans to comprise the seed portfolio to launch the joint venture’s operations. Accordingly, the $242.2 million of commercial non-mortgage loans identified, in aggregate, were reclassified and transferred from Loans and leases to Loans held for sale on the accompanying Condensed Consolidated Balance Sheets. The $1.3 million difference between the lower of the amortized cost basis of the loans and their fair value at the time of transfer was charged-off and recognized in the Provision for credit losses on the accompanying Condensed Consolidated Statements of Income. The seed portfolio loans are included in Commercial Banking for segment reporting purposes.
In July 2025, the Company sold a portion of the seed portfolio loans. The transfer met the requisite criteria to be accounted for as a sale in accordance with ASC 860, Transfers and Servicing. In connection with the sale, the Company derecognized $33.3 million from Loans held for sale and recognized an immaterial gain. The remainder of the seed portfolio loans are expected to be sold later in the third quarter of 2025.
v3.25.2
Investment Securities
 6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Investment Securities Investment Securities
Available-for-Sale
The following tables summarize the amortized cost and fair value of available-for-sale securities by major type:
 June 30, 2025
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Allowance for Credit LossesFair Value
Government agency debentures$222,808 $— $(30,372)$— $192,436 
Municipal bonds and notes117,562 — (13,754)— 103,808 
Agency CMO29,439 — (2,326)— 27,113 
Agency MBS4,980,846 36,060 (185,301)— 4,831,605 
Agency CMBS3,558,974 5,201 (339,977)— 3,224,198 
CMBS791,930 1,054 (2,852)— 790,132 
Corporate debt435,483 264 (31,507)(867)403,373 
Private label MBS42,571 — (4,207)— 38,364 
Other9,868 — (543)— 9,325 
Total available-for-sale$10,189,481 $42,579 $(610,839)$(867)$9,620,354 
December 31, 2024
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Allowance for Credit LossesFair Value
Government agency debentures$222,767 $— $(36,341)$—$186,426
Municipal bonds and notes123,885 2 (13,011)—110,876
Agency CMO32,193 — (3,150)—29,043
Agency MBS4,760,541 11,654 (252,410)—4,519,785
Agency CMBS3,400,021 84 (365,713)—3,034,392
CMBS630,985 411 (6,008)—625,388
Corporate debt496,087 801 (43,755)(867)452,266
Private label MBS 44,081 — (4,862)—39,219
Other9,855 — (650)—9,205
Total available-for-sale$9,720,415 $12,952 $(725,900)$(867)$9,006,600 
(1)Accrued interest receivable on available-for-sale securities of $36.8 million and $35.2 million at June 30, 2025, and December 31, 2024, respectively, is excluded from amortized cost and included in Accrued interest receivable and other assets on the accompanying Condensed Consolidated Balance Sheets.
Unrealized Losses
The following tables summarize the gross unrealized losses and fair value of available-for-sale securities by length of time each major security type has been in a continuous unrealized loss position:
 June 30, 2025
 Less Than 12 Months12 Months or MoreTotal
(Dollars in thousands)Fair
Value		Unrealized
Losses		Fair
Value		Unrealized
Losses		Number of
Holdings		Fair
Value		Unrealized
Losses
Government agency debentures$— $— $192,436 $(30,372)15$192,436 $(30,372)
Municipal bonds and notes— — 103,032 (13,754)38103,032 (13,754)
Agency CMO— — 27,113 (2,326)2827,113 (2,326)
Agency MBS822,663 (5,939)1,218,266 (179,362)3262,040,929 (185,301)
Agency CMBS1,280,991 (27,776)1,558,697 (312,201)1782,839,688 (339,977)
CMBS213,594 (676)252,181 (2,176)32465,775 (2,852)
Corporate debt8,000 (1)375,109 (31,506)51383,109 (31,507)
Private label MBS— — 38,364 (4,207)338,364 (4,207)
Other— — 9,325 (543)29,325 (543)
Total$2,325,248 $(34,392)$3,774,523 $(576,447)673$6,099,771 $(610,839)
 December 31, 2024
 Less Than Twelve MonthsTwelve Months or LongerTotal
(Dollars in thousands)Fair
Value		Unrealized
Losses		Fair
Value		Unrealized
Losses		Number of
Holdings		Fair
Value		Unrealized
Losses
Government agency debentures$— $— $186,427 $(36,341)15$186,427 $(36,341)
Municipal bonds and notes 859 (1)108,013 (13,010)57108,872 (13,011)
Agency CMO— — 29,043 (3,150)2829,043 (3,150)
Agency MBS2,624,722 (31,539)1,246,818 (220,871)3703,871,540 (252,410)
Agency CMBS1,468,615 (32,528)1,540,263 (333,185)1853,008,878 (365,713)
CMBS— — 457,423 (6,008)32457,423 (6,008)
Corporate debt— — 426,805 (43,755)59426,805 (43,755)
Private label MBS— — 39,219 (4,862)339,219 (4,862)
Other— — 9,205 (650)29,205 (650)
Total$4,094,196 $(64,068)$4,043,216 $(661,832)751$8,137,412 $(725,900)
The $115.1 million decrease in gross unrealized losses of available-for-sale securities from December 31, 2024, to
June 30, 2025, is primarily due to lower market interest rates. The Company assesses each available-for-sale security that is in an unrealized loss position on a quarterly basis to determine whether the decline in fair value below the amortized cost basis is a result of any credit related factors. At June 30, 2025 and December 31, 2024, the ACL on available-for-sale securities was $0.9 million, which related to a single Corporate debt security. Each of the Company’s other available-for-sale securities in an unrealized loss position at June 30, 2025 are investment grade, current as to principal and interest, and their price changes are consistent with interest and credit spreads when adjusting for duration, convexity, rating, and industry differences.
Based on current market conditions and the Company’s targeted balance sheet composition strategy, the Company intends to hold its available-for-sale securities with unrealized loss positions through the anticipated recovery period. The issuers of these available-for-sale securities have not, to the Company’s knowledge, established any cause for default. Market prices are expected to approach par as the securities approach maturity.
Contractual Maturities
The following table summarizes the amortized cost and fair value of available-for-sale securities by contractual maturity:
June 30, 2025
(In thousands)Amortized CostFair Value
Maturing within 1 year$884 $881 
After 1 year through 5 years334,324 328,656 
After 5 through 10 years702,943 660,919 
After 10 years9,151,330 8,629,898 
Total available-for-sale$10,189,481 $9,620,354 
Available-for-sale securities that are not due at a single maturity date have been categorized based on the maturity date of the underlying collateral. Actual principal cash flows may differ from this categorization as borrowers have the right to prepay their obligations with or without prepayment penalties.
Sales of Available-for Sale Securities
The following table summarizes information related to sales of available-for-sales securities:
Three months ended June 30,Six months ended June 30,
(In thousands)2025202420252024
Proceeds from sales$— $921,642 $14,880 $1,253,332 
Gross realized gains$— $— $332 $2,240 
Gross realized losses (1)
— (49,915)(112)(64,551)
(1)For the three months and six months ended June 30, 2024, $2.6 million of the gross losses realized on sale of available-for-sale securities was due to credit related factors and, therefore, was included in the Provision for credit losses on the accompanying Condensed Consolidated Statements of Income. There were no gross losses realized on sale of available-for-sale securities due to credit related factors for the three and six months ended June 30, 2025. The net amounts presented as a component of non-interest income for the three and six months ended June 30, 2025, and 2024, respectively, include the portion of any gross losses that were not due to credit related factors.
Other Information
The following table summarizes the carrying value of available-for-sale securities pledged for deposits, borrowings, and other purposes:
(In thousands)June 30, 2025December 31, 2024
Pledged for deposits$1,797,620$1,596,378
Pledged for borrowings and other6,926,9236,863,183
Total available-for-sale securities pledged$8,724,543$8,459,561
Held-to-Maturity
The following tables summarize the amortized cost, fair value, and ACL on held-to-maturity securities by major type:
June 30, 2025
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Fair ValueAllowance for Credit LossesNet Carrying Value
Agency CMO$18,246 $— $(1,282)$16,964 $— $18,246 
Agency MBS2,954,301 11,389 (276,548)2,689,142 — 2,954,301 
Agency CMBS4,315,250 149 (569,802)3,745,597 — 4,315,250 
Municipal bonds and notes839,766 257 (63,392)776,631 (102)839,664 
CMBS65,259 — (2,349)62,910 — 65,259 
Total held-to-maturity$8,192,822 $11,795 $(913,373)$7,291,244 $(102)$8,192,720 
December 31, 2024
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Fair ValueAllowance for Credit LossesNet Carrying Value
Agency CMO$19,847 $— $(1,671)$18,176 $— $19,847 
Agency MBS3,109,411 771 (333,039)2,777,143 — 3,109,411 
Agency CMBS4,357,505 414 (613,914)3,744,005 — 4,357,505 
Municipal bonds and notes891,909 317 (40,266)851,960 (171)891,738 
CMBS65,690 — (3,851)61,839 — 65,690 
Total held-to-maturity$8,444,362 $1,502 $(992,741)$7,453,123 $(171)$8,444,191 
(1)Accrued interest receivable on held-to-maturity securities of $29.1 million and $30.5 million at June 30, 2025, and December 31, 2024, respectively, is excluded from amortized cost and included in Accrued interest receivable and other assets on the accompanying Condensed Consolidated Balance Sheets.
An ACL on held-to-maturity securities is recorded for certain Municipal bonds and notes to account for expected lifetime credit losses. Agency securities represent obligations issued by a U.S. government-sponsored enterprise or other federally related entity and are either explicitly or implicitly guaranteed and, therefore, assumed to be zero loss. Held-to-maturity securities with gross unrealized losses and no ACL are considered to be high credit quality and, therefore, zero credit loss has been recorded.
The following table summarizes the activity in the ACL on held-to-maturity securities:
Three months ended June 30,Six months ended June 30,
(In thousands)2025202420252024
Balance, beginning of period$109 $184 $171$209
(Benefit) for credit losses(7)(2)(69)(27)
Balance, end of period$102 $182 $102$182
Contractual Maturities
The following table summarizes the amortized cost and fair value of held-to-maturity securities by contractual maturity:
June 30, 2025
(In thousands)Amortized CostFair Value
Maturing within 1 year$2,902 $2,903 
After 1 year through 5 years160,194 154,188 
After 5 through 10 years286,121 275,974 
After 10 years7,743,605 6,858,179 
Total held-to-maturity$8,192,822 $7,291,244 
Held-to-maturity securities that are not due at a single maturity date have been categorized based on the maturity date of the underlying collateral. Actual principal cash flows may differ from this categorization as borrowers have the right to prepay their obligations with or without prepayment penalties.
Credit Quality Information
The Company monitors the credit quality of held-to-maturity securities through credit ratings provided by S&P, Moody’s, Fitch Ratings, Inc., Kroll Bond Rating Agency, or DBRS Inc. Credit ratings express opinions about the credit quality of a security and are updated at each quarter end. Investment grade securities are rated BBB- or higher by S&P, or Baa3 or higher by Moody’s, and are generally considered by the rating agencies and market participants to be of low credit risk. Conversely, securities rated below investment grade, which are labeled as speculative grade by the rating agencies, are considered to have distinctively higher credit risk than investment grade securities. At June 30, 2025, and December 31, 2024, there were no speculative grade held-to-maturity securities. Held-to-maturity securities that are not rated are collateralized with U.S. Treasury obligations.
The following tables summarize the amortized cost of held-to-maturity securities based on their lowest publicly available credit rating:
June 30, 2025
Investment Grade
(In thousands)AaaAa1Aa2Aa3A1A2A3Not Rated
Agency CMO$— $18,246 $— $— $— $— $— $— 
Agency MBS— 2,954,301 — — — — — — 
Agency CMBS— 4,315,250 — — — — — — 
Municipal bonds and notes301,307 153,720 244,918 112,768 10,444 4,165 — 12,444 
CMBS65,259 — — — — — — — 
Total held-to-maturity$366,566 $7,441,517 $244,918 $112,768 $10,444 $4,165 $— $12,444 
December 31, 2024
Investment Grade
(In thousands)AaaAa1Aa2Aa3A1A2A3Not Rated
Agency CMO$— $19,847 $— $— $— $— $— $— 
Agency MBS— 3,109,411 — — — — — — 
Agency CMBS— 4,357,505 — — — — — — 
Municipal bonds and notes341,187 158,327 230,986 128,692 13,761 — 4,165 14,791 
CMBS65,690 — — — — — — — 
Total held-to-maturity$406,877 $7,645,090 $230,986 $128,692 $13,761 $— $4,165 $14,791 
At June 30, 2025, and December 31, 2024, there were no held-to-maturity securities past due under the terms of their agreements or in non-accrual status.
Other Information
The following table summarizes the carrying value of held-to-maturity securities pledged for deposits, borrowings, and other purposes:
(In thousands)June 30, 2025December 31, 2024
Pledged for deposits$1,760,751$1,978,445
Pledged for borrowings and other6,039,1736,258,828
Total held-to-maturity securities pledged$7,799,924$8,237,273
v3.25.2
Loans and Leases
 6 Months Ended
Jun. 30, 2025
Loans and Leases Receivable Disclosure [Abstract]  
Loans and Leases Loans and Leases
The following table summarizes loans and leases by portfolio segment and class:
(In thousands)June 30,
2025		December 31, 2024
Commercial non-mortgage$18,724,821 $18,037,942 
Asset-based1,350,006 1,404,007 
Commercial real estate14,539,706 14,492,436 
Multi-family6,819,069 6,898,600 
Equipment financing1,218,276 1,235,016 
Commercial portfolio42,651,878 42,068,001 
Residential9,332,413 8,853,669 
Home equity1,385,746 1,427,692 
Other consumer301,922 155,806 
Consumer portfolio11,020,081 10,437,167 
Loans and leases$53,671,959 $52,505,168 
The carrying amount of loans and leases at June 30, 2025, and December 31, 2024, includes net unamortized
(discounts)/premiums and net unamortized deferred (fees)/costs, in aggregate, of $16.7 million and $(1.8) million, respectively. Accrued interest receivable of $268.8 million and $265.0 million at June 30, 2025, and December 31, 2024, respectively, is excluded from the carrying amount of loans and leases and included in Accrued interest receivable and other assets on the accompanying Condensed Consolidated Balance Sheets. At June 30, 2025, the Company had pledged $17.6 billion and $6.2 billion of eligible loans as collateral to support borrowing capacity at the FHLB and FRB, respectively.
Non-Accrual and Past Due Loans and Leases
The following tables summarize the aging of accrual and non-accrual loans and leases by class:
 June 30, 2025
(In thousands)30-59 Days
Past Due and
Accruing		60-89 Days
Past Due and
Accruing		90 or More Days Past Due
and Accruing		Non-accrualTotal Past Due and
Non-accrual		CurrentTotal Loans
and Leases
Commercial non-mortgage$14,902 $580 $— $216,003 $231,485 $18,493,336 $18,724,821 
Asset-based— — — 44,353 44,353 1,305,653 1,350,006 
Commercial real estate6,267 345 — 200,947 207,559 14,332,147 14,539,706 
Multi-family9,745 — — 23,009 32,754 6,786,315 6,819,069 
Equipment financing683 231 — 14,989 15,903 1,202,373 1,218,276 
Commercial portfolio31,597 1,156 — 499,301 532,054 42,119,824 42,651,878 
Residential8,884 3,769 — 16,024 28,677 9,303,736 9,332,413 
Home equity6,077 2,339 — 18,421 26,837 1,358,909 1,385,746 
Other consumer743 387 — 409 1,539 300,383 301,922 
Consumer portfolio15,704 6,495 — 34,854 57,053 10,963,028 11,020,081 
Total$47,301 $7,651 $— $534,155 $589,107 $53,082,852 $53,671,959 
 December 31, 2024
(In thousands)30-59 Days
Past Due and
Accruing		60-89 Days
Past Due and
Accruing		90 or More Days Past Due
and Accruing		Non-accrualTotal Past Due and
Non-accrual
Current (1)
Total Loans
and Leases
Commercial non-mortgage$3,949 $3,318 $— $248,078 $255,345 $17,782,597 $18,037,942 
Asset-based— 21,997 — 20,787 42,784 1,361,223 1,404,007 
Commercial real estate22,115 558 — 120,151 142,824 14,349,612 14,492,436 
Multi-family2,508 26,377 — 18,043 46,928 6,851,672 6,898,600 
Equipment financing6,096 3,300 — 19,367 28,763 1,206,253 1,235,016 
Commercial portfolio34,668 55,550 — 426,426 516,644 41,551,357 42,068,001 
Residential9,595 4,604 — 12,750 26,949 8,826,720 8,853,669 
Home equity6,273 2,381 — 21,425 30,079 1,397,613 1,427,692 
Other consumer349 162 — 124 635 155,171 155,806 
Consumer portfolio16,217 7,147 — 34,299 57,663 10,379,504 10,437,167 
Total$50,885 $62,697 $— $460,725 $574,307 $51,930,861 $52,505,168 
(1)At December 31, 2024, there were $32.7 million of commercial loans that had reached their contractual maturity but were actively in the process of being refinanced with the Company. Due to the status of the refinancing, these commercial loans have been reported as current in the table above.
The following table provides additional information on non-accrual loans and leases:
June 30, 2025December 31, 2024
(In thousands)Non-accrualNon-accrual with No AllowanceNon-accrualNon-accrual with No Allowance
Commercial non-mortgage$216,003 $42,997 $248,078 $50,943 
Asset-based44,353 18,262 20,787 1,080 
Commercial real estate200,947 37,160 120,151 26,666 
Multi-family23,009 22,877 18,043 17,953 
Equipment financing14,989 1,039 19,367 1,809 
Commercial portfolio499,301 122,335 426,426 98,451 
Residential16,024 7,223 12,750 6,923 
Home equity18,421 9,914 21,425 12,225 
Other consumer409 2 124 3 
Consumer portfolio34,854 17,139 34,299 19,151 
Total $534,155 $139,474 $460,725 $117,602 
Allowance for Credit Losses on Loans and Leases
The following table summarizes the change in the ACL on loans and leases by portfolio segment:
Three months ended June 30,
20252024
(In thousands)Commercial PortfolioConsumer PortfolioTotalCommercial PortfolioConsumer PortfolioTotal
ACL on loans and leases:
Balance, beginning of period$649,450 $63,871 $713,321 $589,109 $52,333 $641,442 
Provision (benefit)45,635 (509)45,126 65,607 (4,566)61,041 
Charge-offs(39,792)(1,446)(41,238)(33,356)(1,418)(34,774)
Recoveries3,250 1,587 4,837 360 1,286 1,646 
Balance, end of period$658,543 $63,503 $722,046 $621,720 $47,635 $669,355 
 Six months ended June 30,
20252024
(In thousands)Commercial PortfolioConsumer PortfolioTotalCommercial PortfolioConsumer PortfolioTotal
ACL on loans and leases:
Balance, beginning of period$635,871 $53,695 $689,566 $577,663 $58,074 $635,737 
Provision (benefit)113,838 10,000 123,838 114,961 (10,726)104,235 
Charge-offs(95,358)(2,498)(97,856)(71,817)(2,748)(74,565)
Recoveries4,192 2,306 6,498 913 3,035 3,948 
Balance, end of period (1)
$658,543 $63,503 $722,046 $621,720 $47,635 $669,355 
Individually evaluated for credit losses95,323 811 96,134 66,943 649 67,592 
Collectively evaluated for credit losses$563,220 $62,692 $625,912 $554,777 $46,986 $601,763 
(1)The $32.4 million increase in the ACL on loans and leases from December 31, 2024, to June 30, 2025, is primarily due to additional reserves resulting from uncertainty in the current macroeconomic environment and organic loan growth, partially offset by net charge-offs and improvements in risk rating migration.
Concentrations of Credit Risk
Concentrations of credit risk may exist when a number of borrowers are engaged in similar activities, or activities in the same geographic region, and have similar economic characteristics that would cause them to be similarly impacted by changes in economic or other conditions. Concentrations of credit risk are controlled and monitored as part of the Company’s credit policies and procedures. The Company is a regional financial services holding company in the Northeast U.S. with a commercial concentration primarily in five geographic markets: New York City, Other New York Counties, Connecticut, New Jersey, and Massachusetts; and secondarily in the Southeast and Other states. At June 30, 2025, and December 31, 2024, the Company’s concentration of credit risk associated with commercial real estate and multi-family loans, in aggregate, represented 39.8% and 40.7% of total loans and leases, respectively. At June 30, 2025, and December 31, 2024, the Company’s concentration of credit risk associated with commercial non-mortgage loans represented 34.9% and 34.4% of total loans and leases, respectively.
Credit Quality Indicators
To measure credit risk for the commercial portfolio, the Company employs a dual grade credit risk grading system for estimating the PD and LGD. The credit risk grade system assigns a rating to each borrower and to the facility, which together form a Composite Credit Risk Profile. The credit risk grade system categorizes borrowers by common financial characteristics that measure the credit strength of borrowers and facilities by common structural characteristics. The Composite Credit Risk Profile has ten grades, with each grade corresponding to a progressively greater risk of loss. Grades (1) to (6) are considered pass ratings, and grades (7) to (10) are considered criticized, as defined by the regulatory agencies. A (7) “Special Mention” rating has a potential weakness that, if left uncorrected, may result in deterioration of the repayment prospects for the asset. An (8) “Substandard” rating has a well-defined weakness that jeopardizes the full repayment of the debt. A (9) “Doubtful” rating has all of the same weaknesses as a substandard asset with the added characteristic that the weakness makes collection or liquidation in full, given current facts, conditions, and values, improbable. Assets classified as a (10) “Loss” rating are considered uncollectible and charged-off. Risk ratings, which are assigned to differentiate risk within the portfolio, are reviewed on an ongoing basis and revised to reflect changes in a borrower’s current financial position and outlook, risk profile, and the related collateral and structural position. Loan officers review updated financial information or other loan factors on at least an annual basis for all pass rated loans to assess the accuracy of the risk grade. Criticized loans undergo more frequent reviews and enhanced monitoring.
To measure credit risk for the consumer portfolio, the most relevant credit characteristic is the FICO score, which is a widely used credit scoring system that ranges from 300 to 850. A lower FICO score is indicative of higher credit risk and a higher FICO score is indicative of lower credit risk. FICO scores are updated at least quarterly. Factors such as past due status, employment status, collateral, geography, loans discharged in bankruptcy, and the status of first lien position loans on second lien position loans, are also considered to be consumer portfolio credit quality indicators. For portfolio monitoring purposes, the Company estimates the current value of property secured as collateral for home equity and residential first mortgage lending products on an ongoing basis. The estimate is based on home price indices compiled by the S&P/Case-Shiller Home Price Indices. Real estate price data is applied to the loan portfolios taking into account the age of the most recent valuation and geographic area.
The following tables summarize the amortized cost basis of commercial loans and leases by Composite Credit Risk Profile grade and origination year:
June 30, 2025
(In thousands)20252024202320222021PriorRevolving Loans Amortized Cost BasisTotal
Commercial non-mortgage:
Risk rating:
Pass$1,426,513 $2,647,354 $1,654,046 $2,464,246 $1,161,443 $1,581,608 $6,721,873 $17,657,083 
Special mention— 36,433 59,114 126,804 91 — 34,158 256,600 
Substandard44,829 46,676 156,110 207,319 90,287 92,189 173,378 810,788 
Doubtful— — — — 43 306 1 350 
Total commercial non-mortgage1,471,342 2,730,463 1,869,270 2,798,369 1,251,864 1,674,103 6,929,410 18,724,821 
Current period gross write-offs1,317 1,242 7,673 5,780 489 8,960 18,291 43,752 
Asset-based:
Risk rating:
Pass2,850 225 10,311 — — 18,246 1,078,602 1,110,234 
Special mention1,562 — — — — 4,818 40,524 46,904 
Substandard— — 2,508 — — 6 190,354 192,868 
Total asset-based4,412 225 12,819 — — 23,070 1,309,480 1,350,006 
Current period gross write-offs— — — — — — 15,975 15,975 
Commercial real estate:
Risk rating:
Pass1,260,773 1,991,259 2,114,596 2,801,954 1,277,393 3,970,260 209,486 13,625,721 
Special mention— — 32,092 148,656 — 82,073 — 262,821 
Substandard— 3,301 134,861 64,746 82,636 364,408 1,212 651,164 
Total commercial real estate1,260,773 1,994,560 2,281,549 3,015,356 1,360,029 4,416,741 210,698 14,539,706 
Current period gross write-offs— — 13,986 255 1,283 18,216 — 33,740 
Multi-family:
Risk rating:
Pass112,060 594,573 1,349,648 1,354,503 855,885 2,164,313 16,997 6,447,979 
Special mention153 — — 114,867 22,725 105,713 — 243,458 
Substandard— — 14,294 16,634 26,950 69,754 — 127,632 
Total multi-family112,213 594,573 1,363,942 1,486,004 905,560 2,339,780 16,997 6,819,069 
Current period gross write-offs— — — — — 247 — 247 
Equipment financing:
Risk rating:
Pass207,586 349,272 202,534 160,138 88,827 140,480 — 1,148,837 
Special mention— — 4,711 13,511 464 1,350 — 20,036 
Substandard3,612 831 10,959 15,718 10,716 7,567 — 49,403 
Total equipment financing211,198 350,103 218,204 189,367 100,007 149,397 — 1,218,276 
Current period gross write-offs1,568 — 67 — 9 — — 1,644 
Total commercial portfolio3,059,938 5,669,924 5,745,784 7,489,096 3,617,460 8,603,091 8,466,585 42,651,878 
Current period gross write-offs$2,885 $1,242 $21,726 $6,035 $1,781 $27,423 $34,266 $95,358 
December 31, 2024
(In thousands)20242023202220212020PriorRevolving Loans Amortized Cost BasisTotal
Commercial non-mortgage:
Risk rating:
Pass$2,917,048 $1,916,905 $2,818,720 $1,100,575 $562,252 $1,211,312 $6,325,637 $16,852,449 
Special mention31,587 66,770 156,555 51,055 30,669 4,203 44,017 384,856 
Substandard56,307 125,735 237,362 92,134 16,466 63,998 208,608 800,610 
Doubtful— — — 1 — 25 1 27 
Total commercial non-mortgage3,004,942 2,109,410 3,212,637 1,243,765 609,387 1,279,538 6,578,263 18,037,942 
Current period gross write-offs— 11,894 45,308 10,668 3,842 3,385 15,169 90,266 
Asset-based:
Risk rating:
Pass1,250 11,684 — — — 20,255 1,132,901 1,166,090 
Special mention— — — — — 5,226 90,372 95,598 
Substandard— 2,562 — — — 1,239 138,518 142,319 
Total asset-based1,250 14,246 — — — 26,720 1,361,791 1,404,007 
Current period gross write-offs— — — — — — 6,091 6,091 
Commercial real estate:
Risk rating:
Pass1,867,468 2,334,965 3,186,098 1,462,814 944,367 3,465,817 197,998 13,459,527 
Special mention— 12,809 175,252 37,307 37,469 64,483 — 327,320 
Substandard— 131,108 69,829 121,139 112,582 262,079 8,852 705,589 
Total commercial real estate1,867,468 2,478,882 3,431,179 1,621,260 1,094,418 3,792,379 206,850 14,492,436 
Current period gross write-offs— 854 1,244 1,579 15,477 22,674 — 41,828 
Multi-family:
Risk rating:
Pass582,363 1,394,855 1,314,395 862,273 245,802 2,179,207 16,991 6,595,886 
Special mention— 14,365 93,396 18,790 70,908 8,588 — 206,047 
Substandard— — 16,761 27,102 26,720 26,084 — 96,667 
Total multi-family582,363 1,409,220 1,424,552 908,165 343,430 2,213,879 16,991 6,898,600 
Current period gross write-offs— — — 4,955 6,264 11,678 — 22,897 
Equipment financing:
Risk rating:
Pass382,783 242,440 207,081 126,399 83,838 124,910 — 1,167,451 
Special mention1,298 231 — 55 — — — 1,584 
Substandard572 16,228 18,341 16,970 5,514 8,356 — 65,981 
Total equipment financing384,653 258,899 225,422 143,424 89,352 133,266 — 1,235,016 
Current period gross write-offs— 5,146 1,705 52 — 3,475 — 10,378 
Total commercial portfolio5,840,676 6,270,657 8,293,790 3,916,614 2,136,587 7,445,782 8,163,895 42,068,001 
Current period gross write-offs$— $17,894 $48,257 $17,254 $25,583 $41,212 $21,260 $171,460 
The following tables summarize the amortized cost basis of consumer loans by FICO score and origination year:
June 30, 2025
(In thousands)20252024202320222021PriorRevolving Loans Amortized Cost BasisTotal
Residential:
Risk rating:
800+$191,796 $501,827 $298,943 $919,014 $1,087,229 $1,311,324 $— $4,310,133 
740-799401,252 546,890 227,983 531,523 629,765 812,135 — 3,149,548 
670-73997,051 162,365 100,743 297,619 237,615 625,265 — 1,520,658 
580-6696,680 20,747 22,924 53,824 43,214 111,958 — 259,347 
579 and below— 915 3,393 15,653 22,914 49,852 — 92,727 
Total residential696,779 1,232,744 653,986 1,817,633 2,020,737 2,910,534 — 9,332,413 
Current period gross write-offs— — — — — 15 — 15 
Home equity:
Risk rating:
800+5,930 11,151 25,589 25,595 30,833 70,449 349,518 519,065 
740-7997,838 12,907 18,702 16,799 22,594 40,189 317,213 436,242 
670-7395,352 10,143 12,131 9,648 11,091 32,121 228,224 308,710 
580-669469 1,555 1,898 2,864 2,927 9,883 60,667 80,263 
579 and below152 215 1,457 2,319 573 4,908 31,842 41,466 
Total home equity19,741 35,971 59,777 57,225 68,018 157,550 987,464 1,385,746 
Current period gross write-offs— 50 — — — 29 161 240 
Other consumer:
Risk rating:
800+3,318 7,264 317 141 1,725 148 14,477 27,390 
740-79934,320 66,461 466 241 214 231 4,287 106,220 
670-73950,326 93,010 408 236 97 162 18,444 162,683 
580-6691,261 2,242 93 115 31 96 1,093 4,931 
579 and below2 55 77 46 28 36 454 698 
Total other consumer89,227 169,032 1,361 779 2,095 673 38,755 301,922 
Current period gross write-offs1,198 901 8 4 8 27 97 2,243 
Total consumer portfolio805,747 1,437,747 715,124 1,875,637 2,090,850 3,068,757 1,026,219 11,020,081 
Current period gross write-offs$1,198 $951 $8 $4 $8 $71 $258 $2,498 
December 31, 2024
(In thousands)20242023202220212020PriorRevolving Loans Amortized Cost BasisTotal
Residential:
Risk rating:
800+$312,771 $299,006 $909,109 $1,097,807 $433,950 $956,478 $— $4,009,121 
740-799649,118 258,699 567,545 656,599 235,749 623,989 — 2,991,699 
670-739172,886 123,354 317,373 271,247 80,318 550,252 — 1,515,430 
580-66916,643 13,382 55,507 35,292 16,738 109,240 — 246,802 
579 and below237 2,680 12,617 21,387 3,791 49,905 — 90,617 
Total residential1,151,655 697,121 1,862,151 2,082,332 770,546 2,289,864 — 8,853,669 
Current period gross write-offs— — — — — 147 — 147 
Home equity:
Risk rating:
800+12,313 25,226 23,512 32,695 22,705 53,844 365,741 536,036 
740-79912,238 21,831 20,718 23,517 10,861 33,703 330,691 453,559 
670-73911,416 14,298 12,732 13,074 6,242 28,638 224,449 310,849 
580-6691,755 2,570 1,685 2,172 754 9,471 67,745 86,152 
579 and below58 799 2,401 726 429 4,254 32,429 41,096 
Total home equity37,780 64,724 61,048 72,184 40,991 129,910 1,021,055 1,427,692 
Current period gross write-offs— — — — 2 444 351 797 
Other consumer:
Risk rating:
800+4,920 312 218 1,765 50 284 31,549 39,098 
740-79945,001 721 301 165 124 266 3,550 50,128 
670-73957,952 432 372 313 220 188 3,349 62,826 
580-6691,417 116 105 69 25 81 1,150 2,963 
579 and below29 93 63 28 9 — 569 791 
Total other consumer109,319 1,674 1,059 2,340 428 819 40,167 155,806 
Current period gross write-offs3,467 17 34 20 113 193 222 4,066 
Total consumer portfolio1,298,754 763,519 1,924,258 2,156,856 811,965 2,420,593 1,061,222 10,437,167 
Current period gross write-offs$3,467 $17 $34 $20 $115 $784 $573 $5,010 
Collateral Dependent Loans and Leases
A non-accrual loan or lease is considered collateral dependent when the borrower is experiencing financial difficulty and when repayment is substantially expected to be provided through the operation or sale of collateral. Commercial non-mortgage loans,
asset-based loans, and equipment financing loans and leases are generally secured by machinery and equipment, inventory, receivables, or other non-real estate assets, whereas commercial real estate, multi-family, residential, and home equity loans are secured by real estate.
At June 30, 2025, and December 31, 2024, the carrying amount of collateral dependent loans was $244.8 million and $139.5 million, respectively, for commercial loans and leases, and $28.3 million and $29.1 million, respectively, for consumer loans. The ACL for collateral dependent loans and leases is individually assessed based on the fair value of the collateral less costs to sell at the reporting date. At June 30, 2025, and December 31, 2024, the collateral value associated with collateral dependent loans and leases was $278.6 million and $200.1 million, respectively.
Modifications to Borrowers Experiencing Financial Difficulty
In certain circumstances, the Company enters into agreements to modify the terms of loans to borrowers experiencing financial difficulty. A variety of solutions are offered to borrowers experiencing financial difficulty, including loan modifications that may result in principal forgiveness, interest rate reductions, payment delays, term extensions, or a combination thereof. The following is a description of each of these types of modifications:
•Principal forgiveness – The outstanding principal balance of a loan may be reduced by a specified amount. Principal forgiveness may occur voluntarily as part of a negotiated agreement with a borrower, or involuntarily through a bankruptcy proceeding.
•Interest rate reductions – Includes modifications where the contractual interest rate of the loan has been reduced.
•Payment delays – Deferral arrangements that allow borrowers to delay a scheduled loan payment to a later date. Deferred loan payments do not affect the original contractual maturity terms of the loan. Modifications that result in only an insignificant payment delay are not disclosed. The Company generally considers a payment delay of three months or less to be insignificant.
•Term extensions – Extensions of the original contractual maturity date of the loan.
•Combination – Combination includes loans that have undergone more than one of the above loan modification types.
Significant judgment is required to determine if a borrower is experiencing financial difficulty. These considerations vary by portfolio class. The Company has identified modifications to borrowers experiencing financial difficulty that are included in its disclosures as follows:
•Commercial: The Company evaluates modifications of loans to commercial borrowers that are rated substandard or worse, and includes the modifications in its disclosures to the extent that the modification is considered
other-than-insignificant.
•Consumer: The Company generally evaluates all modifications of loans to consumer borrowers subject to its loss mitigation program and includes them in its disclosures to the extent that the modification is considered other-than-insignificant.
The following tables summarize the amortized cost basis at June 30, 2025, and 2024, of loans modified to borrowers experiencing financial difficulty, disaggregated by class and type of concession granted:
Three months ended June 30, 2025
Combination
(Dollars in thousands)Interest Rate ReductionTerm ExtensionPayment DelayTerm Extension & Interest Rate ReductionTerm Extension & Payment DelayInterest Rate Reduction & Payment DelayTerm Extension, Interest Rate Reduction, & Payment DelayTotal
% of Total
Class (2)
Commercial non-mortgage$—$43,425$13,161$399$51,313$—$77$108,3750.6  %
Asset-based—11,487—————11,4870.9 
Commercial real estate—18,978—————18,9780.1 
Multi-family1,9816,340———13,241—21,5620.3 
Equipment financing—3,842—————3,8420.3 
Home equity———26———26— 
Total (1)
$1,981$84,072$13,161$425$51,313$13,241$77$164,2700.3  %
Six months ended June 30, 2025
Combination
(Dollars in thousands)Interest Rate ReductionTerm ExtensionPayment DelayTerm Extension & Interest Rate ReductionTerm Extension & Payment Delay Interest Rate Reduction & Payment DelayTerm Extension, Interest Rate Reduction, & Payment DelayTotal
% of Total Class (2)
Commercial non-mortgage$—$84,290$13,161$506$51,313$—$77$149,3470.8  %
Asset-based—11,487—————11,4870.9 
Commercial real estate—39,607512————40,1190.3 
Multi-family1,9818,034———13,241—23,2560.3 
Equipment financing—4,032—————4,0320.3 
Residential———891———891— 
Home equity———66———66— 
Total (1)
$1,981$147,450$13,673$1,463$51,313$13,241$77$229,1980.4  %
Three months ended June 30, 2024
(Dollars in thousands)Term ExtensionPayment DelayCombination -
Term Extension & Interest Rate Reduction		Total
% of Total Class (2)
Commercial non-mortgage$69,182$61$189$69,4320.4  %
Asset-based6,150——6,1500.4 
Commercial real estate43,974359—44,3330.3 
Home equity45—56101— 
Total (1)
$119,351$420$245$120,0160.2  %
Six months ended June 30, 2024
(Dollars in thousands)Interest Rate ReductionTerm ExtensionPayment DelayCombination -
Term Extension & Interest Rate Reduction		Total
% of Total Class (2)
Commercial non-mortgage$11$86,150$42,825$1,267$130,2530.8  %
Asset-based—7,817——7,8170.5 
Commercial real estate—44,474359—44,8330.3 
Multi-family—9,481——9,4810.1 
Equipment financing—490——490— 
Residential626——133759— 
Home equity—45—121166— 
Total (1)
$637$148,457$43,184$1,521$193,7990.4  %
(1)The total amortized cost excludes accrued interest receivable of $0.5 million and $0.3 million for the three months ended June 30, 2025, and 2024, respectively, and $0.6 million and $0.4 million for the six months ended June 30, 2025, and 2024, respectively.
(2)Represents the total amortized cost of the loans modified as a percentage of the total period end loan balance by class.
The following tables describe the financial effect of the modifications made to borrowers experiencing financial difficulty:
Three months ended June 30, 2025
Financial Effect (1)
Interest Rate Reduction:
Multi-family
Reduced weighted average interset rate by 2.0%
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 1.4 years
Asset-based
Extended term by a weighted average of 1.0 year
Commercial real estate
Extended term by a weighted average of 0.4 years
Multi-family
Extended term by a weighted average of 3.0 years
Equipment financing
Extended term by a weighted average of 1.8 years
Payment Delay:
Commercial non-mortgage
Provided payment deferrals for a weighted average of 2.4 years
Combination - Term Extension & Payment Delay:
Commercial non-mortgage
Extended term by a weighted average of 0.3 years and provided payment deferrals for a weighted average of 0.5 years
Combination - Interest Rate Reduction & Payment Delay
Multi-family
Reduced weighted average interest rate by 2.0% and provided payment deferrals for a weighted average of 0.8 years
Six months ended June 30, 2025
Financial Effect (1)
Interest Rate Reduction:
Multi-family
Reduced weighted average interest rate by 2.0%
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 1.3 years
Asset-based
Extended term by a weighted average of 1.0 year
Commercial real estate
Extended term by a weighted average of 0.7 years
Multi-family
Extended term by a weighted average of 2.5 years
Equipment financing
Extended term by a weighted average of 1.8 years
Payment Delay:
Commercial non-mortgage
Provided payment deferrals for a weighted average of 2.4 years
Combination - Term Extension & Payment Delay:
Commercial non-mortgage
Extended term by a weighted average of 0.3 years and provided payment deferrals for a weighted average of 0.5 years
Combination - Interest Rate Reduction & Payment Delay:
Multi-family
Reduced weighted average interest rate by 2.0% and provided payment deferrals for a weighted average of 0.8 years
Three months ended June 30, 2024
Financial Effect (1)
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 0.6 years
Asset-based
Extended term by a weighted average of 0.5 years
Commercial real estate
Extended term by a weighted average of 1.1 years
Six months ended June 30, 2024
Financial Effect (1)
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 0.6 years
Asset-based
Extended term by a weighted average of 0.5 years
Commercial real estate
Extended term by a weighted average of 1.1 years
Multi-family
Extended term by a weighted average of 1.4 years
Payment Delay:
Commercial non-mortgage
Provided partial payment deferrals for a weighted average of 0.5 years
(1)Certain disclosures related to financial effects of modifications do not include those deemed to be immaterial.
The Company closely monitors the performance of the loans that are modified to borrowers experiencing financial difficulty to understand the effectiveness of its modification efforts. The following tables summarize the aging of loans that had been modified in the 12 months preceding June 30, 2025 and June 30, 2024:
June 30, 2025
(In thousands)Current30-59 Days
Past Due		60-89 Days
Past Due		90 or More
Days Past Due		Non-AccrualTotal
Commercial non-mortgage$77,346$3,819$—$—$144,026$225,191
Asset-based11,487———15,00026,487
Commercial real estate85,027———7,77192,798
Multi-family21,275———1,98123,256
Equipment financing4,032—99——4,131
Residential776———9981,774
Home equity583———215798
Total$200,526$3,819$99$—$169,991$374,435
June 30, 2024
(In thousands)Current30-59 Days
Past Due		60-89 Days
Past Due		90 or More
Days Past Due		Non-AccrualTotal
Commercial non-mortgage$53,156$1,375$—$—$120,775$175,306
Asset-based12,817————12,817
Commercial real estate38,327———23,61361,940
Multi-family————9,4819,481
Equipment financing196———581777
Residential268———626894
Home equity350———120470
Total$105,114$1,375$—$—$155,196$261,685
There were $15.0 million of asset-based loans that had been modified in the form of term extensions with borrowers experiencing financial difficulty in the 12 months preceding June 30, 2025, that had a payment default during the three and six months ended June 30, 2025.
Loans that had been modified with borrowers experiencing financial difficulty in the 12 months preceding June 30, 2024, that had a payment default during the three months ended June 30, 2024, were not significant. There were $17.8 million of commercial non-mortgage loans that had been modified in the form of term extensions with borrowers experiencing financial difficulty in the 12 months preceding June 30, 2024, that had a payment default during the six months ended June 30, 2024. These loans were re-modified again in the form of term extensions during the three months ended June 30, 2024.
For the purposes of this disclosure, a payment default is defined as 90 or more days past due. Non-accrual loans that are modified to borrowers experiencing financial difficulty remain on non-accrual status until the borrower has demonstrated performance under the modified terms. Commitments to lend additional funds to borrowers experiencing financial difficulty whose loans had been modified were not significant.
v3.25.2
Goodwill and Other Intangible Assets
 6 Months Ended
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
Goodwill
The following table summarizes changes in the carrying amount of goodwill:
(In thousands)June 30,
2025		December 31,
2024
Balance, beginning of period$2,868,068 $2,631,465 
Ametros acquisition (1)
— 236,603 
Balance, end of period$2,868,068 $2,868,068 
(1)Reflects the $228.2 million of goodwill recorded in connection with the Ametros acquisition in January 2024, and $8.4 million of other adjustments. The allocation of the purchase price and goodwill calculation for the Ametros acquisition was considered final as of December 31, 2024.
Information regarding goodwill by reportable segment can be found within Note 15: Segment Reporting.
Other Intangible Assets
The following table summarizes other intangible assets:
 June 30, 2025December 31, 2024
(In thousands)Gross Carrying
Amount		Accumulated
Amortization		Net Carrying
Amount		Gross Carrying
Amount		Accumulated
Amortization		Net Carrying
Amount
Core deposits$328,837 $87,585 $241,252 $328,837 $76,795 $252,042 
Customer relationships122,063 53,716 68,347 122,063 47,186 74,877 
Non-competition agreement 4,000 2,000 2,000 4,000 1,600 2,400 
Trade name6,100 1,728 4,372 6,100 1,118 4,982 
Total other intangible assets$461,000 $145,029 $315,971 $461,000 $126,699 $334,301 
The remaining estimated aggregate future amortization expense for other intangible assets is as follows:
(In thousands)June 30,
2025
Remainder of 2025$17,721 
202634,083 
202733,033 
202830,162 
202928,289 
Thereafter172,683 
v3.25.2
Deposits
 6 Months Ended
Jun. 30, 2025
Deposit Liabilities [Abstract]  
Deposits Deposits
The following table summarizes deposits by type:
(In thousands)June 30,
2025		December 31,
2024
Non-interest-bearing:
Demand$10,345,761 $10,316,501 
Interest-bearing:
Checking9,933,392 9,834,790 
Health savings accounts9,064,935 8,951,031 
Money market21,679,493 20,433,250 
Savings7,370,959 6,982,554 
Time deposits7,919,885 8,234,954 
Total interest-bearing$55,968,664 $54,436,579 
Total deposits$66,314,425 $64,753,080 
Time deposits, money market, and interest-bearing checking obtained through brokers (1)
$2,624,835 $3,181,298 
Aggregate amount of time deposit accounts that exceeded the FDIC limit (2)
1,465,572 1,407,077 
Deposit overdrafts reclassified as loan balances5,064 7,146 
(1)Excludes money market deposits received through interSYNC of $8.7 billion at June 30, 2025, and $7.3 billion at December 31, 2024.
(2)Excludes an aggregate amount of time deposit accounts that were at the FDIC limit of $19.3 million at June 30, 2025, and $16.8 million at December 31, 2024.
The following table summarizes the scheduled maturities of time deposits:
(In thousands)June 30,
2025
Remainder of 2025$5,946,812 
20261,876,195 
202738,286 
202820,127 
202917,969 
Thereafter20,496 
Total time deposits$7,919,885 
v3.25.2
Borrowings
 6 Months Ended
Jun. 30, 2025
Debt Disclosure [Abstract]  
Borrowings Borrowings
Securities Sold Under Agreements to Repurchase and Federal Funds Purchased
The following table summarizes securities sold under agreements to repurchase and federal funds purchased:
June 30, 2025December 31, 2024
(Dollars in thousands)Total OutstandingRateTotal OutstandingRate
Securities sold under agreements to repurchase (1)
$372,806 3.66 %$344,168 2.98 %
Securities sold under agreements to repurchase and federal funds purchased (2)
$372,806 3.66 %$344,168 2.98 %
(1)Securities sold under agreements to repurchase have an original maturity date of one year or less for the periods presented.
(2)There were no outstanding federal funds purchased at June 30, 2025, and December 31, 2024.
The Company’s repurchase agreement counterparties are limited to primary dealers in government securities and commercial and municipal customers through the Corporate Treasury function. The Company has the right of offset with respect to repurchase agreement assets and liabilities with the same counterparty when master netting agreements are in place. Securities sold under agreements to repurchase are presented as gross transactions at June 30, 2025, and December 31, 2024, since only liabilities are outstanding. Agency MBS securities, which had an aggregate market value of $389.4 million and $358.4 million at June 30, 2025, and December 31, 2024, respectively, are pledged to secure repurchase agreements. These Agency MBS securities are subject to changes in market value and, therefore, the Company may increase or decrease the level of securities pledged as collateral based upon movements in market value.
The following tables represent the offsetting of repurchase agreements that are subject to master netting agreements:
June 30, 2025
Gross Amounts of Recognized LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)
Financial Instruments (1)
Cash Collateral PledgedNet Amount
Repurchase agreements$302,306 $— $302,306 $302,306 $— $— 
December 31, 2024
Gross Amounts of Recognized LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)
Financial Instruments (1)
Cash Collateral PledgedNet Amount
Repurchase agreements$209,961 $— $209,961 $209,961 $— $— 
(1)Amounts disclosed are limited to the balance of securities sold under agreements to repurchase reported on the accompanying Condensed Consolidated Balance Sheets that are subject to master netting agreements and, accordingly, exclude excess collateral pledged. At June 30, 2025, and December 31, 2024, Agency MBS with a carrying amount of $315.1 million and $220.6 million, respectively, were pledged as collateral against such securities sold under agreements to repurchase, resulting in excess collateral positions of $12.8 million and $10.6 million, respectively.
FHLB Advances
The following table summarizes information for FHLB advances:
June 30, 2025December 31, 2024
(Dollars in thousands)Total OutstandingWeighted-
Average Contractual Coupon Rate		Total OutstandingWeighted-
Average Contractual Coupon Rate
Maturing within 1 year$3,330,000 4.49 %$2,100,000 4.50 %
After 1 but within 2 years— — — — 
After 2 but within 3 years417 1.37 218 — 
After 3 but within 4 years— — 215 2.75 
After 4 but within 5 years629 1.75 642 1.75 
After 5 years8,868 2.02 9,033 2.02 
Total FHLB advances$3,339,914 4.48 %$2,110,108 4.49 %
Aggregate market value of assets pledged as collateral$16,530,103 $16,581,133 
Remaining borrowing capacity at FHLB7,557,549 8,670,348 
The Bank may borrow up to a discounted amount of eligible loans and securities that have been pledged as collateral to secure FHLB advances, which includes certain residential, multi-family, and commercial real estate loans, home equity lines of credit, Agency MBS, and Agency CMO. The Bank was in compliance with its FHLB collateral requirements at June 30, 2025, and December 31, 2024.
Long-term Debt
The following table summarizes long-term debt:
(Dollars in thousands)June 30,
2025		December 31,
2024
4.100%
Senior fixed-rate notes due March 25, 2029 (1)
$320,074 $322,751 
Subordinated floating-rate notes due December 30, 2029 (2)
274,000 274,000 
3.875%Subordinated fixed-to-floating rate notes due November 1, 2030225,000 225,000 
Junior subordinated debt Webster Statutory Trust I floating-rate notes due September 17, 2033 (3)
77,320 77,320 
Total senior and subordinated debt896,394 899,071 
Discount on senior fixed-rate notes(373)(423)
Debt issuance cost on senior fixed-rate notes(1,003)(1,137)
Premium on subordinated fixed-to-floating rate notes10,616 11,674 
Long-term debt (4)
$905,634 $909,185 
(1)The Company de-designated its fair value hedging relationship on these senior fixed-rate notes in 2020. A basis adjustment of $20.1 million and $22.8 million at June 30, 2025, and December 31, 2024, respectively, is included in the carrying value and is being amortized over the remaining life of the senior fixed-rate notes.
(2)The interest rate on the 2029 subordinated floating-rate notes varies quarterly based on 3-month term SOFR plus 253 basis points, which yielded 6.82% at June 30, 2025, and 6.84% at December 31, 2024.
(3)The interest rate on the Webster Statutory Trust I floating-rate notes varies quarterly based on 3-month SOFR plus a credit spread adjustment plus a market spread of 2.95%, which yielded 7.52% at June 30, 2025, and 7.56% at December 31, 2024.
(4)The classification of debt as long-term is based on the initial term of greater than one year as of the date of issuance.
Additional information regarding the Company’s long-term debt can be found within Note 11: Borrowings in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
v3.25.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
The following table summarizes the changes in shares of preferred and common stock issued and common stock held as treasury shares:
Preferred Stock Series F IssuedPreferred Stock Series G IssuedCommon Stock IssuedTreasury Stock HeldCommon Stock Outstanding
Balance at March 31, 2025
6,000 135,000 182,778,045 14,183,769 168,594,276 
Stock compensation plan activity (1)
— — — (9,501)9,501 
Common stock repurchase program— — — 1,520,514 (1,520,514)
Balance at June 30, 2025
6,000 135,000 182,778,045 15,694,782 167,083,263 
Balance at March 31, 2024
6,000 135,000 182,778,045 10,314,159 172,463,886 
Stock compensation plan activity (1)
— — — 87,634 (87,634)
Common stock repurchase program— — — 974,365 (974,365)
Balance at June 30, 2024
6,000 135,000 182,778,045 11,376,158 171,401,887 
Preferred Stock Series F IssuedPreferred Stock Series G IssuedCommon Stock IssuedTreasury Stock HeldCommon Stock Outstanding
Balance at December 31, 2024
6,000 135,000 182,778,045 11,386,920 171,391,125 
Stock compensation plan activity (1)
— — — (782,106)782,106 
Common stock repurchase program— — — 5,089,968 (5,089,968)
Balance at June 30, 2025
6,000 135,000 182,778,045 15,694,782 167,083,263 
Balance at December 31, 2023
6,000 135,000 182,778,045 10,756,089 172,021,956 
Stock compensation plan activity (1)
— — — (788,357)788,357 
Common stock repurchase program— — — 1,408,426 (1,408,426)
Balance at June 30, 2024
6,000 135,000 182,778,045 11,376,158 171,401,887 
(1)Reflects (i) common shares issued from Treasury stock for time-based restricted stock award grants, net of forfeitures, and the vesting of performance-based restricted stock awards of 17,602 and (19,350), in aggregate, during the three months ended June 30 2025, and 2024, respectively, and 1,174,880 and 1,137,889, in aggregate, during the six months ended June 30, 2025, and 2024, respectively; less (ii) common shares acquired outside of the Company’s common stock repurchase program related to stock compensation plan activity of 8,101 and 68,284 during the three months ended June 30, 2025, and 2024, respectively, and 392,774 and 349,532 during the six months ended June 30, 2025, and 2024, respectively.
Common Stock Repurchase Program
The Company maintains a common stock repurchase program, which was approved by the Board of Directors on
October 24, 2017, that permits management to repurchase shares of Webster common stock in open market or private transactions, through block trades, and pursuant to any trading plan that may be adopted in accordance with Rule 10b5-1 of the SEC, subject to the availability and trading price of stock, general market conditions, alternative uses for capital, regulatory considerations, and the Company’s financial performance. On April 30, 2025, the Board of Directors increased the Company’s authority to repurchase shares of Webster common stock under the repurchase program by $700.0 million. During the three and six months ended June 30, 2025, the Company repurchased 1,520,514 and 5,089,968 shares, respectively, under the repurchase program at a weighted-average price of $51.70 and $51.00 per share, respectively, totaling $78.6 million and $259.6 million, respectively. At June 30, 2025, the Company’s remaining repurchase authority was $668.4 million.
Preferred Stock
Information regarding the Company’s preferred stock can be found within Note 12: Stockholders’ Equity in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
v3.25.2
Accumulated Other Comprehensive (Loss), Net of Tax
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Accumulated Other Comprehensive (Loss), Net of Tax Accumulated Other Comprehensive (Loss), Net of Tax
The following tables summarize the change in each component of accumulated other comprehensive (loss), net of the related tax impact:
Three months ended June 30, 2025Six months ended June 30, 2025
(In thousands)Investment Securities Available-
for-Sale		Derivative
Financial Instruments		Defined Benefit Pension and Other Postretirement Benefit PlansTotalInvestment Securities Available-for-SaleDerivative Financial InstrumentsDefined Benefit Pension and Other Postretirement Benefit PlansTotal
Balance, beginning of period$(423,737)$524 $(26,188)$(449,401)$(520,318)$(9,600)$(26,465)$(556,383)
Other comprehensive income before reclassifications8,858 44 — 8,902 105,824 7,796 — 113,620 
Amounts reclassified from accumulated other comprehensive (loss) income— 1,960 277 2,237 (385)4,332 554 4,501 
Other comprehensive income, net of tax8,858 2,004 277 11,139 105,439 12,128 554 118,121 
Balance, end of period$(414,879)$2,528 $(25,911)$(438,262)$(414,879)$2,528 $(25,911)$(438,262)
Three months ended June 30, 2024Six months ended June 30, 2024
(In thousands)Investment Securities Available-
for-Sale		Derivative
Financial Instruments		Defined Benefit Pension and Other Postretirement Benefit PlansTotalInvestment Securities Available-for-SaleDerivative Financial InstrumentsDefined Benefit Pension and Other Postretirement Benefit PlansTotal
Balance, beginning of period$(553,721)$(32,858)$(29,522)$(616,101)$(517,450)$(2,869)$(30,252)$(550,571)
Other comprehensive (loss) before reclassifications(43,970)(10,243)(858)(55,071)(86,560)(48,181)(607)(135,348)
Amounts reclassified from accumulated other comprehensive (loss)34,161 8,633 479 43,273 40,480 16,582 958 58,020 
Other comprehensive (loss) income, net of tax(9,809)(1,610)(379)(11,798)(46,080)(31,599)351 (77,328)
Balance, end of period$(563,530)$(34,468)$(29,901)$(627,899)$(563,530)$(34,468)$(29,901)$(627,899)
The following table further summarizes the amounts reclassified from accumulated other comprehensive (loss):
Accumulated Other Comprehensive
(Loss) Components		Three months endedSix months endedAssociated Line Item on the Condensed Consolidated Statements of Income
June 30,June 30,
2025202420252024
(In thousands)
Investment securities available-for-sale:
Net unrealized gains (losses) (1)
$— $(46,496)$528 $(55,183)
Non-interest income (2)
Tax benefit— 12,335 (143)14,703 Income tax expense
Net of tax$— $(34,161)$385 $(40,480)
Derivative financial instruments:
Interest payments (3)
$(2,689)$(11,630)$(5,944)$(22,122)Interest and fees on loans and leases
Hedge terminations— — — (34)Long-term debt interest expense
Premium amortization— (217)— (489)Interest and fees on loans and leases
Tax benefit729 3,214 1,612 6,063 Income tax expense
Net of tax$(1,960)$(8,633)$(4,332)$(16,582)
Defined benefit pension and other postretirement benefit plans:
Actuarial net loss amortization$(380)$(658)$(760)$(1,315)Other expense
Tax benefit103 179 206 357 Income tax expense
Net of tax$(277)$(479)$(554)$(958)
(1)Reclassification adjustments for net unrealized gains (losses) on investment securities available-for-sale that were sold during the reporting period are determined by reference to the unrealized gain or loss reported in the previous reporting period.
(2)Gains and losses realized on sale of investment securities available-for-sale are generally included as a component of non-interest income on the accompanying Condensed Consolidated Statements of Income unless any portion or all of the loss is due to credit related factors, in which the amount is then included in the Provision for credit losses. Additional information regarding the presentation of gains and losses realized on sale of investment securities available-for-sale for the three and six months ended June 30, 2025, and 2024, respectively, can be found within Note 3: Investment Securities.
(3)Over the next 12 months, an estimated $0.3 million related to cash flow hedge gain or loss will be reclassified from AOCL, decreasing Interest and fees on loans and leases as hedge interest payments are made.
v3.25.2
Regulatory Capital and Restrictions
 6 Months Ended
Jun. 30, 2025
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]  
Regulatory Capital and Restrictions Regulatory Capital and Restrictions
Regulatory Capital Requirements
The Company and the Bank are subject to various regulatory capital requirements administered by the federal banking agencies. Failure to meet minimum capital requirements can initiate certain mandatory actions by regulators that could have a direct material effect on the Company’s financial statements. Under capital adequacy guidelines and/or the regulatory framework for prompt corrective action (applies to the Bank only), both the Company and the Bank must meet specific capital guidelines that involve quantitative measures of assets, liabilities, and certain off-balance sheet items calculated pursuant to regulatory directives. Capital amounts and classification are also subject to qualitative judgments by the regulators about components, risk weightings, and other factors.
Quantitative measures established by Basel III to ensure capital adequacy require the Company and the Bank to maintain minimum ratios of CET1 Risk-Based Capital, Tier 1 Risk-Based Capital, Total Risk-Based Capital, and Tier 1 Leverage Capital, as defined in the regulations. CET1 capital consists of common stockholders’ equity, less deductions for goodwill and other intangible assets, and certain deferred tax adjustments. At the time of initial adoption of the Basel III Capital Rules, the Company had elected to opt-out of the requirement to include certain components of AOCI in CET1 capital. Tier 1 capital consists of CET1 capital plus preferred stock. Total capital consists of Tier 1 capital and Tier 2 capital, as defined in the regulations. Tier 2 capital includes qualifying subordinated debt and the permissible portion of the ACL.
At June 30, 2025, and December 31, 2024, both the Company and the Bank were classified as “well-capitalized.”
The following tables provides information on the capital ratios for the Company and the Bank:
June 30, 2025
 ActualMinimum RequirementWell Capitalized
(Dollars in thousands)AmountRatioAmountRatioAmountRatio
Webster Financial Corporation
CET1 Risk-Based Capital$6,406,260 11.35 %$2,539,270 4.5 %$3,667,835 6.5 %
Tier 1 Risk-Based Capital6,690,239 11.86 3,385,694 6.0 4,514,258 8.0 
Total Risk-Based Capital7,927,728 14.05 4,514,258 8.0 5,642,823 10.0 
Tier 1 Leverage Capital 6,690,239 8.57 3,121,275 4.0 3,901,593 5.0 
Webster Bank
CET1 Risk-Based Capital$7,076,737 12.55 %$2,538,304 4.5 %$3,666,439 6.5 %
Tier 1 Risk-Based Capital7,076,737 12.55 3,384,405 6.0 4,512,540 8.0 
Total Risk-Based Capital7,782,131 13.80 4,512,540 8.0 5,640,675 10.0 
Tier 1 Leverage Capital 7,076,737 9.08 3,118,568 4.0 3,898,210 5.0 
December 31, 2024
 
Actual (1)
Minimum RequirementWell Capitalized
(Dollars in thousands)AmountRatioAmountRatioAmountRatio
Webster Financial Corporation
CET1 Risk-Based Capital$6,318,876 11.54 %$2,464,542 4.5 %$3,559,895 6.5 %
Tier 1 Risk-Based Capital6,602,855 12.06 3,286,057 6.0 4,381,409 8.0 
Total Risk-Based Capital7,800,717 14.24 4,381,409 8.0 5,476,761 10.0 
Tier 1 Leverage Capital 6,602,855 8.70 3,034,369 4.0 3,792,961 5.0 
Webster Bank
CET1 Risk-Based Capital$6,847,474 12.53 %$2,460,031 4.5 %$3,553,378 6.5 %
Tier 1 Risk-Based Capital6,847,474 12.53 3,280,042 6.0 4,373,389 8.0 
Total Risk-Based Capital7,512,143 13.74 4,373,389 8.0 5,466,736 10.0 
Tier 1 Leverage Capital 6,847,474 9.04 3,031,190 4.0 3,788,988 5.0 
(1)In accordance with regulatory capital rules, the Company elected to delay the estimated impact of the adoption of CECL on its regulatory capital over a two-year deferral period, which ended on January 1, 2022, and a subsequent three-year transition period, which ended on December 31, 2024. During the three-year transition period, regulatory capital ratios phased out the aggregate amount of the regulatory capital benefit provided from the delayed CECL adoption in the initial two years. For 2024, the Company was allowed 25% of the regulatory capital benefit as of December 31, 2021. Full absorption occurred in 2025.
Dividend Restrictions
The Holding Company is dependent upon dividends from the Bank to provide funds for the payment of dividends to stockholders and for other cash requirements. Dividends paid by the Bank are subject to various federal and state regulatory limitations. Express approval by the OCC is required if the effect of dividends declared would cause the regulatory capital of the Bank to fall below specified minimum levels or if the amount would exceed net income for that year combined with undistributed net income for the preceding two years. The Bank paid the Holding Company dividends of $200.0 million and $300.0 million for the three and six months ended June 30, 2025, respectively, and $125.0 million and $300.0 million for the three and six months ended June 30, 2024, respectively, for which no express approval from the OCC was required.
Cash Restrictions
The Bank is required under Federal Reserve regulations to maintain cash reserve balances in the form of vault cash or deposits held at a FRB to ensure that it is able to meet customer demands. The reserve requirement ratio is subject to adjustment as economic conditions warrant. On March 26, 2020, the Federal Reserve reduced the reserve requirement ratios on all net transaction accounts to zero percent. As a result, the Bank has not been required to hold cash reserve balances since that date.
v3.25.2
Variable Interest Entities
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Variable Interest Entities Variable Interest Entities
The Company has an investment interest in the following entities that each meet the definition of a VIE. Information regarding the consolidation of VIEs can be found within Note 1: Summary of Significant Accounting Policies in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Consolidated
Rabbi Trusts. The Company established a Rabbi Trust to meet its obligations due under the Webster Bank Deferred Compensation Plan for Directors and Officers. The funding of the Rabbi Trust and the discontinuation of the Webster Bank Deferred Compensation Plan for Directors and Officers occurred during 2012. In connection with its merger with Sterling Bancorp in 2022, the Company acquired assets held in a separate Rabbi Trust that was previously established to fund obligations due under the Greater New York Savings Bank Directors’ Retirement Plan. The Company is considered the primary beneficiary of these Rabbi Trusts as it has the power to direct the activities that most significantly impact their economic performance and it has the obligation to absorb losses and/or the right to receive benefits that could potentially be significant.
The Rabbi Trusts’ assets are included in Accrued interest receivable and other assets on the accompanying Condensed Consolidated Balance Sheets. Investment earnings and any changes in fair value are included in Other income on the accompanying Condensed Consolidated Statements of Income. Additional information regarding the Rabbi Trusts’ investments can be found within Note 14: Fair Value Measurements.
Non-Consolidated
Low-Income Housing Tax Credit Investments. The Company makes non-marketable equity investments in entities that sponsor affordable housing and other community development projects that qualify for the LIHTC Program pursuant to Section 42 of the Internal Revenue Code. The purpose of these investments is not only to assist the Bank in meeting its responsibilities under the CRA, but also to provide a return, primarily through the realization of tax benefits. While the Company’s investment in an entity may exceed 50% of its outstanding equity interests, the entity is not consolidated as the Company is not the primary beneficiary. The Company has determined that it is not the primary beneficiary due to its inability to direct the activities that most significantly impact economic performance. The Company applies the proportional amortization method to subsequently measure its investments in qualified affordable housing projects.
The following table summarizes the Company’s LIHTC investments and related unfunded commitments:
(In thousands)June 30, 2025December 31, 2024
Gross investment in LIHTC investments$1,538,516 $1,439,461 
Accumulated amortization(288,773)(222,101)
Net investment in LIHTC investments$1,249,743 $1,217,360 
Unfunded commitments for LIHTC investments$700,153 $720,890 
The aggregate carrying value of the Company’s LIHTC investments and the related unfunded commitments are included in Accrued interest receivable and other assets and Accrued expenses and other liabilities, respectively, on the accompanying Condensed Consolidated Balance Sheets. The Company’s maximum exposure to loss related to its LIHTC investments is generally the aggregate carrying value as of each reporting date. However, income tax credits recognized related to these investments are subject to recapture by taxing authorities for up to a period of 15 years based on compliance provisions that are required to be met at the project level. During the six months ended June 30, 2025, and 2024, there were $99.1 million and $212.0 million of commitments approved to fund LIHTC investments, respectively.
The following table summarizes the amount of income tax credits and other income tax benefits, and investment amortization generated from the Company’s LIHTC investments, which are recognized as a component of income tax expense on the accompanying Condensed Consolidated Statements of Income:
Three months ended June 30,Six months ended June 30,
(In thousands)2025202420252024
Income tax credits and other income tax benefits from LIHTC investments$(40,093)$(27,182)$(81,799)$(55,206)
Investment amortization from LIHTC investments34,611 21,836 66,672 42,249 
Income tax credits and other income tax benefits, and investment amortization generated from the Company’s LIHTC investments, are included as a component of operating activities on the accompanying Condensed Consolidated Statements of Cash Flows.
Webster Statutory Trust I. The Company owns all the outstanding common stock of Webster Statutory Trust I, a financial vehicle that has issued, and in the future may issue, trust preferred securities. The Company is not the primary beneficiary of Webster Statutory Trust I. The only assets of Webster Statutory Trust I are junior subordinated debentures that are issued by the Company, which were acquired using the proceeds from the issuance of trust preferred securities and common stock. The junior subordinated debentures are included in Long-term debt on the accompanying Condensed Consolidated Balance Sheets, and the related interest expense is included in Long-term debt on the accompanying Condensed Consolidated Statements of Income. Additional information regarding these junior subordinated debentures can be found within Note 11: Borrowings in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
Multi-family Securitization Trusts. The Company completed a multi-family securitization in the third quarter of 2024. Additional information regarding this multi-family securitization can be found within Note 5: Transfers and Servicing of Financial Assets in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Form 10-K for the year ended December 31, 2024. The Company has determined that it is not the primary beneficiary of the multi-family securitization trusts since it does not have the power to direct the activities that would have the most significant impact on their economic performance. The Company’s maximum exposure related to the multi-family securitization trusts is $36.4 million, which represents its obligation to Freddie Mac to guarantee losses up to 12% of the aggregate UPB of the loans at the time of sale. The obligation is secured in full by an irrevocable letter of credit issued by the FHLB.
Joint Venture with Marathon Asset Management. The Company, through its subsidiary MW Advisor Holding, LLC, owns a 50 percent interest in both MW Advisor, LLC and Marathon Direct Lending SLP, LLC. The Company (i) will receive a management fee for investment advisory and other related services performed by MW Advisor, LLC on behalf of a certain investment fund formed in connection with the joint venture (the “Fund”), and (ii) may be entitled to receive certain special limited partner carried interest distributions through its interest in Marathon Direct Lending SLP, LLC, as the designated special limited partner of the Fund. The Company has determined that it is not the primary beneficiary of either MW Advisor, LLC, Marathon Direct Lending SLP, LLC, or the Fund since it does not have the power to make decisions or control the activities that would most significantly affect their economic performance.
Other Non-Marketable Investments. The Company invests in alternative investments comprising interests in non-public entities that cannot be redeemed since the investment is distributed as the underlying equity is liquidated. The ultimate timing and amount of these distributions cannot be predicted with reasonable certainty. For each of these alternative investments that is classified as a VIE, the Company has determined that it is not the primary beneficiary due to its inability to direct the activities that most significantly impact economic performance. The aggregate carrying value of the Company’s other non-marketable investments was $237.2 million and $216.5 million at June 30, 2025, and December 31, 2024, respectively, which is included in Accrued interest receivable and other assets on the accompanying Condensed Consolidated Balance Sheets, and its maximum exposure to loss, including unfunded commitments, was $352.7 million and $332.8 million, respectively. Additional information regarding other non-marketable investments can be found within Note 14: Fair Value Measurements.
v3.25.2
Earnings Per Common Share
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Earnings Per Common Share Earnings Per Common Share
The following table summarizes the calculation of basic and diluted earnings per common share:
 Three months ended June 30,Six months ended June 30,
(In thousands, except per share data)2025202420252024
Net income$258,848 $181,633 $485,765 $397,956 
Less: Preferred stock dividends4,162 4,162 8,325 8,325 
  Income allocated to participating securities2,991 1,977 5,361 4,090 
Net income applicable to common stockholders$251,695 $175,494 $472,079 $385,541 
Weighted-average common shares outstanding - basic165,884 169,675 167,524 170,061 
Add: Effect of dilutive stock options and restricted stock247 262 329 290 
Weighted-average common shares - diluted166,131 169,937 167,853 170,351 
Earnings per common share - basic$1.52 $1.03 $2.82 $2.27 
Earnings per common share - diluted1.52 1.03 2.81 2.26 
Earnings per common share is calculated under the two-class method in which all earnings, distributed and undistributed, are allocated to common stock and participating securities based on their respective rights to receive dividends. The Company may provide for the grant of stock options, restricted stock, performance-based restricted stock, and stock units to eligible employees and directors under its stock incentive plan. Holders of restricted stock are entitled to receive non-forfeitable dividends during the vesting period on a basis equivalent to the dividends paid to holders of common stock. These unvested awards meet the definition of participating securities.
Potential common shares from performance-based restricted stock that were not included in the computation of diluted earnings per common share because they were anti-dilutive under the treasury stock method were 147,168 and zero for the three and six months ended June 30, 2025, and respectively, and 80,115 and zero for the three and six months ended June 30, 2024, respectively. Additional information regarding stock awards under the Company’s stock incentive plan can be found within Note 20: Share-Based Plans in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
v3.25.2
Derivative Financial Instruments
 6 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Derivative Positions and Offsetting
Derivatives Designated in Hedge Relationships. Interest rate swaps allow the Company to change the fixed or variable nature of an interest rate without the exchange of the underlying notional amount. Certain pay fixed/receive variable interest rate swaps are designated as cash flow hedges to effectively convert variable-rate debt into fixed-rate debt, whereas certain receive fixed/pay variable interest rate swaps are designated as fair value hedges to effectively convert fixed-rate debt into variable-rate debt. Certain purchased options are also designated as cash flow hedges, allowing the Company to limit the potential adverse impact of variable interest rates by establishing a cap rate or floor rate in exchange for an upfront premium. The purchased options designated as cash flow hedges represent interest rate caps where payment is received from the counterparty if interest rates rise above the cap rate, and interest rate floors where payment is received from the counterparty when interest rates fall below the floor rate. The maximum length of time over which forecasted transactions are hedged is 2.4 years.
Derivatives Not Designated in Hedge Relationships. The Company also enters into derivative transactions that are not designated in hedge relationships. The Company has a back-to-back swap program, whereby it enters into an interest rate swap with a qualified customer and simultaneously enters into an equal and opposite interest-rate swap with a swap counterparty, to hedge interest rate risk. Derivative assets and derivative liabilities with the same counterparty are presented on a net basis when master netting agreements are in place.
The following tables present the notional amounts and fair values, including accrued interest, of derivative positions:
June 30, 2025
Asset DerivativesLiability Derivatives
(In thousands)Notional AmountsFair ValueNotional AmountsFair Value
Designated in hedge relationships:
Interest rate derivatives (1)
$3,500,000 $5,666 $1,750,000 $1,475 
Not designated in hedge relationships:
Interest rate derivatives (1)
8,495,135 241,293 9,406,550 240,723 
Mortgage banking derivatives 364 3 — — 
Other (2)
279,668 593 788,112 1,589 
Total not designated as hedging instruments8,775,167 241,889 10,194,662 242,312 
Gross derivative instruments, before netting$12,275,167 247,555 $11,944,662 243,787 
Less: Master netting agreements59,898 59,898 
Cash collateral pledged114,607 15,860 
Total derivative instruments, after netting$73,050 $168,029 
December 31, 2024
Asset DerivativesLiability Derivatives
(In thousands)Notional AmountsFair ValueNotional AmountsFair Value
Designated in hedge relationships:
Interest rate derivatives (1)
$750,000 $719 $4,250,000 $13,169 
Not designated in hedge relationships:
Interest rate derivatives (1)
8,693,493 300,120 8,728,767 298,296 
Mortgage banking derivatives 584 3 — — 
Other (2)
337,370 1,300 833,449 96 
Total not designated as hedging instruments9,031,447 301,423 9,562,216 298,392 
Gross derivative instruments, before netting$9,781,447 302,142 $13,812,216 311,561 
Less: Master netting agreements31,881 31,881 
Cash collateral pledged251,212 80 
Total derivative instruments, after netting$19,049 $279,600 
(1)The notional amount of interest rate swaps that were centrally-cleared through clearing housings was $68.1 million at June 30, 2025, and $71.1 million at December 31, 2024, for asset derivatives, and $4.2 million at June 30, 2025 and zero at December 31, 2024, for liability derivatives. Interest rate swaps that are centrally-cleared through clearing houses are “settled-to-market” and considered a single unit of account. In accordance with their rule books, clearing houses record the variation margin transferred for settled-to-market derivatives as a legal settlement of the derivative contract (i.e., the variation margin legally settles the outstanding exposure, but does not result in any other change or reset of the contractual terms of the derivative). The fair values of the Company’s settled-to-market interest rate swaps are presented net on the accompanying Condensed Consolidated Balance Sheets and approximated zero.
(2)Other derivatives not designated in hedge relationships include foreign currency forward contracts related to lending arrangements, a Visa equity swap transaction, and risk participation agreements. Notional amounts of risk participation agreements were $265.4 million at June 30, 2025, and $294.5 million at December 31, 2024, for asset derivatives, and $712.6 million at June 30, 2025, and $796.6 million at December 31, 2024, for liability derivatives, all of which had immaterial related fair values.
The following tables represent the off-setting derivative financial instruments that are subject to master netting agreements:
June 30, 2025
Gross Amounts of Recognized Assets/LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Assets/Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)Financial InstrumentsCash Collateral PledgedNet Amount
Asset derivatives$174,505 $59,898 $114,607 $— $114,607 $— 
Liability derivatives76,369 59,898 16,471 — 15,860 611 
December 31, 2024
Gross Amounts of Recognized Assets/LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Assets/Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)Financial InstrumentsCash Collateral PledgedNet Amount
Asset derivatives$283,185 $31,881 $251,304 $— $251,212 $92 
Liability derivatives32,218 31,881 337 — 80 257 
Derivative Activity
The following table summarizes the income statement effect of derivatives designated in hedge relationships:
Recognized inThree months ended June 30,Six months ended June 30,
(In thousands)Net Interest Income2025202420252024
Fair value hedges:
Interest rate derivativesDeposits interest expense$— $— $— $(1,320)
Net recognized on fair value hedges (1)
$— $— $— $1,320 
Cash flow hedges:
Interest rate derivativesLong-term debt interest expense$— $— $— $34 
Interest rate derivativesInterest and fees on loans and leases(2,689)(11,847)(5,944)(22,611)
Net recognized on cash flow hedges (2)
$(2,689)$(11,847)$(5,944)$(22,645)
(1)The Company de-designated its fair value hedging relationship on $400.0 million of deposits, which pertained to a portion of Ametros’ member deposits, in 2023. The $1.3 million basis adjustment included in the carrying amount of deposits at December 31, 2023, was recognized in interest expense in January 2024 upon the acquisition of Ametros.
(2)Additional information regarding the amounts recognized in net income related to cash flow hedge activities can be found within
Note 9: Accumulated Other Comprehensive (Loss), Net of Tax.
The following table summarizes the income statement effect of derivatives not designated in hedge relationships:
Recognized inThree months ended June 30,Six months ended June 30,
(In thousands)Non-interest Income2025202420252024
Interest rate derivativesOther income$896 $(1,734)$(1,928)$(444)
Mortgage banking derivativesOther income(14)(8)(1)(30)
OtherOther income(4,020)659 (5,007)1,936 
Total not designated as hedging instruments$(3,138)$(1,083)$(6,936)$1,462 
Derivative Exposure. At June 30, 2025, the Company had $121.6 million of cash collateral received and $16.4 million of cash collateral posted included in Cash and due from banks on the accompanying Condensed Consolidated Balance Sheets. In addition, the Company had $2.2 million in initial margin posted at clearing houses. The Company regularly evaluates the credit risk of its derivative customers, taking into account the likelihood of default, net exposures, and remaining contractual life, among other related factors. Credit risk exposure is mitigated as transactions with customers are generally secured by the same collateral of the underlying transactions. Current net credit exposure relating to derivatives with the Bank’s customers was $73.0 million at June 30, 2025. In addition, the Company monitors potential future exposure, representing its best estimate of exposure to remaining contractual maturity. The potential future exposure relating to derivatives with the Bank’s customers totaled $105.3 million at June 30, 2025. The Company has incorporated a credit valuation adjustment (contra-liability) to reflect non-performance risk in the fair value measurement of its derivatives, which totaled $4.3 million and $7.6 million at June 30, 2025, and December 31, 2024, respectively. Various factors impact changes in the valuation adjustment over time, such as changes in the credit spreads of the contracted parties, and changes in market rates and volatilities, which affect the total expected exposure of the derivative instruments.
Additional information regarding the Company’s accounting policies for derivatives can be found within Note 1: Summary of Significant Accounting Policies in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.
v3.25.2
Fair Value Measurements
 6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The determination of fair value may require the use of estimates when quoted market prices are not available. Fair value estimates made at a specific point in time are based on management’s judgments regarding future expected losses, current economic conditions, the risk characteristics of each financial instrument, and other subjective factors that cannot be determined with precision.
The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels within the fair value hierarchy are as follows:
•Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date.
•Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability (i.e., interest rates, rate volatility, prepayment speeds, and credit ratings), or inputs that are derived principally from or corroborated by market data, correlation, or other means.
•Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement. This includes certain pricing models or other similar techniques that require significant management judgment or estimation.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Available-for-Sale Securities. When unadjusted quoted prices are available in an active market, the Company classifies its available-for-sale investment securities within Level 1 of the fair value hierarchy. When quoted market prices are not available, the Company employs an independent pricing service that utilizes matrix pricing to calculate fair value. These fair value measurements consider observable data, such as dealer quotes, market spreads, cash flows, yield curves, live trading levels, trade execution data, market consensus prepayments speeds, credit information, and the respective terms and conditions for debt instruments. Management maintains procedures to monitor the pricing service’s results and has a process in place to challenge their valuations and methodologies. Government agency debentures, Municipal bonds and notes, Agency CMO, Agency MBS, Agency CMBS, CMBS, Corporate debt, Private label MBS, and Other available-for-sale securities are classified within Level 2 of the fair value hierarchy.
Derivative Financial Instruments. The fair values presented for derivative financial instruments include any accrued interest. Foreign exchange contracts are valued based on unadjusted quoted prices in active markets and, accordingly, are classified within Level 1 of the fair value hierarchy. Except for mortgage banking derivatives, all other derivative financial instruments are valued using third-party valuation software, which considers the present value of cash flows discounted using observable forward rate assumptions. The resulting fair value is then validated against valuations performed by dealer counterparties. Credit valuation adjustments, which are included in the fair value of derivative financial instruments, utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. When credit valuation adjustments are significant to the overall fair value of a derivative financial instrument, the Company classifies that derivative financial instrument in Level 3 of the fair value hierarchy. Otherwise, derivative financial instruments are generally classified within Level 2 of the fair value hierarchy. At June 30, 2025, and December 31, 2024, these credit valuation adjustments were not considered significant to the overall fair value of the Company’s derivative financial instruments.
Mortgage Banking Derivatives. The Company uses forward sales of mortgage loans and mortgage-backed securities to manage the risk of loss associated with its mortgage loan commitments and mortgage loans held for sale. Prior to closing and funding certain single-family residential mortgage loans, an interest rate lock commitment is generally extended to the borrower. During this in-between time period, the Company is subject to the risk that market interest rates may change. If rates rise, investors generally will pay less to purchase mortgage loans, which would result in a reduction in the gain on sale of the loans, or possibly a loss. In an effort to mitigate this risk, forward delivery sales commitments are established in which the Company agrees to either deliver whole mortgage loans to various investors or issue mortgage-backed securities. The fair value of mortgage banking derivatives is determined based on current market prices for similar assets in the secondary market. Accordingly, mortgage banking derivatives are classified within Level 2 of the fair value hierarchy.
Loans Originated for Sale. The Company has elected to measure residential mortgage loans originated for sale at fair value under the fair value option per ASC Topic 825, Financial Instruments. Electing to measure residential mortgage originated for sale at fair value reduces certain timing differences and better reflects the price the Company would expect to receive from the sale of these loans. The fair value of residential mortgage loans originated for sale is based on quoted market prices of similar loans sold in conjunction with securitization transactions. Accordingly, residential mortgage loans originated for sale are classified within Level 2 of the fair value hierarchy.
The following table compares the fair value to the UPB of residential mortgage loans originated for sale:
June 30, 2025December 31, 2024
(In thousands)Fair ValueUPBDifferenceFair ValueUPBDifference
Originated loans held for sale$75 $75 $— $297 $283 $14 
Rabbi Trust Investments. Investments held in each of the Company’s Rabbi Trusts consist primarily of mutual funds that invest in equity and fixed income securities. Shares of these mutual funds are valued based on the NAV as reported by the trustee of the funds, which represents quoted prices in active markets. Accordingly, the Rabbi Trusts’ investments are classified within Level 1 of the fair value hierarchy. At June 30, 2025, and December 31, 2024, the total cost basis of the investments held in the Rabbi Trusts was $9.5 million and $9.2 million, respectively.
Alternative Investments. Equity investments have a readily determinable fair value when unadjusted quoted prices are available in an active market for identical assets. Accordingly, these alternative investments are classified within Level 1 of the fair value hierarchy. During the second quarter of 2024, the Company sold its equity investments with a readily determinable fair value for proceeds of $1.2 million. Prior to the sale, these alternative investments experienced total write-ups in fair value of $0.3 million. There were no equity investments with a readily determinable fair value at June 30, 2025, and December 31, 2024.
Equity investments that do not have a readily determinable fair value may qualify for the NAV practical expedient if they meet certain requirements. The Company’s alternative investments measured at NAV consist of investments in non-public entities that cannot be redeemed since investments are distributed as the underlying equity is liquidated. Alternative investments measured at NAV are not classified within the fair value hierarchy. At June 30, 2025, and December 31, 2024, these alternative investments had a total carrying amount of $50.5 million and $43.4 million, respectively, and a remaining unfunded commitment of $38.1 million and $30.1 million, respectively.
Contingent Consideration. The Company recorded contingent consideration at fair value related to two earn-out agreements associated with the acquisition of interLINK Insured Sweep LLC from StoneCastle Partners LLC in January 2023. The terms of the purchase agreement specified that the seller would receive earn-outs based on the ability of the Company to: (i) re-sign the existing broker dealers under contract, and (ii) generate $2.5 billion in new broker dealer deposit programs within three years of the acquisition date. The estimated fair values of the contingent consideration liabilities are measured on a recurring basis and determined using an income approach considering management’s evaluation of the probability of achievement, forecasted achievement date (payment term), and a discount rate equivalent to the cost of debt. These significant inputs, which are the responsibility of management and calculated with the assistance of a third-party valuation specialist, are not observable, and accordingly, are classified within Level 3 of the fair value hierarchy.
The following tables summarize the unobservable inputs used to derive the estimated fair value of the Company’s contingent consideration liabilities (dollars in thousands):
June 30, 2025
AgreementMaximum AmountProbability of AchievementPayment Term
(in years)		Discount RateFair Value
(i) Re-sign broker dealers$20799.0 %0.386.40 %$182
(ii) Deposit program growth (1) (2)
n/an/an/an/an/a
December 31, 2024
AgreementMaximum AmountProbability of AchievementPayment Term
(in years)		Discount RateFair Value
(i) Re-sign broker dealers $20799.0 %0.886.40 %$182
(ii) Deposit program growth (1) (2)
$12,500100.0 %0.506.40 %$11,568
(1)During the first quarter of 2025, the Company re-evaluated its estimate of the forecasted achievement date (payment term) for the deposit program growth event earn-out, which resulted in a revised expected achievement date of April 30, 2025, instead of June 30, 2025. This change in estimate resulted in an increase in fair value of $0.9 million.
(2)The Company generated the required $2.5 billion in new broker dealer deposit programs in April 2025, which resulted in the cash payment of $12.5 million on April 22, 2025, to settle its contingent consideration obligation with StoneCastle Partners LLC in accordance with the purchase agreement.
Contingent consideration liabilities are included within Accrued expenses and other liabilities on the accompanying Condensed Consolidated Balance Sheets. Any fair value adjustments to contingent consideration liabilities are included in Other expense on the accompanying Condensed Consolidated Statements of Income.
The following tables summarize the fair values of assets and liabilities measured at fair value on a recurring basis:
 June 30, 2025
(In thousands)Level 1Level 2Level 3Total
Financial Assets:
Available-for-sale securities:
Government agency debentures$— $192,436 $— $192,436 
Municipal bonds and notes— 103,808 — 103,808 
Agency CMO— 27,113 — 27,113 
Agency MBS— 4,831,605 — 4,831,605 
Agency CMBS— 3,224,198 — 3,224,198 
CMBS— 790,132 — 790,132 
Corporate debt— 403,373 — 403,373 
Private label MBS— 38,364 — 38,364 
Other— 9,325 — 9,325 
Total available-for-sale securities— 9,620,354 — 9,620,354 
Gross derivative instruments, before netting (1)
535 247,020 — 247,555 
Originated loans held for sale— 75 — 75 
Investments held in Rabbi Trusts12,900 — — 12,900 
Alternative investments measured at NAV (2)
— — — 50,453 
Total financial assets$13,435 $9,867,449 $— $9,931,337 
Financial Liabilities:
Gross derivative instruments, before netting (1)
$1,515 $242,272 $— $243,787 
Contingent consideration— — 182 182 
Total financial liabilities$1,515 $242,272 $182 $243,969 
 December 31, 2024
(In thousands)Level 1Level 2Level 3Total
Financial Assets:
Available-for-sale securities:
Government agency debentures$— $186,426 $— $186,426 
Municipal bonds and notes— 110,876 — 110,876 
Agency CMO— 29,043 — 29,043 
Agency MBS— 4,519,785 — 4,519,785 
Agency CMBS— 3,034,392 — 3,034,392 
CMBS— 625,388 — 625,388 
Corporate debt— 452,266 — 452,266 
Private label MBS— 39,219 — 39,219 
Other— 9,205 — 9,205 
Total available-for-sale securities— 9,006,600 — 9,006,600 
Gross derivative instruments, before netting (1)
1,263 300,879 — 302,142 
Originated loans held for sale— 297 — 297 
Investments held in Rabbi Trusts13,438 — — 13,438 
Alternative investments measured at NAV (2)
— — — 43,360 
Total financial assets$14,701 $9,307,776 $— $9,365,837 
Financial Liabilities:
Gross derivative instruments, before netting (1)
$43 $311,518 $— $311,561 
Contingent consideration— — 11,750 11,750 
Total financial liabilities$43 $311,518 $11,750 $323,311 
(1)Additional information regarding the impact of netting derivative assets and derivative liabilities, as well as the impact from offsetting cash collateral with the same derivative counterparties, can be found within Note 13: Derivative Financial Instruments.
(2)Certain alternative investments are recorded at NAV. Assets measured at NAV are not classified within the fair value hierarchy.
Assets Measured at Fair Value on a Non-Recurring Basis
The Company measures certain assets at fair value on a non-recurring basis. The following is a description of the valuation methodologies used for assets measured at fair value on a non-recurring basis.
Alternative Investments. The measurement alternative has been elected for alternative investments without readily determinable fair values that do not qualify for the NAV practical expedient. The measurement alternative requires investments to be measured at cost minus impairment, if any, plus or minus adjustments resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Accordingly, these alternative investments are classified within Level 2 of the fair value hierarchy. At June 30, 2025, and December 31, 2024, the carrying amount of these alternative investments was $70.8 million and $61.5 million, respectively, of which $8.2 million and $8.3 million, respectively, were considered to be measured at fair value. During the six months ended June 30, 2025, there were $1.8 million in total write-ups due to observable price changes, and no write-downs due to impairment. Additionally, during the six months ended June 30, 2025, the Company sold alternative investments with a carrying amount of $3.8 million, for which the measurement alternative was elected, for proceeds of $9.5 million, resulting in total gains on sale of $5.7 million.
Loans Transferred to Held for Sale. Once a decision has been made to sell loans that were not previously classified as held for sale, these loans are transferred into the held for sale category and carried at the lower of cost or fair value, less estimated costs to sell. At the time of transfer and classification as held for sale, any amount by which cost exceeds fair value is accounted for as a valuation allowance. This activity generally pertains to loans with observable inputs and, therefore, are classified within Level 2 of the fair value hierarchy. However, should these loans include adjustments for changes in loan characteristics based on unobservable inputs, the loans would then be classified within Level 3 of the fair value hierarchy. At June 30, 2025, and December 31, 2024, there were $278.3 million and $27.3 million, respectively, of loans on the Condensed Consolidated Balance Sheet, that had been transferred to held for sale.
Collateral Dependent Loans and Leases. Loans and leases for which repayment is substantially expected to be provided through the operation or sale of collateral are considered collateral dependent, and are valued based on the estimated fair value of the collateral, less estimated costs to sell at the reporting date, using customized discounting criteria. Accordingly, collateral dependent loans and leases are classified within Level 3 of the fair value hierarchy.
Other Real Estate Owned and Repossessed Assets. OREO and repossessed assets are held at the lower of cost or fair value and are considered to be measured at fair value when recorded below cost. The fair value of OREO is calculated using independent appraisals or internal valuation methods, less estimated selling costs, and may consider available pricing guides, auction results, and price opinions. Certain repossessed assets may also require assumptions about factors that are not observable in an active market when determining fair value. Accordingly, OREO and repossessed assets are classified within Level 3 of the fair value hierarchy. At June 30, 2025, and December 31, 2024, the total carrying value of OREO and repossessed assets was $2.5 million and $0.4 million, respectively. In addition, the amortized cost of consumer loans secured by residential real estate property that were in the process of foreclosure at June 30, 2025, was $10.3 million.
Estimated Fair Values of Financial Instruments
The Company is required to disclose the estimated fair values of certain financial instruments. The following is a description of the valuation methodologies used to estimate fair value for those assets and liabilities.
Cash and Cash Equivalents. Given the short time frame to maturity, the carrying amount of cash and cash equivalents, which is comprised of Cash and due from banks and Interest-bearing deposits, approximates fair value. Cash and cash equivalents are classified within Level 1 of the fair value hierarchy.
Held-to-Maturity Securities. When quoted market prices are not available, the Company employs an independent pricing service that utilizes matrix pricing to calculate fair value. These fair value measurements consider observable data, such as dealer quotes, market spreads, cash flows, yield curves, live trading levels, trade execution data, market consensus prepayment speeds, credit information, and the respective terms and conditions for debt instruments. Management maintains procedures to monitor the pricing service’s results and has a process in place to challenge their valuations and methodologies. Held-to-maturity securities, which include Agency CMO, Agency MBS, Agency CMBS, Municipal bonds and notes, and CMBS, are classified within Level 2 of the fair value hierarchy.
Loans and Leases, net. Except for collateral dependent loans and leases, the fair value of loans and leases held for investment is estimated using a discounted cash flow methodology, based on future prepayments and market interest rates inclusive of an illiquidity discount for comparable loans and leases. The associated cash flows are then adjusted for associated credit risks and other potential losses, as appropriate. Loans and leases are classified within Level 3 of the fair value hierarchy.
Deposit Liabilities. The fair value of deposit liabilities, which is comprised of demand deposits, interest-bearing checking, savings, health savings, and money market accounts, reflects the amount payable on demand at the reporting date. Deposit liabilities are classified within Level 2 of the fair value hierarchy.
Time Deposits. The fair value of fixed-maturity certificates of deposit is estimated using rates that are currently offered for deposits with similar remaining maturities. Time deposits are classified within Level 2 of the fair value hierarchy.
Securities Sold Under Agreements to Repurchase and Federal Funds Purchased. The fair value of securities sold under agreements to repurchase and federal funds purchased that mature within 90 days approximates their carrying value. The fair value of securities sold under agreements to repurchase and federal funds purchased that mature after 90 days is estimated using a discounted cash flow methodology based on current market rates and adjusted for associated credit risks, as appropriate. Securities sold under agreements to repurchase and federal funds purchased are classified within Level 2 of the fair value hierarchy.
Federal Home Loan Bank Advances and Long-Term Debt. The fair value of FHLB advances and long-term debt is estimated using a discounted cash flow methodology in which discount rates are matched with the time period of the expected cash flows and adjusted for associated credit risks, as appropriate. FHLB advances and long-term debt are classified within Level 2 of the fair value hierarchy.
The following table summarizes the carrying amounts, estimated fair values, and classifications within the fair value hierarchy of selected financial instruments:
 June 30, 2025December 31, 2024
(In thousands)Carrying
Amount		Fair
Value		Carrying
Amount		Fair
Value
Assets:
Level 1
Cash and cash equivalents$2,993,919 $2,993,919 $2,074,434 $2,074,434 
Level 2
Held-to-maturity investment securities, net8,192,720 7,291,244 8,444,191 7,453,123 
Level 3
Loans and leases, net52,949,913 51,416,732 51,815,602 50,245,305 
Liabilities:
Level 2
Deposit liabilities$58,394,540 $58,394,540 $56,518,126 $56,518,126 
Time deposits7,919,885 7,895,161 8,234,954 8,211,582 
Securities sold under agreements to repurchase and federal funds purchased372,806 372,858 344,168 344,166 
FHLB advances3,339,914 3,337,057 2,110,108 2,107,790 
Long-term debt (1)
905,634 909,945 909,185 860,200 
(1)Any unamortized premiums/discounts, debt issuance costs, or basis adjustments to long-term debt, as applicable, are excluded from the determination of fair value.
v3.25.2
Segment Reporting
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
The Company’s operations are organized into three reportable segments that represent its differentiated lines of business: Commercial Banking, Healthcare Financial Services, and Consumer Banking. The Company’s CODM is the Chairman and Chief Executive Officer. The CODM uses income before income taxes and the provision for credit losses, referred to as PPNR, to allocate resources, including financial and capital resources, employees, and property, for each segment predominantly in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a monthly basis when making decisions about allocating resources to the segments. The CODM also uses PPNR to assess the performance of each segment and in the compensation of certain employees.
Commercial Banking delivers financial solutions both nationally and regionally to a wide range of companies, investors, government entities, and other public and private institutions. Commercial Banking helps its clients achieve their business and financial goals with expertise in Commercial & Institutional Lending, Commercial Real Estate, Capital Markets, Capital Finance, and Treasury Management. Its Private Banking team also pairs holistic wealth solutions, including tailored lending, with commercial banking services.
Healthcare Financial Services includes HSA Bank and Ametros. HSA Bank is one the country’s largest providers of employee benefits solutions, including being one of the leading bank administrators of HSAs, emergency savings accounts, and flexible spending accounts administration services in 50 states. Ametros, the nation’s largest professional administrator of medical insurance claim settlements, helps individuals manage their ongoing medical care through their CareGuard service and proprietary technology platform.
Consumer Banking delivers customized financial solutions for individuals and families, private clients, and small business owners across 196 banking centers throughout the Northeast. Consumer Banking offers a full suite of deposit, lending, treasury management, and wealth management solutions delivered by experienced relationship managers and financial advisors. Consumer Banking also provides a fully digital banking experience through its mobile banking apps and BrioDirect.
Corporate and Reconciling Category
Certain Treasury activities and other corporate and functional divisions, such as information technology, human resources, risk management, bank operations, and the operations of interSYNC, and amounts required to reconcile non-GAAP profitability metrics to those reported in accordance with GAAP are included in the Corporate and Reconciling category.
In addition to the amounts required to reconcile non-GAAP profitability metrics (i.e., estimates for FTP, allocations of equity capital) to those reported in accordance with GAAP, revenues reported in the Corporate and Reconciling category also include gains and losses on sale of investment securities and immaterial revenues from contracts with customers attributable to interSYNC. Neither the Treasury function nor interSYNC operations meet the definition of an operating segment, and therefore, are not considered for determining reportable segments.
Total assets reported in the Corporate and Reconciling category consists primarily of cash and cash equivalents, investment securities, FHLB/FRB stock, and other assets. The ACL on loans and leases is also reported in Total assets in the Corporate and Reconciling category. A provision for credit losses is allocated from the Corporate and Reconciling category to Commercial Banking and Consumer Banking based on the expected loss content of their specific loan and lease portfolios over a 3-year period (non-GAAP). There is no provision for credit losses associated with Healthcare Financial Services since that segment does not originate nor acquire loans and leases. Business development expenses, which include merger-related expenses and other strategic initiatives and restructuring costs, are also generally included in the Corporate and Reconciling category.
Change in Reportable Segments
From time to time, the Company may make reclassifications among the reportable segments to more appropriately reflect management’s view of the business and/or based on changes in the Company’s organizational structure or product lines. Accordingly, the results derived are not necessarily comparable with similar financial information published by other financial institutions. Additionally, because of the interrelationships of the segments, the financial information presented is not indicative of how the segments would perform if they operated as independent entities.
Segment Reporting Methodology
The Company uses an internal profitability reporting system to generate PPNR by reportable segment, which is comprised of direct revenues, direct expenses, estimates for FTP, and allocations for equity capital, net operating costs and total support costs. Since the majority of each reportable segment’s revenue is interest, each segment’s interest revenue is reported net of its interest expense (net interest income). Estimates for FTP and allocations of equity capital and non-interest expense, certain of which are subjective in nature, are periodically reviewed and refined. Equity capital is allocated using a combination of risk-weighted asset and management assessment methodologies across the differentiated lines of business. Net operating costs and total support costs, which reflect costs for shared services and back-office support areas, are allocated using an activity and driver-based costing process. The full profitability measurement reports, which are prepared for each reportable segment and reviewed by the CODM on a monthly basis, reflect non-GAAP reporting methodologies. The differences between full profitability and GAAP results are reconciled in the Corporate and Reconciling category.
The goal of FTP is to encourage loan and deposit growth consistent with the Company’s overall profitability objectives. The FTP process considers the specific interest rate risk and liquidity risk of financial instruments, other assets, and other liabilities included in each reportable segment. Loans and deposits are assigned FTP rates, and segments are charged a cost to fund loans and are paid a credit for deposit funds provided. Consideration is given to the origination date and the earlier of the maturity date or the repricing date of a financial instrument to assign an FTP rate for loans and deposits originated each day. Overall, the FTP process reflects the transfer of interest rate risk exposure to the Treasury function included within the Corporate and Reconciling category, where such exposures are centrally managed.
Financial Information
The following table presents certain balance sheet financial information for the Company’s reportable segments:
June 30, 2025
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and ReconcilingConsolidated Total
Goodwill$1,960,363 $285,670 $622,035 $— $2,868,068 
Total assets43,908,431 477,234 13,499,277 24,029,328 81,914,270 
December 31, 2024
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and ReconcilingConsolidated Total
Goodwill (1)
$1,960,363 $285,670 $622,035 $— $2,868,068 
Total assets43,010,580 488,194 12,932,260 22,594,039 79,025,073 
(1)The allocation of the purchase price and goodwill calculation for the Ametros acquisition was considered final at December 31, 2024. The $228.2 million of goodwill recorded related to Ametros was allocated entirely to Healthcare Financial Services.
The following tables present certain income statement information for the Company’s reportable segments:
 Three months ended June 30, 2025
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$318,518 $97,625 $212,672 $628,815 
Non-interest income30,628 28,687 24,591 83,906 
Total segment revenues349,146 126,312 237,263 712,721 
Reconciliation of revenue:
Corporate and reconciling3,118 
Total consolidated revenues715,839 
Less:
Compensation and benefits50,807 24,171 37,285 
Occupancy (1)
— — 13,835 
Technology and equipment (1)
2,336 7,524 2,917 
Marketing— — 2,043 
Other segment items (1) (2) (3)
55,229 23,758 66,964 
Segment pre-tax, pre-provision net revenue240,774 70,859 114,219 425,852 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(55,727)
Total consolidated pre-tax, pre-provision net revenue370,125 
Total consolidated provision for credit losses46,500 
Total consolidated income before income taxes323,625 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $1.5 million for Healthcare Financial Services, and $2.4 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $2.7 million for Commercial Banking, $3.4 million for Healthcare Financial Services, and $1.8 million for Consumer Banking.
 Three months ended June 30, 2024
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$337,588 $91,664 $202,679 $631,931 
Non-interest income34,510 27,465 24,392 86,367 
Total segment revenues372,098 119,129 227,071 718,298 
Reconciliation of revenue:
Corporate and reconciling(103,703)
Total consolidated revenues614,595 
Less:
Compensation and benefits49,904 22,915 36,526 
Occupancy (1)
— — 13,683 
Technology and equipment (1)
2,051 8,092 2,331 
Marketing— — 1,714 
Other segment items (1) (2) (3)
52,633 20,260 61,651 
Segment pre-tax, pre-provision net revenue267,510 67,862 111,166 446,538 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(157,964)
Total consolidated pre-tax, pre-provision net revenue288,574 
Total consolidated provision for credit losses59,000 
Total consolidated income before income taxes229,574 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $1.3 million for Healthcare Financial Services, and $2.3 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $1.7 million for Commercial Banking, $3.6 million for Healthcare Financial Services, and $2.1 million for Consumer Banking.
 Six months ended June 30, 2025
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$637,641 $193,986 $414,736 $1,246,363 
Non-interest income59,586 58,077 50,795 168,458 
Total segment revenues697,227 252,063 465,531 1,414,821 
Reconciliation of revenue:
Corporate and reconciling5,816 
Total consolidated revenues1,420,637 
Less:
Compensation and benefits102,916 47,508 74,569 
Occupancy (1)
— — 28,183 
Technology and equipment (1)
4,447 16,288 5,966 
Marketing— — 4,025 
Other segment items (1) (2) (3)
107,591 47,377 132,957 
Segment pre-tax, pre-provision net revenue482,273 140,890 219,831 842,994 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(111,715)
Total consolidated pre-tax, pre-provision net revenue731,279 
Total consolidated provision for credit losses124,000 
Total consolidated income before income taxes607,279 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $2.9 million for Healthcare Financial Services, and $5.0 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $5.5 million for Commercial Banking, $6.9 million for Healthcare Financial Services, and $3.6 million for Consumer Banking.
Six months ended June 30, 2024
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$679,530 $177,802 $408,456 $1,265,788 
Non-interest income68,790 58,526 58,370 185,686 
Total segment revenues748,320 236,328 466,826 1,451,474 
Reconciliation of revenue:
Corporate and reconciling(169,787)
Total consolidated revenues1,281,687 
Less:
Compensation and benefits100,662 44,277 73,421 
Occupancy (1)
— — 28,221 
Technology and equipment (1)
4,009 16,098 4,759 
Marketing— — 3,561 
Other segment items (1) (2) (3)
106,142 43,019 126,064 
Segment pre-tax, pre-provision net revenue537,507 132,934 230,800 901,241 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(281,498)
Total consolidated pre-tax, pre-provision net revenue619,743 
Total consolidated provision for credit losses104,500 
Total consolidated income before income taxes515,243 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $2.6 million for Healthcare Financial Services, and $4.6 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $4.7 million for Commercial Banking, $6.3 million for Healthcare Financial Services, and $4.3 million for Consumer Banking.
v3.25.2
Revenue from Contracts with Customers
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
The following tables summarize revenues recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers. These disaggregated amounts, together with sources of other non-interest income that are subject to other GAAP topics, have been reconciled to non-interest income by reportable segment as presented within Note 15: Segment Reporting.
Three months ended June 30, 2025
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$4,550 $20,282 $16,268 $(166)$40,934 
Loan and lease related fees (1)
2,520 — — — 2,520 
Wealth and investment services3,353 — 4,432 (6)7,779 
Other (2)
— 8,077 416 (296)8,197 
Revenue from contracts with customers10,423 28,359 21,116 (468)59,430 
Other sources of non-interest income20,205 328 3,475 11,219 35,227 
Total non-interest income$30,628 $28,687 $24,591 $10,751 $94,657 
Three months ended June 30, 2024
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$5,160 $20,460 $15,552 $(145)$41,027 
Loan and lease related fees (1)
3,943 — — — 3,943 
Wealth and investment services3,208 — 5,354 (6)8,556 
Other (2)
— 7,005 416 887 8,308 
Revenue from contracts with customers12,311 27,465 21,322 736 61,834 
Other sources of non-interest income22,199 — 3,070 (44,805)(19,536)
Total non-interest income$34,510 $27,465 $24,392 $(44,069)$42,298 
Six months ended June 30, 2025
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$9,289 $39,351 $31,562 $(373)$79,829 
Loan and lease related fees (1)
4,745 — — — 4,745 
Wealth and investment services6,669 — 8,910 (11)15,568 
Other (2)
— 18,377 833 856 20,066 
Revenue from contracts with customers20,703 57,728 41,305 472 120,208 
Other sources of non-interest income38,883 349 9,490 18,333 67,055 
Total non-interest income$59,586 $58,077 $50,795 $18,805 $187,263 
Six months ended June 30, 2024
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$11,002 $42,512 $30,348 $(246)$83,616 
Loan and lease related fees (1)
7,565 — — — 7,565 
Wealth and investment services6,386 — 10,105 (11)16,480 
Other (2)
— 16,014 233 1,931 18,178 
Revenue from contracts with customers24,953 58,526 40,686 1,674 125,839 
Other sources of non-interest income43,837 — 17,684 (45,709)15,812 
Total non-interest income$68,790 $58,526 $58,370 $(44,035)$141,651 
(1)A portion of Loan and lease related fees on the Condensed Consolidated Statements of Income is comprised of income generated from factored receivables activities (through the third quarter of 2024 only) and payroll financing activities that is within the scope of ASC Topic 606.
(2)Other income included in the Corporate and Reconciling category that is in scope of ASC Topic 606 is comprised entirely of immaterial fee revenue from contracts with customers attributable to interSYNC.
Major Revenue Streams
Deposit Service Fees. The deposit service fees revenue stream consists of fees earned from commercial and consumer customer deposit accounts, such as account maintenance and cash management/analysis fees, as well as other transactional service charges (i.e., insufficient funds, wire transfers, stop payment fees, etc.). Performance obligations for account maintenance services and cash management/analysis fees are satisfied on a monthly basis at a fixed transaction price, whereas performance obligations for other deposit service charges that result from various customer-initiated transactions are satisfied at a point-in-time when the service is rendered. Payment for deposit service fees is generally received immediately or in the following month through a direct charge to the customers’ accounts. Certain commercial customer contracts include credit clauses, whereby the Company will grant credit upon the customer meeting pre-determined conditions, which can be used to offset fees. In addition, certain healthcare financial services contracts include revenue share clauses, whereby the Company will reduce or refund deposit service fees or make referral payments to attract and retain customers and their accounts. Such revenue share costs are recognized as a reduction to revenue in the period incurred. On occasion, the Company may also waive certain fees. Fee waivers are recognized as a reduction to revenue in the period the waiver is granted to the customer.
The deposit service fees revenue stream also includes interchange fees earned from debit and credit card transactions. The transaction price for interchange services is based on the transaction value and the interchange rate set by the card network. Performance obligations for interchange fees are satisfied at a point-in-time when the cardholders’ transaction is authorized and settled. Payment for interchange fees is generally received immediately or in the following month.
Loan and Lease Related Fees. The Company sold its factored receivables loan portfolio, which included the related customer contracts, in the third quarter of 2024. Additional information regarding the Company’s sale of its factored receivables portfolio can be found within Note 5: Transfers and Servicing of Financial Assets in the Notes to Consolidated Financial Statements contained in Part II - Item 8. Financial Statements and Supplementary Data of the Company’s Form 10-K for the year ended December 31, 2024. Prior to the completion of that transaction, the Company recognized factored receivables non-interest income from fees earned from accounts receivable management services. The Company factored accounts receivable, with and without recourse, for customers whereby the Company purchased their accounts receivable at a discount and assumed the risk, as applicable, and ownership of the assets through direct cash receipt from the end consumer. Factoring services were performed in exchange for a non-refundable fee at a transaction price based on a percentage of the gross invoice amount of each receivable purchased, subject to a minimum required amount. The performance obligation for factoring services was generally satisfied at a point-in-time when the receivable was assigned to the Company. However, if the commission earned did not meet or exceed the minimum required annual amount, the difference between that and the actual amount was recognized at the end of the contract term. Other fees associated with factoring receivables included wire transfer and technology fees, field examination fees, and Uniform Commercial Code fees, where the performance obligations were satisfied at a point-in-time when the services were rendered. Payment from the customer for factoring services was generally received immediately or within the following month.
Payroll finance non-interest income consists of fees earned from performing payroll financing and business process outsourcing services, including full back-office technology and tax accounting services, along with payroll preparation, making payroll tax payments, invoice billings, and collections for independently-owned temporary staffing companies nationwide. Performance obligations for payroll finance and business processing activities are either satisfied upon completion of the support services or as payroll remittances are made on behalf of customers to fund their employee payroll, which generally occurs on a weekly basis. The agreed-upon transaction price is based on a fixed-percentage per the terms of the contract, which could be subject to a hold-back reserve to provide for any balances that are assessed to be at risk of collection. When the Company collects on amounts due from end consumers on behalf of its customers and at the time of financing payroll, the Company retains the agreed-upon transaction price payable for the performance of its services and remits an amount to the customer net of any advances and payroll tax withholdings, as applicable.
Wealth and Investment Services. Wealth and investment services consist of fees earned from asset management, trust administration, and investment advisory services, and through facilitating securities transactions. Performance obligations for asset management and trust administration services are satisfied on a monthly or quarterly basis at a transaction price based on a percentage of the period-end market value of the assets under administration. Payment for asset management and trust administration services is generally received a few days after period-end through a direct charge to the customers’ accounts. Performance obligations for investment advisory services are satisfied over the period in which the services are provided through a time-based measurement of progress, and the agreed-upon transaction price with the customer varies depending on the nature of the services performed. Performance obligations for facilitating securities transactions are satisfied at a point-in-time when the securities are sold at a transaction price that is based on a percentage of the contract value. Payment for both investment advisory services and facilitating securities transactions may be received in advance of the service, but generally is received immediately or in the following period, in arrears.
Other Income - Ametros. Other income for the Healthcare Financial Services segment primarily includes revenues recognized in connection with contracts with customers from the acquired Ametros business. The nature of such revenue primarily pertains to income earned from arranging sales of in-network products and services, which is recognized at a point in time. Under the terms of these arrangements, the Company has determined that it acts in the capacity as an agent and, therefore, records revenue on a net basis. Other income related to Ametros also includes revenues earned from providing post-settlement medical management and compliance services, which are recognized over time.
The Company evaluates its contracts with Ametros customers for material rights, or options, to acquire additional goods or services for free or at a discount. The contracts for post-settlement medical management and compliance services contain renewal options that represent a material right, which is recognized as a separate performance obligation at the inception of the arrangement. The Company allocates the transaction price to material rights using the practical alternative, which allocates the transaction price to the services expected to be provided and the corresponding expected consideration. Material rights are recognized at the time the service is transferred or when the option expires.
In addition, a fixed, non-refundable fee that represents an advance payment for access to future services is initially deferred and subsequently amortized into other income ratably over the estimated life expectancy of the member. During the three months ended June 30, 2025, and 2024, and during the six months ended June 30, 2025, and 2024, $0.5 million and $0.4 million, respectively, and $0.9 million and $0.7 million, respectively, of such deferred revenue was recognized in Other income.
Contract Balances and Deferred Costs
Contracts with customers generated accounts receivable, deferred costs, and deferred revenue of $3.6 million, $4.6 million, and $24.0 million, respectively, at June 30, 2025, and $2.7 million, $3.0 million and $22.8 million, respectively at December 31, 2024. All of these balances pertain to contracts with customers from the acquired Ametros business.
v3.25.2
Commitments and Contingencies
 6 Months Ended
Jun. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Credit-Related Financial Instruments
In the normal course of business, the Company offers financial instruments with off-balance sheet risk to meet the financing needs of its customers. These transactions include commitments to extend credit, standby letters of credit, and commercial letters of credit, which involve, to varying degrees, elements of credit risk.
The following table summarizes the outstanding amounts of credit-related financial instruments with off-balance sheet risk:
(In thousands)June 30,
2025		December 31, 2024
Commitments to extend credit$12,285,376 $11,630,765 
Standby letters of credit608,752 578,912 
Commercial letters of credit27,842 28,287 
Total credit-related financial instruments with off-balance sheet risk$12,921,970 $12,237,964 
The Company enters into contractual commitments to extend credit to its customers (i.e., revolving credit arrangements, term loan commitments, and short-term borrowing agreements), generally with fixed expiration dates or other termination clauses and that require payment of a fee. Substantially all of the Company’s commitments to extend credit are contingent upon its customers maintaining specific credit standards at the time of loan funding, and are often secured by real estate collateral. Since the majority of the Company’s commitments typically expire without being funded, the total contractual amount does not necessarily represent the Company’s future payment requirements.
Standby letters of credit are written conditional commitments issued by the Company to guarantee its customers’ performance to a third party. In the event the customer does not perform in accordance with the terms of its agreement with a third-party, the Company would be required to fund the commitment. The contractual amount of each standby letter of credit represents the maximum amount of potential future payments the Company could be required to make. Historically, the majority of the Company’s standby letters of credit expire without being funded. However, if the commitment were funded, the Company has recourse against the customer. The Company’s standby letter of credit agreements are often secured by cash or other collateral.
Commercial letters of credit are issued to finance either domestic or foreign customer trade arrangements. As a general rule, drafts are committed to be drawn when the goods underlying the transaction are in transit. Similar to standby letters of credit, the Company’s commercial letter of credit agreements are often secured by the underlying goods subject to trade.
Allowance for Credit Losses on Unfunded Loan Commitments
An ACL is recorded under the CECL methodology to provide for the unused portion of commitments to lend that are not unconditionally cancellable by the Company. At June 30, 2025, and December 31, 2024, the ACL on unfunded loan commitments was $22.8 million and $22.6 million, respectively.
Litigation
The Company is subject to certain legal proceedings and unasserted claims and assessments in the ordinary course of business. Legal contingencies are evaluated based on information currently available, including advice of counsel and assessment of available insurance coverage. The Company establishes an accrual for specific legal matters when it determines that the likelihood of an unfavorable outcome is probable and the loss is reasonably estimable. Once established, each accrual is adjusted to reflect any subsequent developments. Legal contingencies are subject to inherent uncertainties, and unfavorable rulings may occur that could cause the Company to either adjust its litigation accrual or incur actual losses that exceed the current estimate, which ultimately could have a material adverse effect, either individually or in the aggregate, on its business, financial condition, or operating results. The Company will consider settlement of cases when it is in the best interest of the Company and its stakeholders. The Company intends to defend itself in all claims asserted against it, and management currently believes that the outcome of these contingencies will not be material, either individually or in the aggregate, to the Company or its consolidated financial position.
Federal Deposit Insurance Corporation Special Assessment
On November 29, 2023, the FDIC published a final rule implementing a special assessment for certain banks to recover losses incurred by protecting uninsured depositors of Silicon Valley Bank and Signature Bank upon their failure in March 2023. The special assessment is to be collected for an anticipated total of ten quarterly assessment periods, which began during the second quarter of 2024. At June 30, 2025, and December 31, 2024, the Company’s remaining accrual for its estimated special assessment charge was $28.0 million and $39.8 million, respectively. The FDIC retains the right to cease collection early, extend the special assessment collection period, and impose shortfall special assessments if actual losses exceed the amounts collected. The Company continues to monitor the estimated loss attributable to the protection of uninsured depositors at Silicon Valley Bank and Signature Bank, which could impact the amount of its accrued liability.
v3.25.2
Subsequent Events
 6 Months Ended
Jun. 30, 2025
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
The Company has evaluated subsequent events from the date of the Condensed Consolidated Financial Statements, and accompanying Notes thereto, through the date of issuance, and determined that, except for the sale of a portion of the seed portfolio loans used to launch the joint venture’s operations, as discussed in Note 2: Business Developments, no other significant events were identified requiring recognition or disclosure.
v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
John Ciulla [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement John Ciulla, our Chairman and Chief Executive Officer, entered into a Rule 10b5-1 trading agreement with a brokerage firm, intended to satisfy the affirmative defense of Rule 10b5-1(c), on April 30, 2025 for trades over a period of time from August 1, 2025 until August 3, 2026, or such earlier time as when 32,000 shares of Webster common stock are sold.
Name John Ciulla
Title Chairman and Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date April 30, 2025
Expiration Date August 3, 2026
Arrangement Duration 367 days
Aggregate Available 32,000
v3.25.2
Basis of Presentation and Accounting Standards Updates (Policies)
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The unaudited Condensed Consolidated Financial Statements of the Company have been prepared in accordance with GAAP for interim financial information and Article 10 of Regulation S-X. Certain information and footnote disclosures required by GAAP for complete financial statements have been omitted or condensed. Therefore, the Condensed Consolidated Financial Statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. The Company’s financial condition, results of operations, and cash flows, for the three and six months ended June 30, 2025, as compared to 2024, are not necessarily indicative of the future results that may be attained for the entire year or other interim periods.
In the opinion of management, all necessary adjustments have been reflected to present fairly the financial position, results of operations, and cash flows for the reporting periods presented. Intercompany transactions and balances have been eliminated in consolidation. Assets under administration or assets under management that the Company holds or manages in a fiduciary or agency capacity for customers are not included in the Condensed Consolidated Financial Statements.
Certain prior period amounts disclosed in Note 9: Accumulated Other Comprehensive (Loss), Net of Tax have been reclassified to conform to the current period presentation. These reclassifications did not have a material impact on the Company’s Condensed Consolidated Financial Statements.
Use of Estimates
Use of Estimates
The preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Relevant Accounting Standards Issued But Not Yet Adopted
Relevant Accounting Standards Issued But Not Yet Adopted
ASU No. 2023-09—Income Taxes (Topic 740)—Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU No. 2023-09—Income Taxes (Topic 740)—Improvements to Income Tax Disclosures, to provide more transparency about income tax information through improvements to income tax disclosures, primarily related to the rate reconciliation and income taxes paid information. Specifically, the amendments in this Update require disclosure of: (i) a tabular reconciliation, using both percentages and reporting currency amounts, with prescribed categories that are required to be disclosed, and the separate disclosure and disaggregation of prescribed reconciling items with an effect equal to 5% or more of the amount determined by multiplying pre-tax income from continuing operations by the application statutory rate; (ii) a qualitative description of the states and local jurisdictions that make up the majority (greater than 50%) of the effect of the state and local income taxes; and (iii) the amount of income taxes paid, net of refunds received, disaggregated by federal, state, and foreign taxes and by individual jurisdictions that comprise 5% or more of total income taxes paid, net of refunds received. The amendments in this Update also include certain other amendments to improve the effectiveness of income tax disclosures.
The Update is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The amendments should be applied on a prospective basis; however, retrospective application is permitted. The Company is currently evaluating this guidance, which it will adopt in the fourth quarter of 2025, to determine the impact on its income tax disclosures.
ASU No. 2024-03—Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures
(Subtopic 220-40): Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires entities to disclose specified information about certain costs and expenses in the notes to financial statements at each interim and annual reporting period, including the amounts of: (a) purchases of inventory, (b) employee compensation, (c) depreciation, (d) intangible asset amortization, and (e) depletion included in each relevant expense caption. For the employee compensation category, bank holding companies may continue to present compensation expense on the face of the income statement in accordance with Regulation S-X Rule 210.9-04. A qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively are also required to be disclosed. In addition, entities must disclose the total amount of selling expenses and, in annual reporting periods, their definition of selling expenses.
The Update is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The amendments may be applied on either a prospective or retrospective basis. The Company is currently evaluating this guidance to determine the impact on its non-interest expense disclosures; however, the impact is not expected to be material.
v3.25.2
Basis of Presentation and Accounting Standards Updates (Tables)
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Cash Flow Information
The following table summarizes supplemental disclosures of cash flow information and non-cash investing and financing activities:
Six months ended June 30,
(In thousands)20252024
Supplemental disclosure of cash flow information:
Interest paid$765,626 $811,338 
Income taxes paid53,100 84,450 
Non-cash investing and financing activities:
Transfer of loans held for investment to foreclosed properties and repossessed assets$3,967 $1,925 
Transfer of returned finance lease equipment to assets held for sale579 2,316 
Transfer of loans held for investment to loans held for sale317,172 333,483 
ROU lease assets obtained in exchange for operating lease liabilities28,437 8,259 
Approved commitments to fund LIHTC investments 99,054 212,041 
Acquisition of Ametros:
Tangible assets acquired$— $256,957 
Goodwill and other intangible assets— 417,085 
Liabilities assumed (1)
— 299,507 
Forgiveness of long-term debt— 12,875 
Pre-existing equity interest— 2,200 
(1)Reflects the sum of the $293.7 million of liabilities assumed from Ametros and the $5.8 million liability assumed for the Seller’s transaction expenses, which was included as part of the purchase price consideration and paid by the Company at closing.
v3.25.2
Business Developments (Tables)
 6 Months Ended
Jun. 30, 2025
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Summary of Purchase Price Allocation
The acquisition was accounted for as a business combination. Accordingly, the total purchase price, which included cash paid of $359.7 million, the forgiveness of $12.9 million in long-term debt, and the assumption of a $5.8 million liability for the Seller’s transaction expenses, has been allocated to the identifiable assets acquired and liabilities assumed based on their acquisition-date fair values, as summarized in the following table:
(In thousands)Fair Value
Purchase price consideration$378,424 
Assets:
Cash and due from banks310 
Premises and equipment
1,078 
Other intangible assets188,900 
Deferred tax assets, net(35,889)
Other assets:
Funds held in escrow288,167 
Accounts receivable 2,435 
Prepaid expenses1,166 
Total other assets291,768 
Total assets acquired$446,167 
Liabilities:
Interest-bearing deposits (1)
(20,622)
Other liabilities:
Accounts payable 684 
Accrued expenses4,270 
Deferred revenue20,391 
Members’ funds288,167 
Operating lease liabilities838 
Total other liabilities314,350 
Total liabilities assumed$293,728 
Net assets acquired152,439 
Pre-existing equity interest (2)
$2,200 
Goodwill$228,185 
(1)The $20.6 million reflects the amount held in Ametros’ operating cash account at the Bank on January 24, 2024. Upon acquisition, such cash and the Bank’s corresponding deposit liability owed to Ametros were eliminated in consolidation, which resulted in a decrease to interest-bearing deposits for the Bank and the Bank’s legal title to the funds being held in such operating cash account.
(2)Prior to the acquisition date, the Company had a 0.6% equity interest in Ametros. The consideration transferred reflects the purchase price for the remaining 99.4% of the business. Upon acquisition, the Company recognized a $1.5 million gain in Other income on the accompanying Condensed Consolidated Statement of Income, which represents the difference between the cost basis and estimated acquisition-date fair value of the Company’s pre-existing equity interest in Ametros.
v3.25.2
Investment Securities (Tables)
 6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Summary of Investment Securities
The following tables summarize the amortized cost and fair value of available-for-sale securities by major type:
 June 30, 2025
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Allowance for Credit LossesFair Value
Government agency debentures$222,808 $— $(30,372)$— $192,436 
Municipal bonds and notes117,562 — (13,754)— 103,808 
Agency CMO29,439 — (2,326)— 27,113 
Agency MBS4,980,846 36,060 (185,301)— 4,831,605 
Agency CMBS3,558,974 5,201 (339,977)— 3,224,198 
CMBS791,930 1,054 (2,852)— 790,132 
Corporate debt435,483 264 (31,507)(867)403,373 
Private label MBS42,571 — (4,207)— 38,364 
Other9,868 — (543)— 9,325 
Total available-for-sale$10,189,481 $42,579 $(610,839)$(867)$9,620,354 
December 31, 2024
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Allowance for Credit LossesFair Value
Government agency debentures$222,767 $— $(36,341)$—$186,426
Municipal bonds and notes123,885 2 (13,011)—110,876
Agency CMO32,193 — (3,150)—29,043
Agency MBS4,760,541 11,654 (252,410)—4,519,785
Agency CMBS3,400,021 84 (365,713)—3,034,392
CMBS630,985 411 (6,008)—625,388
Corporate debt496,087 801 (43,755)(867)452,266
Private label MBS 44,081 — (4,862)—39,219
Other9,855 — (650)—9,205
Total available-for-sale$9,720,415 $12,952 $(725,900)$(867)$9,006,600 
(1)Accrued interest receivable on available-for-sale securities of $36.8 million and $35.2 million at June 30, 2025, and December 31, 2024, respectively, is excluded from amortized cost and included in Accrued interest receivable and other assets on the accompanying Condensed Consolidated Balance Sheets.
Summary of Gross Unrealized Losses and Fair Value of Available for Sale Securities
The following tables summarize the gross unrealized losses and fair value of available-for-sale securities by length of time each major security type has been in a continuous unrealized loss position:
 June 30, 2025
 Less Than 12 Months12 Months or MoreTotal
(Dollars in thousands)Fair
Value		Unrealized
Losses		Fair
Value		Unrealized
Losses		Number of
Holdings		Fair
Value		Unrealized
Losses
Government agency debentures$— $— $192,436 $(30,372)15$192,436 $(30,372)
Municipal bonds and notes— — 103,032 (13,754)38103,032 (13,754)
Agency CMO— — 27,113 (2,326)2827,113 (2,326)
Agency MBS822,663 (5,939)1,218,266 (179,362)3262,040,929 (185,301)
Agency CMBS1,280,991 (27,776)1,558,697 (312,201)1782,839,688 (339,977)
CMBS213,594 (676)252,181 (2,176)32465,775 (2,852)
Corporate debt8,000 (1)375,109 (31,506)51383,109 (31,507)
Private label MBS— — 38,364 (4,207)338,364 (4,207)
Other— — 9,325 (543)29,325 (543)
Total$2,325,248 $(34,392)$3,774,523 $(576,447)673$6,099,771 $(610,839)
 December 31, 2024
 Less Than Twelve MonthsTwelve Months or LongerTotal
(Dollars in thousands)Fair
Value		Unrealized
Losses		Fair
Value		Unrealized
Losses		Number of
Holdings		Fair
Value		Unrealized
Losses
Government agency debentures$— $— $186,427 $(36,341)15$186,427 $(36,341)
Municipal bonds and notes 859 (1)108,013 (13,010)57108,872 (13,011)
Agency CMO— — 29,043 (3,150)2829,043 (3,150)
Agency MBS2,624,722 (31,539)1,246,818 (220,871)3703,871,540 (252,410)
Agency CMBS1,468,615 (32,528)1,540,263 (333,185)1853,008,878 (365,713)
CMBS— — 457,423 (6,008)32457,423 (6,008)
Corporate debt— — 426,805 (43,755)59426,805 (43,755)
Private label MBS— — 39,219 (4,862)339,219 (4,862)
Other— — 9,205 (650)29,205 (650)
Total$4,094,196 $(64,068)$4,043,216 $(661,832)751$8,137,412 $(725,900)
Summary of Debt Securities by Contractual Maturity
The following table summarizes the amortized cost and fair value of available-for-sale securities by contractual maturity:
June 30, 2025
(In thousands)Amortized CostFair Value
Maturing within 1 year$884 $881 
After 1 year through 5 years334,324 328,656 
After 5 through 10 years702,943 660,919 
After 10 years9,151,330 8,629,898 
Total available-for-sale$10,189,481 $9,620,354 
Schedule of Realized Gain (Loss)
The following table summarizes information related to sales of available-for-sales securities:
Three months ended June 30,Six months ended June 30,
(In thousands)2025202420252024
Proceeds from sales$— $921,642 $14,880 $1,253,332 
Gross realized gains$— $— $332 $2,240 
Gross realized losses (1)
— (49,915)(112)(64,551)
(1)For the three months and six months ended June 30, 2024, $2.6 million of the gross losses realized on sale of available-for-sale securities was due to credit related factors and, therefore, was included in the Provision for credit losses on the accompanying Condensed Consolidated Statements of Income. There were no gross losses realized on sale of available-for-sale securities due to credit related factors for the three and six months ended June 30, 2025. The net amounts presented as a component of non-interest income for the three and six months ended June 30, 2025, and 2024, respectively, include the portion of any gross losses that were not due to credit related factors.
Summary of Amortized Cost and Fair Value of Available for Sale Securities
The following table summarizes the carrying value of available-for-sale securities pledged for deposits, borrowings, and other purposes:
(In thousands)June 30, 2025December 31, 2024
Pledged for deposits$1,797,620$1,596,378
Pledged for borrowings and other6,926,9236,863,183
Total available-for-sale securities pledged$8,724,543$8,459,561
Summary of Debt Securities Held-to-Maturity
The following tables summarize the amortized cost, fair value, and ACL on held-to-maturity securities by major type:
June 30, 2025
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Fair ValueAllowance for Credit LossesNet Carrying Value
Agency CMO$18,246 $— $(1,282)$16,964 $— $18,246 
Agency MBS2,954,301 11,389 (276,548)2,689,142 — 2,954,301 
Agency CMBS4,315,250 149 (569,802)3,745,597 — 4,315,250 
Municipal bonds and notes839,766 257 (63,392)776,631 (102)839,664 
CMBS65,259 — (2,349)62,910 — 65,259 
Total held-to-maturity$8,192,822 $11,795 $(913,373)$7,291,244 $(102)$8,192,720 
December 31, 2024
(In thousands)
Amortized
Cost (1)
Unrealized
Gains		Unrealized
Losses		Fair ValueAllowance for Credit LossesNet Carrying Value
Agency CMO$19,847 $— $(1,671)$18,176 $— $19,847 
Agency MBS3,109,411 771 (333,039)2,777,143 — 3,109,411 
Agency CMBS4,357,505 414 (613,914)3,744,005 — 4,357,505 
Municipal bonds and notes891,909 317 (40,266)851,960 (171)891,738 
CMBS65,690 — (3,851)61,839 — 65,690 
Total held-to-maturity$8,444,362 $1,502 $(992,741)$7,453,123 $(171)$8,444,191 
(1)Accrued interest receivable on held-to-maturity securities of $29.1 million and $30.5 million at June 30, 2025, and December 31, 2024, respectively, is excluded from amortized cost and included in Accrued interest receivable and other assets on the accompanying Condensed Consolidated Balance Sheets.
The following table summarizes the activity in the ACL on held-to-maturity securities:
Three months ended June 30,Six months ended June 30,
(In thousands)2025202420252024
Balance, beginning of period$109 $184 $171$209
(Benefit) for credit losses(7)(2)(69)(27)
Balance, end of period$102 $182 $102$182
The following table summarizes the carrying value of held-to-maturity securities pledged for deposits, borrowings, and other purposes:
(In thousands)June 30, 2025December 31, 2024
Pledged for deposits$1,760,751$1,978,445
Pledged for borrowings and other6,039,1736,258,828
Total held-to-maturity securities pledged$7,799,924$8,237,273
Summary of Activity in the ACL on Held-to-Maturity Securities
The following table summarizes the amortized cost and fair value of held-to-maturity securities by contractual maturity:
June 30, 2025
(In thousands)Amortized CostFair Value
Maturing within 1 year$2,902 $2,903 
After 1 year through 5 years160,194 154,188 
After 5 through 10 years286,121 275,974 
After 10 years7,743,605 6,858,179 
Total held-to-maturity$8,192,822 $7,291,244 
Summary of Amortized Cost of Held-to-Maturity Securities
The following tables summarize the amortized cost of held-to-maturity securities based on their lowest publicly available credit rating:
June 30, 2025
Investment Grade
(In thousands)AaaAa1Aa2Aa3A1A2A3Not Rated
Agency CMO$— $18,246 $— $— $— $— $— $— 
Agency MBS— 2,954,301 — — — — — — 
Agency CMBS— 4,315,250 — — — — — — 
Municipal bonds and notes301,307 153,720 244,918 112,768 10,444 4,165 — 12,444 
CMBS65,259 — — — — — — — 
Total held-to-maturity$366,566 $7,441,517 $244,918 $112,768 $10,444 $4,165 $— $12,444 
December 31, 2024
Investment Grade
(In thousands)AaaAa1Aa2Aa3A1A2A3Not Rated
Agency CMO$— $19,847 $— $— $— $— $— $— 
Agency MBS— 3,109,411 — — — — — — 
Agency CMBS— 4,357,505 — — — — — — 
Municipal bonds and notes341,187 158,327 230,986 128,692 13,761 — 4,165 14,791 
CMBS65,690 — — — — — — — 
Total held-to-maturity$406,877 $7,645,090 $230,986 $128,692 $13,761 $— $4,165 $14,791 
v3.25.2
Loans and Leases (Tables)
 6 Months Ended
Jun. 30, 2025
Loans and Leases Receivable Disclosure [Abstract]  
Summary of Loans and Leases by Segment
The following table summarizes loans and leases by portfolio segment and class:
(In thousands)June 30,
2025		December 31, 2024
Commercial non-mortgage$18,724,821 $18,037,942 
Asset-based1,350,006 1,404,007 
Commercial real estate14,539,706 14,492,436 
Multi-family6,819,069 6,898,600 
Equipment financing1,218,276 1,235,016 
Commercial portfolio42,651,878 42,068,001 
Residential9,332,413 8,853,669 
Home equity1,385,746 1,427,692 
Other consumer301,922 155,806 
Consumer portfolio11,020,081 10,437,167 
Loans and leases$53,671,959 $52,505,168 
Summary of Loans and Leases
The following tables summarize the aging of accrual and non-accrual loans and leases by class:
 June 30, 2025
(In thousands)30-59 Days
Past Due and
Accruing		60-89 Days
Past Due and
Accruing		90 or More Days Past Due
and Accruing		Non-accrualTotal Past Due and
Non-accrual		CurrentTotal Loans
and Leases
Commercial non-mortgage$14,902 $580 $— $216,003 $231,485 $18,493,336 $18,724,821 
Asset-based— — — 44,353 44,353 1,305,653 1,350,006 
Commercial real estate6,267 345 — 200,947 207,559 14,332,147 14,539,706 
Multi-family9,745 — — 23,009 32,754 6,786,315 6,819,069 
Equipment financing683 231 — 14,989 15,903 1,202,373 1,218,276 
Commercial portfolio31,597 1,156 — 499,301 532,054 42,119,824 42,651,878 
Residential8,884 3,769 — 16,024 28,677 9,303,736 9,332,413 
Home equity6,077 2,339 — 18,421 26,837 1,358,909 1,385,746 
Other consumer743 387 — 409 1,539 300,383 301,922 
Consumer portfolio15,704 6,495 — 34,854 57,053 10,963,028 11,020,081 
Total$47,301 $7,651 $— $534,155 $589,107 $53,082,852 $53,671,959 
 December 31, 2024
(In thousands)30-59 Days
Past Due and
Accruing		60-89 Days
Past Due and
Accruing		90 or More Days Past Due
and Accruing		Non-accrualTotal Past Due and
Non-accrual
Current (1)
Total Loans
and Leases
Commercial non-mortgage$3,949 $3,318 $— $248,078 $255,345 $17,782,597 $18,037,942 
Asset-based— 21,997 — 20,787 42,784 1,361,223 1,404,007 
Commercial real estate22,115 558 — 120,151 142,824 14,349,612 14,492,436 
Multi-family2,508 26,377 — 18,043 46,928 6,851,672 6,898,600 
Equipment financing6,096 3,300 — 19,367 28,763 1,206,253 1,235,016 
Commercial portfolio34,668 55,550 — 426,426 516,644 41,551,357 42,068,001 
Residential9,595 4,604 — 12,750 26,949 8,826,720 8,853,669 
Home equity6,273 2,381 — 21,425 30,079 1,397,613 1,427,692 
Other consumer349 162 — 124 635 155,171 155,806 
Consumer portfolio16,217 7,147 — 34,299 57,663 10,379,504 10,437,167 
Total$50,885 $62,697 $— $460,725 $574,307 $51,930,861 $52,505,168 
(1)At December 31, 2024, there were $32.7 million of commercial loans that had reached their contractual maturity but were actively in the process of being refinanced with the Company. Due to the status of the refinancing, these commercial loans have been reported as current in the table above.
The following table provides additional information on non-accrual loans and leases:
June 30, 2025December 31, 2024
(In thousands)Non-accrualNon-accrual with No AllowanceNon-accrualNon-accrual with No Allowance
Commercial non-mortgage$216,003 $42,997 $248,078 $50,943 
Asset-based44,353 18,262 20,787 1,080 
Commercial real estate200,947 37,160 120,151 26,666 
Multi-family23,009 22,877 18,043 17,953 
Equipment financing14,989 1,039 19,367 1,809 
Commercial portfolio499,301 122,335 426,426 98,451 
Residential16,024 7,223 12,750 6,923 
Home equity18,421 9,914 21,425 12,225 
Other consumer409 2 124 3 
Consumer portfolio34,854 17,139 34,299 19,151 
Total $534,155 $139,474 $460,725 $117,602 
Summary of Activity on Loans and Leases
The following table summarizes the change in the ACL on loans and leases by portfolio segment:
Three months ended June 30,
20252024
(In thousands)Commercial PortfolioConsumer PortfolioTotalCommercial PortfolioConsumer PortfolioTotal
ACL on loans and leases:
Balance, beginning of period$649,450 $63,871 $713,321 $589,109 $52,333 $641,442 
Provision (benefit)45,635 (509)45,126 65,607 (4,566)61,041 
Charge-offs(39,792)(1,446)(41,238)(33,356)(1,418)(34,774)
Recoveries3,250 1,587 4,837 360 1,286 1,646 
Balance, end of period$658,543 $63,503 $722,046 $621,720 $47,635 $669,355 
 Six months ended June 30,
20252024
(In thousands)Commercial PortfolioConsumer PortfolioTotalCommercial PortfolioConsumer PortfolioTotal
ACL on loans and leases:
Balance, beginning of period$635,871 $53,695 $689,566 $577,663 $58,074 $635,737 
Provision (benefit)113,838 10,000 123,838 114,961 (10,726)104,235 
Charge-offs(95,358)(2,498)(97,856)(71,817)(2,748)(74,565)
Recoveries4,192 2,306 6,498 913 3,035 3,948 
Balance, end of period (1)
$658,543 $63,503 $722,046 $621,720 $47,635 $669,355 
Individually evaluated for credit losses95,323 811 96,134 66,943 649 67,592 
Collectively evaluated for credit losses$563,220 $62,692 $625,912 $554,777 $46,986 $601,763 
(1)The $32.4 million increase in the ACL on loans and leases from December 31, 2024, to June 30, 2025, is primarily due to additional reserves resulting from uncertainty in the current macroeconomic environment and organic loan growth, partially offset by net charge-offs and improvements in risk rating migration.
Summary of Amortized Cost Basis of Loans and Leases
The following tables summarize the amortized cost basis of commercial loans and leases by Composite Credit Risk Profile grade and origination year:
June 30, 2025
(In thousands)20252024202320222021PriorRevolving Loans Amortized Cost BasisTotal
Commercial non-mortgage:
Risk rating:
Pass$1,426,513 $2,647,354 $1,654,046 $2,464,246 $1,161,443 $1,581,608 $6,721,873 $17,657,083 
Special mention— 36,433 59,114 126,804 91 — 34,158 256,600 
Substandard44,829 46,676 156,110 207,319 90,287 92,189 173,378 810,788 
Doubtful— — — — 43 306 1 350 
Total commercial non-mortgage1,471,342 2,730,463 1,869,270 2,798,369 1,251,864 1,674,103 6,929,410 18,724,821 
Current period gross write-offs1,317 1,242 7,673 5,780 489 8,960 18,291 43,752 
Asset-based:
Risk rating:
Pass2,850 225 10,311 — — 18,246 1,078,602 1,110,234 
Special mention1,562 — — — — 4,818 40,524 46,904 
Substandard— — 2,508 — — 6 190,354 192,868 
Total asset-based4,412 225 12,819 — — 23,070 1,309,480 1,350,006 
Current period gross write-offs— — — — — — 15,975 15,975 
Commercial real estate:
Risk rating:
Pass1,260,773 1,991,259 2,114,596 2,801,954 1,277,393 3,970,260 209,486 13,625,721 
Special mention— — 32,092 148,656 — 82,073 — 262,821 
Substandard— 3,301 134,861 64,746 82,636 364,408 1,212 651,164 
Total commercial real estate1,260,773 1,994,560 2,281,549 3,015,356 1,360,029 4,416,741 210,698 14,539,706 
Current period gross write-offs— — 13,986 255 1,283 18,216 — 33,740 
Multi-family:
Risk rating:
Pass112,060 594,573 1,349,648 1,354,503 855,885 2,164,313 16,997 6,447,979 
Special mention153 — — 114,867 22,725 105,713 — 243,458 
Substandard— — 14,294 16,634 26,950 69,754 — 127,632 
Total multi-family112,213 594,573 1,363,942 1,486,004 905,560 2,339,780 16,997 6,819,069 
Current period gross write-offs— — — — — 247 — 247 
Equipment financing:
Risk rating:
Pass207,586 349,272 202,534 160,138 88,827 140,480 — 1,148,837 
Special mention— — 4,711 13,511 464 1,350 — 20,036 
Substandard3,612 831 10,959 15,718 10,716 7,567 — 49,403 
Total equipment financing211,198 350,103 218,204 189,367 100,007 149,397 — 1,218,276 
Current period gross write-offs1,568 — 67 — 9 — — 1,644 
Total commercial portfolio3,059,938 5,669,924 5,745,784 7,489,096 3,617,460 8,603,091 8,466,585 42,651,878 
Current period gross write-offs$2,885 $1,242 $21,726 $6,035 $1,781 $27,423 $34,266 $95,358 
December 31, 2024
(In thousands)20242023202220212020PriorRevolving Loans Amortized Cost BasisTotal
Commercial non-mortgage:
Risk rating:
Pass$2,917,048 $1,916,905 $2,818,720 $1,100,575 $562,252 $1,211,312 $6,325,637 $16,852,449 
Special mention31,587 66,770 156,555 51,055 30,669 4,203 44,017 384,856 
Substandard56,307 125,735 237,362 92,134 16,466 63,998 208,608 800,610 
Doubtful— — — 1 — 25 1 27 
Total commercial non-mortgage3,004,942 2,109,410 3,212,637 1,243,765 609,387 1,279,538 6,578,263 18,037,942 
Current period gross write-offs— 11,894 45,308 10,668 3,842 3,385 15,169 90,266 
Asset-based:
Risk rating:
Pass1,250 11,684 — — — 20,255 1,132,901 1,166,090 
Special mention— — — — — 5,226 90,372 95,598 
Substandard— 2,562 — — — 1,239 138,518 142,319 
Total asset-based1,250 14,246 — — — 26,720 1,361,791 1,404,007 
Current period gross write-offs— — — — — — 6,091 6,091 
Commercial real estate:
Risk rating:
Pass1,867,468 2,334,965 3,186,098 1,462,814 944,367 3,465,817 197,998 13,459,527 
Special mention— 12,809 175,252 37,307 37,469 64,483 — 327,320 
Substandard— 131,108 69,829 121,139 112,582 262,079 8,852 705,589 
Total commercial real estate1,867,468 2,478,882 3,431,179 1,621,260 1,094,418 3,792,379 206,850 14,492,436 
Current period gross write-offs— 854 1,244 1,579 15,477 22,674 — 41,828 
Multi-family:
Risk rating:
Pass582,363 1,394,855 1,314,395 862,273 245,802 2,179,207 16,991 6,595,886 
Special mention— 14,365 93,396 18,790 70,908 8,588 — 206,047 
Substandard— — 16,761 27,102 26,720 26,084 — 96,667 
Total multi-family582,363 1,409,220 1,424,552 908,165 343,430 2,213,879 16,991 6,898,600 
Current period gross write-offs— — — 4,955 6,264 11,678 — 22,897 
Equipment financing:
Risk rating:
Pass382,783 242,440 207,081 126,399 83,838 124,910 — 1,167,451 
Special mention1,298 231 — 55 — — — 1,584 
Substandard572 16,228 18,341 16,970 5,514 8,356 — 65,981 
Total equipment financing384,653 258,899 225,422 143,424 89,352 133,266 — 1,235,016 
Current period gross write-offs— 5,146 1,705 52 — 3,475 — 10,378 
Total commercial portfolio5,840,676 6,270,657 8,293,790 3,916,614 2,136,587 7,445,782 8,163,895 42,068,001 
Current period gross write-offs$— $17,894 $48,257 $17,254 $25,583 $41,212 $21,260 $171,460 
The following tables summarize the amortized cost basis of consumer loans by FICO score and origination year:
June 30, 2025
(In thousands)20252024202320222021PriorRevolving Loans Amortized Cost BasisTotal
Residential:
Risk rating:
800+$191,796 $501,827 $298,943 $919,014 $1,087,229 $1,311,324 $— $4,310,133 
740-799401,252 546,890 227,983 531,523 629,765 812,135 — 3,149,548 
670-73997,051 162,365 100,743 297,619 237,615 625,265 — 1,520,658 
580-6696,680 20,747 22,924 53,824 43,214 111,958 — 259,347 
579 and below— 915 3,393 15,653 22,914 49,852 — 92,727 
Total residential696,779 1,232,744 653,986 1,817,633 2,020,737 2,910,534 — 9,332,413 
Current period gross write-offs— — — — — 15 — 15 
Home equity:
Risk rating:
800+5,930 11,151 25,589 25,595 30,833 70,449 349,518 519,065 
740-7997,838 12,907 18,702 16,799 22,594 40,189 317,213 436,242 
670-7395,352 10,143 12,131 9,648 11,091 32,121 228,224 308,710 
580-669469 1,555 1,898 2,864 2,927 9,883 60,667 80,263 
579 and below152 215 1,457 2,319 573 4,908 31,842 41,466 
Total home equity19,741 35,971 59,777 57,225 68,018 157,550 987,464 1,385,746 
Current period gross write-offs— 50 — — — 29 161 240 
Other consumer:
Risk rating:
800+3,318 7,264 317 141 1,725 148 14,477 27,390 
740-79934,320 66,461 466 241 214 231 4,287 106,220 
670-73950,326 93,010 408 236 97 162 18,444 162,683 
580-6691,261 2,242 93 115 31 96 1,093 4,931 
579 and below2 55 77 46 28 36 454 698 
Total other consumer89,227 169,032 1,361 779 2,095 673 38,755 301,922 
Current period gross write-offs1,198 901 8 4 8 27 97 2,243 
Total consumer portfolio805,747 1,437,747 715,124 1,875,637 2,090,850 3,068,757 1,026,219 11,020,081 
Current period gross write-offs$1,198 $951 $8 $4 $8 $71 $258 $2,498 
December 31, 2024
(In thousands)20242023202220212020PriorRevolving Loans Amortized Cost BasisTotal
Residential:
Risk rating:
800+$312,771 $299,006 $909,109 $1,097,807 $433,950 $956,478 $— $4,009,121 
740-799649,118 258,699 567,545 656,599 235,749 623,989 — 2,991,699 
670-739172,886 123,354 317,373 271,247 80,318 550,252 — 1,515,430 
580-66916,643 13,382 55,507 35,292 16,738 109,240 — 246,802 
579 and below237 2,680 12,617 21,387 3,791 49,905 — 90,617 
Total residential1,151,655 697,121 1,862,151 2,082,332 770,546 2,289,864 — 8,853,669 
Current period gross write-offs— — — — — 147 — 147 
Home equity:
Risk rating:
800+12,313 25,226 23,512 32,695 22,705 53,844 365,741 536,036 
740-79912,238 21,831 20,718 23,517 10,861 33,703 330,691 453,559 
670-73911,416 14,298 12,732 13,074 6,242 28,638 224,449 310,849 
580-6691,755 2,570 1,685 2,172 754 9,471 67,745 86,152 
579 and below58 799 2,401 726 429 4,254 32,429 41,096 
Total home equity37,780 64,724 61,048 72,184 40,991 129,910 1,021,055 1,427,692 
Current period gross write-offs— — — — 2 444 351 797 
Other consumer:
Risk rating:
800+4,920 312 218 1,765 50 284 31,549 39,098 
740-79945,001 721 301 165 124 266 3,550 50,128 
670-73957,952 432 372 313 220 188 3,349 62,826 
580-6691,417 116 105 69 25 81 1,150 2,963 
579 and below29 93 63 28 9 — 569 791 
Total other consumer109,319 1,674 1,059 2,340 428 819 40,167 155,806 
Current period gross write-offs3,467 17 34 20 113 193 222 4,066 
Total consumer portfolio1,298,754 763,519 1,924,258 2,156,856 811,965 2,420,593 1,061,222 10,437,167 
Current period gross write-offs$3,467 $17 $34 $20 $115 $784 $573 $5,010 
The following tables summarize the amortized cost basis at June 30, 2025, and 2024, of loans modified to borrowers experiencing financial difficulty, disaggregated by class and type of concession granted:
Three months ended June 30, 2025
Combination
(Dollars in thousands)Interest Rate ReductionTerm ExtensionPayment DelayTerm Extension & Interest Rate ReductionTerm Extension & Payment DelayInterest Rate Reduction & Payment DelayTerm Extension, Interest Rate Reduction, & Payment DelayTotal
% of Total
Class (2)
Commercial non-mortgage$—$43,425$13,161$399$51,313$—$77$108,3750.6  %
Asset-based—11,487—————11,4870.9 
Commercial real estate—18,978—————18,9780.1 
Multi-family1,9816,340———13,241—21,5620.3 
Equipment financing—3,842—————3,8420.3 
Home equity———26———26— 
Total (1)
$1,981$84,072$13,161$425$51,313$13,241$77$164,2700.3  %
Six months ended June 30, 2025
Combination
(Dollars in thousands)Interest Rate ReductionTerm ExtensionPayment DelayTerm Extension & Interest Rate ReductionTerm Extension & Payment Delay Interest Rate Reduction & Payment DelayTerm Extension, Interest Rate Reduction, & Payment DelayTotal
% of Total Class (2)
Commercial non-mortgage$—$84,290$13,161$506$51,313$—$77$149,3470.8  %
Asset-based—11,487—————11,4870.9 
Commercial real estate—39,607512————40,1190.3 
Multi-family1,9818,034———13,241—23,2560.3 
Equipment financing—4,032—————4,0320.3 
Residential———891———891— 
Home equity———66———66— 
Total (1)
$1,981$147,450$13,673$1,463$51,313$13,241$77$229,1980.4  %
Three months ended June 30, 2024
(Dollars in thousands)Term ExtensionPayment DelayCombination -
Term Extension & Interest Rate Reduction		Total
% of Total Class (2)
Commercial non-mortgage$69,182$61$189$69,4320.4  %
Asset-based6,150——6,1500.4 
Commercial real estate43,974359—44,3330.3 
Home equity45—56101— 
Total (1)
$119,351$420$245$120,0160.2  %
Six months ended June 30, 2024
(Dollars in thousands)Interest Rate ReductionTerm ExtensionPayment DelayCombination -
Term Extension & Interest Rate Reduction		Total
% of Total Class (2)
Commercial non-mortgage$11$86,150$42,825$1,267$130,2530.8  %
Asset-based—7,817——7,8170.5 
Commercial real estate—44,474359—44,8330.3 
Multi-family—9,481——9,4810.1 
Equipment financing—490——490— 
Residential626——133759— 
Home equity—45—121166— 
Total (1)
$637$148,457$43,184$1,521$193,7990.4  %
(1)The total amortized cost excludes accrued interest receivable of $0.5 million and $0.3 million for the three months ended June 30, 2025, and 2024, respectively, and $0.6 million and $0.4 million for the six months ended June 30, 2025, and 2024, respectively.
(2)Represents the total amortized cost of the loans modified as a percentage of the total period end loan balance by class.
The following tables describe the financial effect of the modifications made to borrowers experiencing financial difficulty:
Three months ended June 30, 2025
Financial Effect (1)
Interest Rate Reduction:
Multi-family
Reduced weighted average interset rate by 2.0%
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 1.4 years
Asset-based
Extended term by a weighted average of 1.0 year
Commercial real estate
Extended term by a weighted average of 0.4 years
Multi-family
Extended term by a weighted average of 3.0 years
Equipment financing
Extended term by a weighted average of 1.8 years
Payment Delay:
Commercial non-mortgage
Provided payment deferrals for a weighted average of 2.4 years
Combination - Term Extension & Payment Delay:
Commercial non-mortgage
Extended term by a weighted average of 0.3 years and provided payment deferrals for a weighted average of 0.5 years
Combination - Interest Rate Reduction & Payment Delay
Multi-family
Reduced weighted average interest rate by 2.0% and provided payment deferrals for a weighted average of 0.8 years
Six months ended June 30, 2025
Financial Effect (1)
Interest Rate Reduction:
Multi-family
Reduced weighted average interest rate by 2.0%
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 1.3 years
Asset-based
Extended term by a weighted average of 1.0 year
Commercial real estate
Extended term by a weighted average of 0.7 years
Multi-family
Extended term by a weighted average of 2.5 years
Equipment financing
Extended term by a weighted average of 1.8 years
Payment Delay:
Commercial non-mortgage
Provided payment deferrals for a weighted average of 2.4 years
Combination - Term Extension & Payment Delay:
Commercial non-mortgage
Extended term by a weighted average of 0.3 years and provided payment deferrals for a weighted average of 0.5 years
Combination - Interest Rate Reduction & Payment Delay:
Multi-family
Reduced weighted average interest rate by 2.0% and provided payment deferrals for a weighted average of 0.8 years
Three months ended June 30, 2024
Financial Effect (1)
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 0.6 years
Asset-based
Extended term by a weighted average of 0.5 years
Commercial real estate
Extended term by a weighted average of 1.1 years
Six months ended June 30, 2024
Financial Effect (1)
Term Extension:
Commercial non-mortgage
Extended term by a weighted average of 0.6 years
Asset-based
Extended term by a weighted average of 0.5 years
Commercial real estate
Extended term by a weighted average of 1.1 years
Multi-family
Extended term by a weighted average of 1.4 years
Payment Delay:
Commercial non-mortgage
Provided partial payment deferrals for a weighted average of 0.5 years
(1)Certain disclosures related to financial effects of modifications do not include those deemed to be immaterial.
Summary of Aging of Loans Modified in Twelve Months Preceding The following tables summarize the aging of loans that had been modified in the 12 months preceding June 30, 2025 and June 30, 2024:
June 30, 2025
(In thousands)Current30-59 Days
Past Due		60-89 Days
Past Due		90 or More
Days Past Due		Non-AccrualTotal
Commercial non-mortgage$77,346$3,819$—$—$144,026$225,191
Asset-based11,487———15,00026,487
Commercial real estate85,027———7,77192,798
Multi-family21,275———1,98123,256
Equipment financing4,032—99——4,131
Residential776———9981,774
Home equity583———215798
Total$200,526$3,819$99$—$169,991$374,435
June 30, 2024
(In thousands)Current30-59 Days
Past Due		60-89 Days
Past Due		90 or More
Days Past Due		Non-AccrualTotal
Commercial non-mortgage$53,156$1,375$—$—$120,775$175,306
Asset-based12,817————12,817
Commercial real estate38,327———23,61361,940
Multi-family————9,4819,481
Equipment financing196———581777
Residential268———626894
Home equity350———120470
Total$105,114$1,375$—$—$155,196$261,685
v3.25.2
Goodwill and Other Intangible Assets (Tables)
 6 Months Ended
Jun. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes changes in the carrying amount of goodwill:
(In thousands)June 30,
2025		December 31,
2024
Balance, beginning of period$2,868,068 $2,631,465 
Ametros acquisition (1)
— 236,603 
Balance, end of period$2,868,068 $2,868,068 
(1)Reflects the $228.2 million of goodwill recorded in connection with the Ametros acquisition in January 2024, and $8.4 million of other adjustments. The allocation of the purchase price and goodwill calculation for the Ametros acquisition was considered final as of December 31, 2024.
Schedule of Finite-Lived Intangible Assets
The following table summarizes other intangible assets:
 June 30, 2025December 31, 2024
(In thousands)Gross Carrying
Amount		Accumulated
Amortization		Net Carrying
Amount		Gross Carrying
Amount		Accumulated
Amortization		Net Carrying
Amount
Core deposits$328,837 $87,585 $241,252 $328,837 $76,795 $252,042 
Customer relationships122,063 53,716 68,347 122,063 47,186 74,877 
Non-competition agreement 4,000 2,000 2,000 4,000 1,600 2,400 
Trade name6,100 1,728 4,372 6,100 1,118 4,982 
Total other intangible assets$461,000 $145,029 $315,971 $461,000 $126,699 $334,301 
Schedule of Expected Amortization Expense
The remaining estimated aggregate future amortization expense for other intangible assets is as follows:
(In thousands)June 30,
2025
Remainder of 2025$17,721 
202634,083 
202733,033 
202830,162 
202928,289 
Thereafter172,683 
v3.25.2
Deposits (Tables)
 6 Months Ended
Jun. 30, 2025
Deposit Liabilities [Abstract]  
Summary of Deposits by Type
The following table summarizes deposits by type:
(In thousands)June 30,
2025		December 31,
2024
Non-interest-bearing:
Demand$10,345,761 $10,316,501 
Interest-bearing:
Checking9,933,392 9,834,790 
Health savings accounts9,064,935 8,951,031 
Money market21,679,493 20,433,250 
Savings7,370,959 6,982,554 
Time deposits7,919,885 8,234,954 
Total interest-bearing$55,968,664 $54,436,579 
Total deposits$66,314,425 $64,753,080 
Time deposits, money market, and interest-bearing checking obtained through brokers (1)
$2,624,835 $3,181,298 
Aggregate amount of time deposit accounts that exceeded the FDIC limit (2)
1,465,572 1,407,077 
Deposit overdrafts reclassified as loan balances5,064 7,146 
(1)Excludes money market deposits received through interSYNC of $8.7 billion at June 30, 2025, and $7.3 billion at December 31, 2024.
(2)Excludes an aggregate amount of time deposit accounts that were at the FDIC limit of $19.3 million at June 30, 2025, and $16.8 million at December 31, 2024.
Scheduled Maturities of Time Deposits
The following table summarizes the scheduled maturities of time deposits:
(In thousands)June 30,
2025
Remainder of 2025$5,946,812 
20261,876,195 
202738,286 
202820,127 
202917,969 
Thereafter20,496 
Total time deposits$7,919,885 
v3.25.2
Borrowings (Tables)
 6 Months Ended
Jun. 30, 2025
Debt Disclosure [Abstract]  
Schedule of Repurchase Agreements
The following table summarizes securities sold under agreements to repurchase and federal funds purchased:
June 30, 2025December 31, 2024
(Dollars in thousands)Total OutstandingRateTotal OutstandingRate
Securities sold under agreements to repurchase (1)
$372,806 3.66 %$344,168 2.98 %
Securities sold under agreements to repurchase and federal funds purchased (2)
$372,806 3.66 %$344,168 2.98 %
(1)Securities sold under agreements to repurchase have an original maturity date of one year or less for the periods presented.
(2)There were no outstanding federal funds purchased at June 30, 2025, and December 31, 2024.
Summary of Repurchase Agreement Offsetting
The following tables represent the offsetting of repurchase agreements that are subject to master netting agreements:
June 30, 2025
Gross Amounts of Recognized LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)
Financial Instruments (1)
Cash Collateral PledgedNet Amount
Repurchase agreements$302,306 $— $302,306 $302,306 $— $— 
December 31, 2024
Gross Amounts of Recognized LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)
Financial Instruments (1)
Cash Collateral PledgedNet Amount
Repurchase agreements$209,961 $— $209,961 $209,961 $— $— 
(1)Amounts disclosed are limited to the balance of securities sold under agreements to repurchase reported on the accompanying Condensed Consolidated Balance Sheets that are subject to master netting agreements and, accordingly, exclude excess collateral pledged. At June 30, 2025, and December 31, 2024, Agency MBS with a carrying amount of $315.1 million and $220.6 million, respectively, were pledged as collateral against such securities sold under agreements to repurchase, resulting in excess collateral positions of $12.8 million and $10.6 million, respectively.
Summary of FHLB Advances
The following table summarizes information for FHLB advances:
June 30, 2025December 31, 2024
(Dollars in thousands)Total OutstandingWeighted-
Average Contractual Coupon Rate		Total OutstandingWeighted-
Average Contractual Coupon Rate
Maturing within 1 year$3,330,000 4.49 %$2,100,000 4.50 %
After 1 but within 2 years— — — — 
After 2 but within 3 years417 1.37 218 — 
After 3 but within 4 years— — 215 2.75 
After 4 but within 5 years629 1.75 642 1.75 
After 5 years8,868 2.02 9,033 2.02 
Total FHLB advances$3,339,914 4.48 %$2,110,108 4.49 %
Aggregate market value of assets pledged as collateral$16,530,103 $16,581,133 
Remaining borrowing capacity at FHLB7,557,549 8,670,348 
Schedule of Long-Term Debt
The following table summarizes long-term debt:
(Dollars in thousands)June 30,
2025		December 31,
2024
4.100%
Senior fixed-rate notes due March 25, 2029 (1)
$320,074 $322,751 
Subordinated floating-rate notes due December 30, 2029 (2)
274,000 274,000 
3.875%Subordinated fixed-to-floating rate notes due November 1, 2030225,000 225,000 
Junior subordinated debt Webster Statutory Trust I floating-rate notes due September 17, 2033 (3)
77,320 77,320 
Total senior and subordinated debt896,394 899,071 
Discount on senior fixed-rate notes(373)(423)
Debt issuance cost on senior fixed-rate notes(1,003)(1,137)
Premium on subordinated fixed-to-floating rate notes10,616 11,674 
Long-term debt (4)
$905,634 $909,185 
(1)The Company de-designated its fair value hedging relationship on these senior fixed-rate notes in 2020. A basis adjustment of $20.1 million and $22.8 million at June 30, 2025, and December 31, 2024, respectively, is included in the carrying value and is being amortized over the remaining life of the senior fixed-rate notes.
(2)The interest rate on the 2029 subordinated floating-rate notes varies quarterly based on 3-month term SOFR plus 253 basis points, which yielded 6.82% at June 30, 2025, and 6.84% at December 31, 2024.
(3)The interest rate on the Webster Statutory Trust I floating-rate notes varies quarterly based on 3-month SOFR plus a credit spread adjustment plus a market spread of 2.95%, which yielded 7.52% at June 30, 2025, and 7.56% at December 31, 2024.
(4)The classification of debt as long-term is based on the initial term of greater than one year as of the date of issuance.
v3.25.2
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of Stock by Class
The following table summarizes the changes in shares of preferred and common stock issued and common stock held as treasury shares:
Preferred Stock Series F IssuedPreferred Stock Series G IssuedCommon Stock IssuedTreasury Stock HeldCommon Stock Outstanding
Balance at March 31, 2025
6,000 135,000 182,778,045 14,183,769 168,594,276 
Stock compensation plan activity (1)
— — — (9,501)9,501 
Common stock repurchase program— — — 1,520,514 (1,520,514)
Balance at June 30, 2025
6,000 135,000 182,778,045 15,694,782 167,083,263 
Balance at March 31, 2024
6,000 135,000 182,778,045 10,314,159 172,463,886 
Stock compensation plan activity (1)
— — — 87,634 (87,634)
Common stock repurchase program— — — 974,365 (974,365)
Balance at June 30, 2024
6,000 135,000 182,778,045 11,376,158 171,401,887 
Preferred Stock Series F IssuedPreferred Stock Series G IssuedCommon Stock IssuedTreasury Stock HeldCommon Stock Outstanding
Balance at December 31, 2024
6,000 135,000 182,778,045 11,386,920 171,391,125 
Stock compensation plan activity (1)
— — — (782,106)782,106 
Common stock repurchase program— — — 5,089,968 (5,089,968)
Balance at June 30, 2025
6,000 135,000 182,778,045 15,694,782 167,083,263 
Balance at December 31, 2023
6,000 135,000 182,778,045 10,756,089 172,021,956 
Stock compensation plan activity (1)
— — — (788,357)788,357 
Common stock repurchase program— — — 1,408,426 (1,408,426)
Balance at June 30, 2024
6,000 135,000 182,778,045 11,376,158 171,401,887 
(1)Reflects (i) common shares issued from Treasury stock for time-based restricted stock award grants, net of forfeitures, and the vesting of performance-based restricted stock awards of 17,602 and (19,350), in aggregate, during the three months ended June 30 2025, and 2024, respectively, and 1,174,880 and 1,137,889, in aggregate, during the six months ended June 30, 2025, and 2024, respectively; less (ii) common shares acquired outside of the Company’s common stock repurchase program related to stock compensation plan activity of 8,101 and 68,284 during the three months ended June 30, 2025, and 2024, respectively, and 392,774 and 349,532 during the six months ended June 30, 2025, and 2024, respectively.
v3.25.2
Accumulated Other Comprehensive (Loss), Net of Tax (Tables)
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of Other Comprehensive Income (Loss)
The following tables summarize the change in each component of accumulated other comprehensive (loss), net of the related tax impact:
Three months ended June 30, 2025Six months ended June 30, 2025
(In thousands)Investment Securities Available-
for-Sale		Derivative
Financial Instruments		Defined Benefit Pension and Other Postretirement Benefit PlansTotalInvestment Securities Available-for-SaleDerivative Financial InstrumentsDefined Benefit Pension and Other Postretirement Benefit PlansTotal
Balance, beginning of period$(423,737)$524 $(26,188)$(449,401)$(520,318)$(9,600)$(26,465)$(556,383)
Other comprehensive income before reclassifications8,858 44 — 8,902 105,824 7,796 — 113,620 
Amounts reclassified from accumulated other comprehensive (loss) income— 1,960 277 2,237 (385)4,332 554 4,501 
Other comprehensive income, net of tax8,858 2,004 277 11,139 105,439 12,128 554 118,121 
Balance, end of period$(414,879)$2,528 $(25,911)$(438,262)$(414,879)$2,528 $(25,911)$(438,262)
Three months ended June 30, 2024Six months ended June 30, 2024
(In thousands)Investment Securities Available-
for-Sale		Derivative
Financial Instruments		Defined Benefit Pension and Other Postretirement Benefit PlansTotalInvestment Securities Available-for-SaleDerivative Financial InstrumentsDefined Benefit Pension and Other Postretirement Benefit PlansTotal
Balance, beginning of period$(553,721)$(32,858)$(29,522)$(616,101)$(517,450)$(2,869)$(30,252)$(550,571)
Other comprehensive (loss) before reclassifications(43,970)(10,243)(858)(55,071)(86,560)(48,181)(607)(135,348)
Amounts reclassified from accumulated other comprehensive (loss)34,161 8,633 479 43,273 40,480 16,582 958 58,020 
Other comprehensive (loss) income, net of tax(9,809)(1,610)(379)(11,798)(46,080)(31,599)351 (77,328)
Balance, end of period$(563,530)$(34,468)$(29,901)$(627,899)$(563,530)$(34,468)$(29,901)$(627,899)
Schedule of Accumulated Other Comprehensive Income (Loss)
The following table further summarizes the amounts reclassified from accumulated other comprehensive (loss):
Accumulated Other Comprehensive
(Loss) Components		Three months endedSix months endedAssociated Line Item on the Condensed Consolidated Statements of Income
June 30,June 30,
2025202420252024
(In thousands)
Investment securities available-for-sale:
Net unrealized gains (losses) (1)
$— $(46,496)$528 $(55,183)
Non-interest income (2)
Tax benefit— 12,335 (143)14,703 Income tax expense
Net of tax$— $(34,161)$385 $(40,480)
Derivative financial instruments:
Interest payments (3)
$(2,689)$(11,630)$(5,944)$(22,122)Interest and fees on loans and leases
Hedge terminations— — — (34)Long-term debt interest expense
Premium amortization— (217)— (489)Interest and fees on loans and leases
Tax benefit729 3,214 1,612 6,063 Income tax expense
Net of tax$(1,960)$(8,633)$(4,332)$(16,582)
Defined benefit pension and other postretirement benefit plans:
Actuarial net loss amortization$(380)$(658)$(760)$(1,315)Other expense
Tax benefit103 179 206 357 Income tax expense
Net of tax$(277)$(479)$(554)$(958)
(1)Reclassification adjustments for net unrealized gains (losses) on investment securities available-for-sale that were sold during the reporting period are determined by reference to the unrealized gain or loss reported in the previous reporting period.
(2)Gains and losses realized on sale of investment securities available-for-sale are generally included as a component of non-interest income on the accompanying Condensed Consolidated Statements of Income unless any portion or all of the loss is due to credit related factors, in which the amount is then included in the Provision for credit losses. Additional information regarding the presentation of gains and losses realized on sale of investment securities available-for-sale for the three and six months ended June 30, 2025, and 2024, respectively, can be found within Note 3: Investment Securities.
(3)Over the next 12 months, an estimated $0.3 million related to cash flow hedge gain or loss will be reclassified from AOCL, decreasing Interest and fees on loans and leases as hedge interest payments are made.
v3.25.2
Regulatory Capital and Restrictions (Tables)
 6 Months Ended
Jun. 30, 2025
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]  
Schedule of Information on Capital Ratios
The following tables provides information on the capital ratios for the Company and the Bank:
June 30, 2025
 ActualMinimum RequirementWell Capitalized
(Dollars in thousands)AmountRatioAmountRatioAmountRatio
Webster Financial Corporation
CET1 Risk-Based Capital$6,406,260 11.35 %$2,539,270 4.5 %$3,667,835 6.5 %
Tier 1 Risk-Based Capital6,690,239 11.86 3,385,694 6.0 4,514,258 8.0 
Total Risk-Based Capital7,927,728 14.05 4,514,258 8.0 5,642,823 10.0 
Tier 1 Leverage Capital 6,690,239 8.57 3,121,275 4.0 3,901,593 5.0 
Webster Bank
CET1 Risk-Based Capital$7,076,737 12.55 %$2,538,304 4.5 %$3,666,439 6.5 %
Tier 1 Risk-Based Capital7,076,737 12.55 3,384,405 6.0 4,512,540 8.0 
Total Risk-Based Capital7,782,131 13.80 4,512,540 8.0 5,640,675 10.0 
Tier 1 Leverage Capital 7,076,737 9.08 3,118,568 4.0 3,898,210 5.0 
December 31, 2024
 
Actual (1)
Minimum RequirementWell Capitalized
(Dollars in thousands)AmountRatioAmountRatioAmountRatio
Webster Financial Corporation
CET1 Risk-Based Capital$6,318,876 11.54 %$2,464,542 4.5 %$3,559,895 6.5 %
Tier 1 Risk-Based Capital6,602,855 12.06 3,286,057 6.0 4,381,409 8.0 
Total Risk-Based Capital7,800,717 14.24 4,381,409 8.0 5,476,761 10.0 
Tier 1 Leverage Capital 6,602,855 8.70 3,034,369 4.0 3,792,961 5.0 
Webster Bank
CET1 Risk-Based Capital$6,847,474 12.53 %$2,460,031 4.5 %$3,553,378 6.5 %
Tier 1 Risk-Based Capital6,847,474 12.53 3,280,042 6.0 4,373,389 8.0 
Total Risk-Based Capital7,512,143 13.74 4,373,389 8.0 5,466,736 10.0 
Tier 1 Leverage Capital 6,847,474 9.04 3,031,190 4.0 3,788,988 5.0 
(1)In accordance with regulatory capital rules, the Company elected to delay the estimated impact of the adoption of CECL on its regulatory capital over a two-year deferral period, which ended on January 1, 2022, and a subsequent three-year transition period, which ended on December 31, 2024. During the three-year transition period, regulatory capital ratios phased out the aggregate amount of the regulatory capital benefit provided from the delayed CECL adoption in the initial two years. For 2024, the Company was allowed 25% of the regulatory capital benefit as of December 31, 2021. Full absorption occurred in 2025.
v3.25.2
Variable Interest Entities (Tables)
 6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of LIHTC Investments and Commitments
The following table summarizes the Company’s LIHTC investments and related unfunded commitments:
(In thousands)June 30, 2025December 31, 2024
Gross investment in LIHTC investments$1,538,516 $1,439,461 
Accumulated amortization(288,773)(222,101)
Net investment in LIHTC investments$1,249,743 $1,217,360 
Unfunded commitments for LIHTC investments$700,153 $720,890 
Schedule of Components of Income Tax Expense (Benefit)
The following table summarizes the amount of income tax credits and other income tax benefits, and investment amortization generated from the Company’s LIHTC investments, which are recognized as a component of income tax expense on the accompanying Condensed Consolidated Statements of Income:
Three months ended June 30,Six months ended June 30,
(In thousands)2025202420252024
Income tax credits and other income tax benefits from LIHTC investments$(40,093)$(27,182)$(81,799)$(55,206)
Investment amortization from LIHTC investments34,611 21,836 66,672 42,249 
v3.25.2
Earnings Per Common Share (Tables)
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share Basic and Diluted
The following table summarizes the calculation of basic and diluted earnings per common share:
 Three months ended June 30,Six months ended June 30,
(In thousands, except per share data)2025202420252024
Net income$258,848 $181,633 $485,765 $397,956 
Less: Preferred stock dividends4,162 4,162 8,325 8,325 
  Income allocated to participating securities2,991 1,977 5,361 4,090 
Net income applicable to common stockholders$251,695 $175,494 $472,079 $385,541 
Weighted-average common shares outstanding - basic165,884 169,675 167,524 170,061 
Add: Effect of dilutive stock options and restricted stock247 262 329 290 
Weighted-average common shares - diluted166,131 169,937 167,853 170,351 
Earnings per common share - basic$1.52 $1.03 $2.82 $2.27 
Earnings per common share - diluted1.52 1.03 2.81 2.26 
v3.25.2
Derivative Financial Instruments (Tables)
 6 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amounts and Fair Values
The following tables present the notional amounts and fair values, including accrued interest, of derivative positions:
June 30, 2025
Asset DerivativesLiability Derivatives
(In thousands)Notional AmountsFair ValueNotional AmountsFair Value
Designated in hedge relationships:
Interest rate derivatives (1)
$3,500,000 $5,666 $1,750,000 $1,475 
Not designated in hedge relationships:
Interest rate derivatives (1)
8,495,135 241,293 9,406,550 240,723 
Mortgage banking derivatives 364 3 — — 
Other (2)
279,668 593 788,112 1,589 
Total not designated as hedging instruments8,775,167 241,889 10,194,662 242,312 
Gross derivative instruments, before netting$12,275,167 247,555 $11,944,662 243,787 
Less: Master netting agreements59,898 59,898 
Cash collateral pledged114,607 15,860 
Total derivative instruments, after netting$73,050 $168,029 
December 31, 2024
Asset DerivativesLiability Derivatives
(In thousands)Notional AmountsFair ValueNotional AmountsFair Value
Designated in hedge relationships:
Interest rate derivatives (1)
$750,000 $719 $4,250,000 $13,169 
Not designated in hedge relationships:
Interest rate derivatives (1)
8,693,493 300,120 8,728,767 298,296 
Mortgage banking derivatives 584 3 — — 
Other (2)
337,370 1,300 833,449 96 
Total not designated as hedging instruments9,031,447 301,423 9,562,216 298,392 
Gross derivative instruments, before netting$9,781,447 302,142 $13,812,216 311,561 
Less: Master netting agreements31,881 31,881 
Cash collateral pledged251,212 80 
Total derivative instruments, after netting$19,049 $279,600 
(1)The notional amount of interest rate swaps that were centrally-cleared through clearing housings was $68.1 million at June 30, 2025, and $71.1 million at December 31, 2024, for asset derivatives, and $4.2 million at June 30, 2025 and zero at December 31, 2024, for liability derivatives. Interest rate swaps that are centrally-cleared through clearing houses are “settled-to-market” and considered a single unit of account. In accordance with their rule books, clearing houses record the variation margin transferred for settled-to-market derivatives as a legal settlement of the derivative contract (i.e., the variation margin legally settles the outstanding exposure, but does not result in any other change or reset of the contractual terms of the derivative). The fair values of the Company’s settled-to-market interest rate swaps are presented net on the accompanying Condensed Consolidated Balance Sheets and approximated zero.
(2)Other derivatives not designated in hedge relationships include foreign currency forward contracts related to lending arrangements, a Visa equity swap transaction, and risk participation agreements. Notional amounts of risk participation agreements were $265.4 million at June 30, 2025, and $294.5 million at December 31, 2024, for asset derivatives, and $712.6 million at June 30, 2025, and $796.6 million at December 31, 2024, for liability derivatives, all of which had immaterial related fair values.
Summary of Income Statement Effect of Derivatives Designated as Hedging Instruments
The following tables represent the off-setting derivative financial instruments that are subject to master netting agreements:
June 30, 2025
Gross Amounts of Recognized Assets/LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Assets/Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)Financial InstrumentsCash Collateral PledgedNet Amount
Asset derivatives$174,505 $59,898 $114,607 $— $114,607 $— 
Liability derivatives76,369 59,898 16,471 — 15,860 611 
December 31, 2024
Gross Amounts of Recognized Assets/LiabilitiesGross Amounts Offset in the Statement of Financial PositionNet Amounts of Assets/Liabilities Presented in the Statement of Financial PositionGross Amounts Not Offset in the Statement of Financial Position
(In thousands)Financial InstrumentsCash Collateral PledgedNet Amount
Asset derivatives$283,185 $31,881 $251,304 $— $251,212 $92 
Liability derivatives32,218 31,881 337 — 80 257 
Schedule of Derivative Financial Instruments
The following table summarizes the income statement effect of derivatives designated in hedge relationships:
Recognized inThree months ended June 30,Six months ended June 30,
(In thousands)Net Interest Income2025202420252024
Fair value hedges:
Interest rate derivativesDeposits interest expense$— $— $— $(1,320)
Net recognized on fair value hedges (1)
$— $— $— $1,320 
Cash flow hedges:
Interest rate derivativesLong-term debt interest expense$— $— $— $34 
Interest rate derivativesInterest and fees on loans and leases(2,689)(11,847)(5,944)(22,611)
Net recognized on cash flow hedges (2)
$(2,689)$(11,847)$(5,944)$(22,645)
(1)The Company de-designated its fair value hedging relationship on $400.0 million of deposits, which pertained to a portion of Ametros’ member deposits, in 2023. The $1.3 million basis adjustment included in the carrying amount of deposits at December 31, 2023, was recognized in interest expense in January 2024 upon the acquisition of Ametros.
(2)Additional information regarding the amounts recognized in net income related to cash flow hedge activities can be found within
Note 9: Accumulated Other Comprehensive (Loss), Net of Tax.
Summary of Income Statement Effect of Derivatives Not Designated as Hedging Instruments
The following table summarizes the income statement effect of derivatives not designated in hedge relationships:
Recognized inThree months ended June 30,Six months ended June 30,
(In thousands)Non-interest Income2025202420252024
Interest rate derivativesOther income$896 $(1,734)$(1,928)$(444)
Mortgage banking derivativesOther income(14)(8)(1)(30)
OtherOther income(4,020)659 (5,007)1,936 
Total not designated as hedging instruments$(3,138)$(1,083)$(6,936)$1,462 
v3.25.2
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Summary of Comparison to Loans Held-for-Sale
The following table compares the fair value to the UPB of residential mortgage loans originated for sale:
June 30, 2025December 31, 2024
(In thousands)Fair ValueUPBDifferenceFair ValueUPBDifference
Originated loans held for sale$75 $75 $— $297 $283 $14 
Summary of Unobservable Inputs
The following tables summarize the unobservable inputs used to derive the estimated fair value of the Company’s contingent consideration liabilities (dollars in thousands):
June 30, 2025
AgreementMaximum AmountProbability of AchievementPayment Term
(in years)		Discount RateFair Value
(i) Re-sign broker dealers$20799.0 %0.386.40 %$182
(ii) Deposit program growth (1) (2)
n/an/an/an/an/a
December 31, 2024
AgreementMaximum AmountProbability of AchievementPayment Term
(in years)		Discount RateFair Value
(i) Re-sign broker dealers $20799.0 %0.886.40 %$182
(ii) Deposit program growth (1) (2)
$12,500100.0 %0.506.40 %$11,568
(1)During the first quarter of 2025, the Company re-evaluated its estimate of the forecasted achievement date (payment term) for the deposit program growth event earn-out, which resulted in a revised expected achievement date of April 30, 2025, instead of June 30, 2025. This change in estimate resulted in an increase in fair value of $0.9 million.
(2)The Company generated the required $2.5 billion in new broker dealer deposit programs in April 2025, which resulted in the cash payment of $12.5 million on April 22, 2025, to settle its contingent consideration obligation with StoneCastle Partners LLC in accordance with the purchase agreement.
Summary of Fair Values of Assets and Liabilities Measured at Fair Value
The following tables summarize the fair values of assets and liabilities measured at fair value on a recurring basis:
 June 30, 2025
(In thousands)Level 1Level 2Level 3Total
Financial Assets:
Available-for-sale securities:
Government agency debentures$— $192,436 $— $192,436 
Municipal bonds and notes— 103,808 — 103,808 
Agency CMO— 27,113 — 27,113 
Agency MBS— 4,831,605 — 4,831,605 
Agency CMBS— 3,224,198 — 3,224,198 
CMBS— 790,132 — 790,132 
Corporate debt— 403,373 — 403,373 
Private label MBS— 38,364 — 38,364 
Other— 9,325 — 9,325 
Total available-for-sale securities— 9,620,354 — 9,620,354 
Gross derivative instruments, before netting (1)
535 247,020 — 247,555 
Originated loans held for sale— 75 — 75 
Investments held in Rabbi Trusts12,900 — — 12,900 
Alternative investments measured at NAV (2)
— — — 50,453 
Total financial assets$13,435 $9,867,449 $— $9,931,337 
Financial Liabilities:
Gross derivative instruments, before netting (1)
$1,515 $242,272 $— $243,787 
Contingent consideration— — 182 182 
Total financial liabilities$1,515 $242,272 $182 $243,969 
 December 31, 2024
(In thousands)Level 1Level 2Level 3Total
Financial Assets:
Available-for-sale securities:
Government agency debentures$— $186,426 $— $186,426 
Municipal bonds and notes— 110,876 — 110,876 
Agency CMO— 29,043 — 29,043 
Agency MBS— 4,519,785 — 4,519,785 
Agency CMBS— 3,034,392 — 3,034,392 
CMBS— 625,388 — 625,388 
Corporate debt— 452,266 — 452,266 
Private label MBS— 39,219 — 39,219 
Other— 9,205 — 9,205 
Total available-for-sale securities— 9,006,600 — 9,006,600 
Gross derivative instruments, before netting (1)
1,263 300,879 — 302,142 
Originated loans held for sale— 297 — 297 
Investments held in Rabbi Trusts13,438 — — 13,438 
Alternative investments measured at NAV (2)
— — — 43,360 
Total financial assets$14,701 $9,307,776 $— $9,365,837 
Financial Liabilities:
Gross derivative instruments, before netting (1)
$43 $311,518 $— $311,561 
Contingent consideration— — 11,750 11,750 
Total financial liabilities$43 $311,518 $11,750 $323,311 
(1)Additional information regarding the impact of netting derivative assets and derivative liabilities, as well as the impact from offsetting cash collateral with the same derivative counterparties, can be found within Note 13: Derivative Financial Instruments.
(2)Certain alternative investments are recorded at NAV. Assets measured at NAV are not classified within the fair value hierarchy.
Summary of Estimated Fair Values of Significant Financial Instruments
The following table summarizes the carrying amounts, estimated fair values, and classifications within the fair value hierarchy of selected financial instruments:
 June 30, 2025December 31, 2024
(In thousands)Carrying
Amount		Fair
Value		Carrying
Amount		Fair
Value
Assets:
Level 1
Cash and cash equivalents$2,993,919 $2,993,919 $2,074,434 $2,074,434 
Level 2
Held-to-maturity investment securities, net8,192,720 7,291,244 8,444,191 7,453,123 
Level 3
Loans and leases, net52,949,913 51,416,732 51,815,602 50,245,305 
Liabilities:
Level 2
Deposit liabilities$58,394,540 $58,394,540 $56,518,126 $56,518,126 
Time deposits7,919,885 7,895,161 8,234,954 8,211,582 
Securities sold under agreements to repurchase and federal funds purchased372,806 372,858 344,168 344,166 
FHLB advances3,339,914 3,337,057 2,110,108 2,107,790 
Long-term debt (1)
905,634 909,945 909,185 860,200 
(1)Any unamortized premiums/discounts, debt issuance costs, or basis adjustments to long-term debt, as applicable, are excluded from the determination of fair value.
v3.25.2
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Summary of Balance Sheet Information by Segment
The following table presents certain balance sheet financial information for the Company’s reportable segments:
June 30, 2025
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and ReconcilingConsolidated Total
Goodwill$1,960,363 $285,670 $622,035 $— $2,868,068 
Total assets43,908,431 477,234 13,499,277 24,029,328 81,914,270 
December 31, 2024
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and ReconcilingConsolidated Total
Goodwill (1)
$1,960,363 $285,670 $622,035 $— $2,868,068 
Total assets43,010,580 488,194 12,932,260 22,594,039 79,025,073 
(1)The allocation of the purchase price and goodwill calculation for the Ametros acquisition was considered final at December 31, 2024. The $228.2 million of goodwill recorded related to Ametros was allocated entirely to Healthcare Financial Services.
The following tables present certain income statement information for the Company’s reportable segments:
 Three months ended June 30, 2025
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$318,518 $97,625 $212,672 $628,815 
Non-interest income30,628 28,687 24,591 83,906 
Total segment revenues349,146 126,312 237,263 712,721 
Reconciliation of revenue:
Corporate and reconciling3,118 
Total consolidated revenues715,839 
Less:
Compensation and benefits50,807 24,171 37,285 
Occupancy (1)
— — 13,835 
Technology and equipment (1)
2,336 7,524 2,917 
Marketing— — 2,043 
Other segment items (1) (2) (3)
55,229 23,758 66,964 
Segment pre-tax, pre-provision net revenue240,774 70,859 114,219 425,852 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(55,727)
Total consolidated pre-tax, pre-provision net revenue370,125 
Total consolidated provision for credit losses46,500 
Total consolidated income before income taxes323,625 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $1.5 million for Healthcare Financial Services, and $2.4 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $2.7 million for Commercial Banking, $3.4 million for Healthcare Financial Services, and $1.8 million for Consumer Banking.
 Three months ended June 30, 2024
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$337,588 $91,664 $202,679 $631,931 
Non-interest income34,510 27,465 24,392 86,367 
Total segment revenues372,098 119,129 227,071 718,298 
Reconciliation of revenue:
Corporate and reconciling(103,703)
Total consolidated revenues614,595 
Less:
Compensation and benefits49,904 22,915 36,526 
Occupancy (1)
— — 13,683 
Technology and equipment (1)
2,051 8,092 2,331 
Marketing— — 1,714 
Other segment items (1) (2) (3)
52,633 20,260 61,651 
Segment pre-tax, pre-provision net revenue267,510 67,862 111,166 446,538 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(157,964)
Total consolidated pre-tax, pre-provision net revenue288,574 
Total consolidated provision for credit losses59,000 
Total consolidated income before income taxes229,574 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $1.3 million for Healthcare Financial Services, and $2.3 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $1.7 million for Commercial Banking, $3.6 million for Healthcare Financial Services, and $2.1 million for Consumer Banking.
 Six months ended June 30, 2025
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$637,641 $193,986 $414,736 $1,246,363 
Non-interest income59,586 58,077 50,795 168,458 
Total segment revenues697,227 252,063 465,531 1,414,821 
Reconciliation of revenue:
Corporate and reconciling5,816 
Total consolidated revenues1,420,637 
Less:
Compensation and benefits102,916 47,508 74,569 
Occupancy (1)
— — 28,183 
Technology and equipment (1)
4,447 16,288 5,966 
Marketing— — 4,025 
Other segment items (1) (2) (3)
107,591 47,377 132,957 
Segment pre-tax, pre-provision net revenue482,273 140,890 219,831 842,994 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(111,715)
Total consolidated pre-tax, pre-provision net revenue731,279 
Total consolidated provision for credit losses124,000 
Total consolidated income before income taxes607,279 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $2.9 million for Healthcare Financial Services, and $5.0 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $5.5 million for Commercial Banking, $6.9 million for Healthcare Financial Services, and $3.6 million for Consumer Banking.
Six months ended June 30, 2024
(In thousands)Commercial
Banking		Healthcare Financial
Services		Consumer
Banking		Totals
Net interest income$679,530 $177,802 $408,456 $1,265,788 
Non-interest income68,790 58,526 58,370 185,686 
Total segment revenues748,320 236,328 466,826 1,451,474 
Reconciliation of revenue:
Corporate and reconciling(169,787)
Total consolidated revenues1,281,687 
Less:
Compensation and benefits100,662 44,277 73,421 
Occupancy (1)
— — 28,221 
Technology and equipment (1)
4,009 16,098 4,759 
Marketing— — 3,561 
Other segment items (1) (2) (3)
106,142 43,019 126,064 
Segment pre-tax, pre-provision net revenue537,507 132,934 230,800 901,241 
Reconciliation of pre-tax, pre-provision net revenue:
Corporate and reconciling(281,498)
Total consolidated pre-tax, pre-provision net revenue619,743 
Total consolidated provision for credit losses104,500 
Total consolidated income before income taxes515,243 
(1)Occupancy and Technology and equipment include, in aggregate, $0.1 million of depreciation expense for Commercial Banking, $2.6 million for Healthcare Financial Services, and $4.6 million for Consumer Banking.
(2)Other segment items for each reportable segment includes:
•Commercial Banking--occupancy, marketing, outside professional services, loan workout expense, foreclosed property expense, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Healthcare Financial Services--occupancy, marketing, outside professional services, other non-interest expense, allocated net operating costs, and allocated total support costs.
•Consumer Banking--outside professional services, loan workout expense, foreclosed property expense, other-non interest expense, allocated net operating costs, and allocated total support costs.
(3)Intangible assets amortization, which is a component of other non-interest expense presented in Other segment items, was $4.7 million for Commercial Banking, $6.3 million for Healthcare Financial Services, and $4.3 million for Consumer Banking.
v3.25.2
Revenue from Contracts with Customers (Tables)
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Summary of Revenues From Contracts With Customers
The following tables summarize revenues recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers. These disaggregated amounts, together with sources of other non-interest income that are subject to other GAAP topics, have been reconciled to non-interest income by reportable segment as presented within Note 15: Segment Reporting.
Three months ended June 30, 2025
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$4,550 $20,282 $16,268 $(166)$40,934 
Loan and lease related fees (1)
2,520 — — — 2,520 
Wealth and investment services3,353 — 4,432 (6)7,779 
Other (2)
— 8,077 416 (296)8,197 
Revenue from contracts with customers10,423 28,359 21,116 (468)59,430 
Other sources of non-interest income20,205 328 3,475 11,219 35,227 
Total non-interest income$30,628 $28,687 $24,591 $10,751 $94,657 
Three months ended June 30, 2024
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$5,160 $20,460 $15,552 $(145)$41,027 
Loan and lease related fees (1)
3,943 — — — 3,943 
Wealth and investment services3,208 — 5,354 (6)8,556 
Other (2)
— 7,005 416 887 8,308 
Revenue from contracts with customers12,311 27,465 21,322 736 61,834 
Other sources of non-interest income22,199 — 3,070 (44,805)(19,536)
Total non-interest income$34,510 $27,465 $24,392 $(44,069)$42,298 
Six months ended June 30, 2025
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$9,289 $39,351 $31,562 $(373)$79,829 
Loan and lease related fees (1)
4,745 — — — 4,745 
Wealth and investment services6,669 — 8,910 (11)15,568 
Other (2)
— 18,377 833 856 20,066 
Revenue from contracts with customers20,703 57,728 41,305 472 120,208 
Other sources of non-interest income38,883 349 9,490 18,333 67,055 
Total non-interest income$59,586 $58,077 $50,795 $18,805 $187,263 
Six months ended June 30, 2024
(In thousands)Commercial BankingHealthcare Financial ServicesConsumer BankingCorporate and
Reconciling		Consolidated
Total
Non-interest Income:
Deposit service fees$11,002 $42,512 $30,348 $(246)$83,616 
Loan and lease related fees (1)
7,565 — — — 7,565 
Wealth and investment services6,386 — 10,105 (11)16,480 
Other (2)
— 16,014 233 1,931 18,178 
Revenue from contracts with customers24,953 58,526 40,686 1,674 125,839 
Other sources of non-interest income43,837 — 17,684 (45,709)15,812 
Total non-interest income$68,790 $58,526 $58,370 $(44,035)$141,651 
(1)A portion of Loan and lease related fees on the Condensed Consolidated Statements of Income is comprised of income generated from factored receivables activities (through the third quarter of 2024 only) and payroll financing activities that is within the scope of ASC Topic 606.
(2)Other income included in the Corporate and Reconciling category that is in scope of ASC Topic 606 is comprised entirely of immaterial fee revenue from contracts with customers attributable to interSYNC.
v3.25.2
Commitments and Contingencies (Tables)
 6 Months Ended
Jun. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Summary of Credit Related Financial Instruments With Off-Balance Sheet Risk
The following table summarizes the outstanding amounts of credit-related financial instruments with off-balance sheet risk:
(In thousands)June 30,
2025		December 31, 2024
Commitments to extend credit$12,285,376 $11,630,765 
Standby letters of credit608,752 578,912 
Commercial letters of credit27,842 28,287 
Total credit-related financial instruments with off-balance sheet risk$12,921,970 $12,237,964 
v3.25.2
Basis of Presentation and Accounting Standards Updates - Schedule of Cash Flow Information (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Supplemental disclosure of cash flow information:    
Interest paid $ 765,626 $ 811,338
Income taxes paid 53,100 84,450
Non-cash investing and financing activities:    
Transfer of loans held for investment to foreclosed properties and repossessed assets 3,967 1,925
Transfer of returned finance lease equipment to assets held for sale 579 2,316
Transfer of loans held for investment to loans held for sale 317,172 333,483
ROU lease assets obtained in exchange for operating lease liabilities 28,437 8,259
Approved commitments to fund LIHTC investments 99,054 212,041
Tangible assets acquired 0 256,957
Goodwill and other intangible assets 0 417,085
Liabilities assumed 0 299,507
Forgiveness of long-term debt 0 12,875
Pre-existing equity interest 0 $ 2,200
Ametros    
Non-cash investing and financing activities:    
Liabilities assumed 293,700  
Sellers Transaction Expenses    
Non-cash investing and financing activities:    
Liabilities assumed $ 5,800  
v3.25.2
Business Developments - Summary of Purchase Price Allocation (Details) - USD ($)
$ in Thousands
Jan. 24, 2024
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2023
Liabilities:        
Goodwill   $ 2,868,068 $ 2,868,068 $ 2,631,465
Ametros        
Business Combination [Line Items]        
Cash consideration $ 359,700      
Forgiveness in long-term debt 12,900      
Liability assumption 5,800      
Purchase price consideration 378,424      
Assets:        
Cash and due from banks 310      
Premises and equipment 1,078      
Other intangible assets 188,900      
Deferred tax assets, net (35,889)      
Funds held in escrow 288,167      
Accounts receivable 2,435      
Prepaid expenses 1,166      
Total other assets 291,768      
Total assets acquired 446,167      
Liabilities:        
Interest-bearing deposits (20,622)      
Accounts payable 684      
Accrued expenses 4,270      
Deferred revenue 20,391      
Members’ funds 288,167      
Operating lease liabilities 838      
Total other liabilities 314,350      
Total liabilities assumed 293,728      
Net assets acquired 152,439      
Pre-existing equity interest 2,200      
Goodwill 228,185      
Amount held in operating cash amount $ 20,600      
Equity interest in acquiree 0.60%      
Equity interests acquired 99.40%      
Gain in other income $ 1,500      
v3.25.2
Business Developments - Narrative (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
USD ($)
Feb. 12, 2024
USD ($)
loan
Jan. 24, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jul. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Business Combination [Line Items]                      
Goodwill $ 2,868,068     $ 2,868,068     $ 2,868,068     $ 2,868,068 $ 2,631,465
Professional and outside services       18,394 $ 14,066   35,620 $ 27,047      
Transfer of loans held for investment to loans held for sale             317,172 333,483      
Provision for credit losses       $ 46,500 $ 59,000   124,000 $ 104,500      
Commercial portfolio | Commercial non-mortgage                      
Business Combination [Line Items]                      
Transfer of loans held for investment to loans held for sale $ 242,200                    
Provision for credit losses             $ 1,300        
Subsequent Event | Commercial portfolio | Commercial non-mortgage                      
Business Combination [Line Items]                      
Derecognition of loans held for sale                 $ 33,300    
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Mortgage Servicing Portfolio                      
Business Combination [Line Items]                      
Individual residential mortgage loans | loan   9,184                  
Aggregate UPB   $ 1,400,000                  
Cash proceeds from sale of business   18,400                  
Mortgage servicing rights   6,700                  
Gain recognized on sale   $ 11,700                  
Ametros                      
Business Combination [Line Items]                      
Goodwill     $ 228,185                
Professional and outside services           $ 3,100          
Ametros | Core deposits                      
Business Combination [Line Items]                      
Recognized identifiable assets acquired     $ 182,800                
Acquired intangible assets, useful life     25 years                
Ametros | Trade name                      
Business Combination [Line Items]                      
Recognized identifiable assets acquired     $ 6,100                
Acquired intangible assets, useful life     5 years                
v3.25.2
Investment Securities - Summary of Investment Securities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Schedule of Investments [Line Items]    
Amortized cost $ 10,189,481 $ 9,720,415
Unrealized Gains 42,579 12,952
Unrealized Losses (610,839) (725,900)
Allowance for Credit Losses (867) (867)
Fair Value [1] 9,620,354 9,006,600
Debt Securities, Available-For-Sale    
Schedule of Investments [Line Items]    
Interest receivable 36,800 35,200
Government agency debentures    
Schedule of Investments [Line Items]    
Amortized cost 222,808 222,767
Unrealized Gains 0 0
Unrealized Losses (30,372) (36,341)
Allowance for Credit Losses 0 0
Fair Value 192,436 186,426
Municipal bonds and notes    
Schedule of Investments [Line Items]    
Amortized cost 117,562 123,885
Unrealized Gains 0 2
Unrealized Losses (13,754) (13,011)
Allowance for Credit Losses 0 0
Fair Value 103,808 110,876
Agency CMO    
Schedule of Investments [Line Items]    
Amortized cost 29,439 32,193
Unrealized Gains 0 0
Unrealized Losses (2,326) (3,150)
Allowance for Credit Losses 0 0
Fair Value 27,113 29,043
Agency MBS    
Schedule of Investments [Line Items]    
Amortized cost 4,980,846 4,760,541
Unrealized Gains 36,060 11,654
Unrealized Losses (185,301) (252,410)
Allowance for Credit Losses 0 0
Fair Value 4,831,605 4,519,785
Agency CMBS    
Schedule of Investments [Line Items]    
Amortized cost 3,558,974 3,400,021
Unrealized Gains 5,201 84
Unrealized Losses (339,977) (365,713)
Allowance for Credit Losses 0 0
Fair Value 3,224,198 3,034,392
CMBS    
Schedule of Investments [Line Items]    
Amortized cost 791,930 630,985
Unrealized Gains 1,054 411
Unrealized Losses (2,852) (6,008)
Allowance for Credit Losses 0 0
Fair Value 790,132 625,388
Corporate debt    
Schedule of Investments [Line Items]    
Amortized cost 435,483 496,087
Unrealized Gains 264 801
Unrealized Losses (31,507) (43,755)
Allowance for Credit Losses (867) (867)
Fair Value 403,373 452,266
Private label MBS    
Schedule of Investments [Line Items]    
Amortized cost 42,571 44,081
Unrealized Gains 0 0
Unrealized Losses (4,207) (4,862)
Allowance for Credit Losses 0 0
Fair Value 38,364 39,219
Other    
Schedule of Investments [Line Items]    
Amortized cost 9,868 9,855
Unrealized Gains 0 0
Unrealized Losses (543) (650)
Allowance for Credit Losses 0 0
Fair Value $ 9,325 $ 9,205
[1] Investment securities available-for-sale had an amortized cost basis of $10,189,481 at June 30, 2025, and $9,720,415 at December 31, 2024.
v3.25.2
Investment Securities - Summary of Gross Unrealized Losses and Fair Value of Available-for-Sale Securities (Detail)
$ in Thousands
Jun. 30, 2025
USD ($)
holding
Dec. 31, 2024
USD ($)
holding
Schedule of Investments [Line Items]    
Less than 12 months, fair value $ 2,325,248 $ 4,094,196
Less Than 12 Months, Unrealized Losses (34,392) (64,068)
12 months or more, fair value 3,774,523 4,043,216
12 Months or More, Unrealized Losses $ (576,447) $ (661,832)
Total, number of holdings | holding 673 751
Total, fair value $ 6,099,771 $ 8,137,412
Total, unrealized losses (610,839) (725,900)
Government agency debentures    
Schedule of Investments [Line Items]    
12 months or more, fair value 192,436 186,427
12 Months or More, Unrealized Losses $ (30,372) $ (36,341)
Total, number of holdings | holding 15 15
Total, fair value $ 192,436 $ 186,427
Total, unrealized losses (30,372) (36,341)
Municipal bonds and notes    
Schedule of Investments [Line Items]    
Less than 12 months, fair value   859
Less Than 12 Months, Unrealized Losses   (1)
12 months or more, fair value 103,032 108,013
12 Months or More, Unrealized Losses $ (13,754) $ (13,010)
Total, number of holdings | holding 38 57
Total, fair value $ 103,032 $ 108,872
Total, unrealized losses (13,754) (13,011)
Agency CMO    
Schedule of Investments [Line Items]    
12 months or more, fair value 27,113 29,043
12 Months or More, Unrealized Losses $ (2,326) $ (3,150)
Total, number of holdings | holding 28 28
Total, fair value $ 27,113 $ 29,043
Total, unrealized losses (2,326) (3,150)
Agency MBS    
Schedule of Investments [Line Items]    
Less than 12 months, fair value 822,663 2,624,722
Less Than 12 Months, Unrealized Losses (5,939) (31,539)
12 months or more, fair value 1,218,266 1,246,818
12 Months or More, Unrealized Losses $ (179,362) $ (220,871)
Total, number of holdings | holding 326 370
Total, fair value $ 2,040,929 $ 3,871,540
Total, unrealized losses (185,301) (252,410)
Agency CMBS    
Schedule of Investments [Line Items]    
Less than 12 months, fair value 1,280,991 1,468,615
Less Than 12 Months, Unrealized Losses (27,776) (32,528)
12 months or more, fair value 1,558,697 1,540,263
12 Months or More, Unrealized Losses $ (312,201) $ (333,185)
Total, number of holdings | holding 178 185
Total, fair value $ 2,839,688 $ 3,008,878
Total, unrealized losses (339,977) (365,713)
CMBS    
Schedule of Investments [Line Items]    
Less than 12 months, fair value 213,594  
Less Than 12 Months, Unrealized Losses (676)  
12 months or more, fair value 252,181 457,423
12 Months or More, Unrealized Losses $ (2,176) $ (6,008)
Total, number of holdings | holding 32 32
Total, fair value $ 465,775 $ 457,423
Total, unrealized losses (2,852) (6,008)
Corporate debt    
Schedule of Investments [Line Items]    
Less than 12 months, fair value 8,000  
Less Than 12 Months, Unrealized Losses (1)  
12 months or more, fair value 375,109 426,805
12 Months or More, Unrealized Losses $ (31,506) $ (43,755)
Total, number of holdings | holding 51 59
Total, fair value $ 383,109 $ 426,805
Total, unrealized losses (31,507) (43,755)
Private label MBS    
Schedule of Investments [Line Items]    
Less than 12 months, fair value 0 0
Less Than 12 Months, Unrealized Losses 0 0
12 months or more, fair value 38,364 39,219
12 Months or More, Unrealized Losses $ (4,207) $ (4,862)
Total, number of holdings | holding 3 3
Total, fair value $ 38,364 $ 39,219
Total, unrealized losses (4,207) (4,862)
Other    
Schedule of Investments [Line Items]    
12 months or more, fair value 9,325 9,205
12 Months or More, Unrealized Losses $ (543) $ (650)
Total, number of holdings | holding 2 2
Total, fair value $ 9,325 $ 9,205
Total, unrealized losses $ (543) $ (650)
v3.25.2
Investment Securities - Narrative (Detail) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Increase (decrease) in gross unrealized losses $ (115,100,000)  
Securities held-to-maturity 0 $ 0
Corporate debt    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Investment securities available-for-sale, at fair value $ 900,000 $ 900,000
v3.25.2
Investment Securities - Summary of Debt Securities by Contractual Maturity (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Amortized Cost    
Maturing within 1 year $ 884  
After 1 year through 5 years 334,324  
After 5 through 10 years 702,943  
After 10 years 9,151,330  
Amortized Cost - Total available-for-sale debt securities 10,189,481 $ 9,720,415
Fair Value    
Maturing within 1 year 881  
After 1 year through 5 years 328,656  
After 5 through 10 years 660,919  
After 10 years 8,629,898  
Fair Value, Total available-for-sale debt securities [1] $ 9,620,354 $ 9,006,600
[1] Investment securities available-for-sale had an amortized cost basis of $10,189,481 at June 30, 2025, and $9,720,415 at December 31, 2024.
v3.25.2
Investment Securities - Schedule of Realized Gain (Loss) (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]        
Proceeds from sales $ 0 $ 921,642 $ 14,880 $ 1,253,332
Gross realized gains 0 0 332 2,240
Gross realized losses 0 (49,915) (112) (64,551)
Gross losses realized on sale of available-for-sale securities $ 0 $ 2,600 $ 0 $ 2,600
v3.25.2
Investment Securities - Summary of Carrying Value of Available-for-Sale Securities (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total available-for-sale securities pledged $ 8,724,543 $ 8,459,561
Pledged for deposits    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total available-for-sale securities pledged 1,797,620 1,596,378
Pledged for borrowings and other    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total available-for-sale securities pledged $ 6,926,923 $ 6,863,183
v3.25.2
Investment Securities - Summary of Debt Securities Held-to-Maturity (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Financing Receivable, Credit Quality Indicator [Line Items]            
Amortized Cost $ 8,192,822   $ 8,444,362      
Unrealized Gains 11,795   1,502      
Unrealized Losses (913,373)   (992,741)      
Fair Value 7,291,244   7,453,123      
Allowance for Credit Losses (102) $ (109) (171) $ (182) $ (184) $ (209)
Net Carrying Value 8,192,720   8,444,191      
Held-to-maturity Securities            
Financing Receivable, Credit Quality Indicator [Line Items]            
Interest receivable 29,100   30,500      
Agency CMO            
Financing Receivable, Credit Quality Indicator [Line Items]            
Amortized Cost 18,246   19,847      
Unrealized Gains 0   0      
Unrealized Losses (1,282)   (1,671)      
Fair Value 16,964   18,176      
Allowance for Credit Losses 0   0      
Net Carrying Value 18,246   19,847      
Agency MBS            
Financing Receivable, Credit Quality Indicator [Line Items]            
Amortized Cost 2,954,301   3,109,411      
Unrealized Gains 11,389   771      
Unrealized Losses (276,548)   (333,039)      
Fair Value 2,689,142   2,777,143      
Allowance for Credit Losses 0   0      
Net Carrying Value 2,954,301   3,109,411      
Agency CMBS            
Financing Receivable, Credit Quality Indicator [Line Items]            
Amortized Cost 4,315,250   4,357,505      
Unrealized Gains 149   414      
Unrealized Losses (569,802)   (613,914)      
Fair Value 3,745,597   3,744,005      
Allowance for Credit Losses 0   0      
Net Carrying Value 4,315,250   4,357,505      
Municipal bonds and notes            
Financing Receivable, Credit Quality Indicator [Line Items]            
Amortized Cost 839,766   891,909      
Unrealized Gains 257   317      
Unrealized Losses (63,392)   (40,266)      
Fair Value 776,631   851,960      
Allowance for Credit Losses (102)   (171)      
Net Carrying Value 839,664   891,738      
CMBS            
Financing Receivable, Credit Quality Indicator [Line Items]            
Amortized Cost 65,259   65,690      
Unrealized Gains 0   0      
Unrealized Losses (2,349)   (3,851)      
Fair Value 62,910   61,839      
Allowance for Credit Losses 0   0      
Net Carrying Value $ 65,259   $ 65,690      
v3.25.2
Investments Securities - Allowance for Credit Losses (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Roll Forward]        
Balance, beginning of period $ 109 $ 184 $ 171 $ 209
(Benefit) for credit losses (7) (2) (69) (27)
Balance, end of period $ 102 $ 182 $ 102 $ 182
v3.25.2
Investment Securities - Summary Of Debt Securities Held-to Maturity - Contractual Maturities, Credit Quality and Other Information (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Amortized Cost    
Maturing within 1 year $ 2,902  
After 1 year through 5 years 160,194  
After 5 through 10 years 286,121  
After 10 years 7,743,605  
Amortized Cost 8,192,822 $ 8,444,362
Fair Value    
Maturing within 1 year 2,903  
After 1 year through 5 years 154,188  
After 5 through 10 years 275,974  
After 10 years 6,858,179  
Fair Value $ 7,291,244 $ 7,453,123
v3.25.2
Investment Securities - Summary of Amortized Cost of Held-to-Maturity Securities (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity $ 8,192,822 $ 8,444,362
Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 18,246 19,847
Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 2,954,301 3,109,411
Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 4,315,250 4,357,505
Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 839,766 891,909
CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 65,259 65,690
Aaa    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 366,566 406,877
Aaa | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aaa | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aaa | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aaa | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 301,307 341,187
Aaa | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 65,259 65,690
Aa1    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 7,441,517 7,645,090
Aa1 | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 18,246 19,847
Aa1 | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 2,954,301 3,109,411
Aa1 | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 4,315,250 4,357,505
Aa1 | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 153,720 158,327
Aa1 | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa2    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 244,918 230,986
Aa2 | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa2 | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa2 | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa2 | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 244,918 230,986
Aa2 | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa3    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 112,768 128,692
Aa3 | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa3 | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa3 | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Aa3 | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 112,768 128,692
Aa3 | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A1    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 10,444 13,761
A1 | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A1 | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A1 | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A1 | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 10,444 13,761
A1 | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A2    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 4,165 0
A2 | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A2 | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A2 | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A2 | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 4,165 0
A2 | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A3    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 4,165
A3 | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A3 | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A3 | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
A3 | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 4,165
A3 | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Not Rated    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 12,444 14,791
Not Rated | Agency CMO    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Not Rated | Agency MBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Not Rated | Agency CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 0 0
Not Rated | Municipal bonds and notes    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity 12,444 14,791
Not Rated | CMBS    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Total held-to-maturity $ 0 $ 0
v3.25.2
Investment Securities - Summary of Carrying Value of Held-to-Maturity Securities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Held-to-maturity securities pledged $ 7,799,924 $ 8,237,273
Pledged for deposits    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Held-to-maturity securities pledged 1,760,751 1,978,445
Pledged for borrowings and other    
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]    
Held-to-maturity securities pledged $ 6,039,173 $ 6,258,828
v3.25.2
Loans and Leases - Summary of Loans and Leases by Segment (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases $ 53,671,959 $ 52,505,168
Commercial portfolio    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 42,651,878 42,068,001
Commercial portfolio | Commercial non-mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 18,724,821 18,037,942
Commercial portfolio | Asset-based    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 1,350,006 1,404,007
Commercial portfolio | Commercial real estate    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 14,539,706 14,492,436
Commercial portfolio | Multi-family    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 6,819,069 6,898,600
Commercial portfolio | Equipment financing    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 1,218,276 1,235,016
Consumer portfolio    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 11,020,081 10,437,167
Consumer portfolio | Residential    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 9,332,413 8,853,669
Consumer portfolio | Home equity    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases 1,385,746 1,427,692
Consumer portfolio | Other consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans and leases $ 301,922 $ 155,806
v3.25.2
Loans and Leases - Narrative (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Unamortized premiums $ 16,700 $ 16,700   $ (1,800)
Interest receivable 268,800 268,800   265,000
Loans and leases, net 52,949,913 $ 52,949,913   $ 51,815,602
Commercial real estate | Customer Concentration Risk | Loans and Finance Receivables        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Concentration of credit risk   39.80%   40.70%
Asset-based | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Modified loans 15,000 $ 15,000    
Commercial non-mortgage | Customer Concentration Risk | Loans and Finance Receivables        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Concentration of credit risk   34.90%   34.40%
Commercial non-mortgage | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Modified loans     $ 17,800  
Collateral Pledged | Commercial portfolio        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Recorded investment 244,800 $ 244,800   $ 139,500
Collateral Pledged | Consumer portfolio        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Recorded investment 28,300 28,300   29,100
Collateral Pledged | Asset Pledged as Collateral | Federal Home Loan Bank Certificates and Obligations (FHLB)        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Loans and leases, net 17,600,000 17,600,000    
Collateral Pledged | Asset Pledged as Collateral | Federal Reserve Bank Certificates And Obligations (FRB)        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Loans and leases, net 6,200,000 6,200,000    
Collateral Value        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Recorded investment $ 278,600 $ 278,600   $ 200,100
v3.25.2
Loans and Leases - Summary Of Loan And Lease Portfolio Aging By Class Of Loan (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Financing Receivable, Past Due [Line Items]    
Loans and leases $ 53,671,959 $ 52,505,168
90 or More Days Past Due and Accruing 0 0
Non-accrual 534,155 460,725
Non-accrual with No Allowance 139,474 117,602
Commercial portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 42,651,878 42,068,001
90 or More Days Past Due and Accruing 0 0
Non-accrual 499,301 426,426
Non-accrual with No Allowance 122,335 98,451
Commercial portfolio | Commercial non-mortgage    
Financing Receivable, Past Due [Line Items]    
Loans and leases 18,724,821 18,037,942
90 or More Days Past Due and Accruing 0 0
Non-accrual 216,003 248,078
Non-accrual with No Allowance 42,997 50,943
Commercial portfolio | Asset-based    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,350,006 1,404,007
90 or More Days Past Due and Accruing 0 0
Non-accrual 44,353 20,787
Non-accrual with No Allowance 18,262 1,080
Commercial portfolio | Commercial real estate    
Financing Receivable, Past Due [Line Items]    
Loans and leases 14,539,706 14,492,436
90 or More Days Past Due and Accruing 0 0
Non-accrual 200,947 120,151
Non-accrual with No Allowance 37,160 26,666
Commercial portfolio | Multi-family    
Financing Receivable, Past Due [Line Items]    
Loans and leases 6,819,069 6,898,600
90 or More Days Past Due and Accruing 0 0
Non-accrual 23,009 18,043
Non-accrual with No Allowance 22,877 17,953
Commercial portfolio | Equipment financing    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,218,276 1,235,016
90 or More Days Past Due and Accruing 0 0
Non-accrual 14,989 19,367
Non-accrual with No Allowance 1,039 1,809
Consumer portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 11,020,081 10,437,167
90 or More Days Past Due and Accruing 0 0
Non-accrual 34,854 34,299
Non-accrual with No Allowance 17,139 19,151
Consumer portfolio | Residential    
Financing Receivable, Past Due [Line Items]    
Loans and leases 9,332,413 8,853,669
90 or More Days Past Due and Accruing 0 0
Non-accrual 16,024 12,750
Non-accrual with No Allowance 7,223 6,923
Consumer portfolio | Home equity    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,385,746 1,427,692
90 or More Days Past Due and Accruing 0 0
Non-accrual 18,421 21,425
Non-accrual with No Allowance 9,914 12,225
Consumer portfolio | Other consumer    
Financing Receivable, Past Due [Line Items]    
Loans and leases 301,922 155,806
90 or More Days Past Due and Accruing 0 0
Non-accrual 409 124
Non-accrual with No Allowance 2 3
Total  Past Due and Non-accrual    
Financing Receivable, Past Due [Line Items]    
Loans and leases 589,107 574,307
Total  Past Due and Non-accrual | Commercial portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 532,054 516,644
Total  Past Due and Non-accrual | Commercial portfolio | Commercial non-mortgage    
Financing Receivable, Past Due [Line Items]    
Loans and leases 231,485 255,345
Total  Past Due and Non-accrual | Commercial portfolio | Asset-based    
Financing Receivable, Past Due [Line Items]    
Loans and leases 44,353 42,784
Total  Past Due and Non-accrual | Commercial portfolio | Commercial real estate    
Financing Receivable, Past Due [Line Items]    
Loans and leases 207,559 142,824
Total  Past Due and Non-accrual | Commercial portfolio | Multi-family    
Financing Receivable, Past Due [Line Items]    
Loans and leases 32,754 46,928
Total  Past Due and Non-accrual | Commercial portfolio | Equipment financing    
Financing Receivable, Past Due [Line Items]    
Loans and leases 15,903 28,763
Total  Past Due and Non-accrual | Consumer portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 57,053 57,663
Total  Past Due and Non-accrual | Consumer portfolio | Residential    
Financing Receivable, Past Due [Line Items]    
Loans and leases 28,677 26,949
Total  Past Due and Non-accrual | Consumer portfolio | Home equity    
Financing Receivable, Past Due [Line Items]    
Loans and leases 26,837 30,079
Total  Past Due and Non-accrual | Consumer portfolio | Other consumer    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,539 635
30-59 Days Past Due and Accruing    
Financing Receivable, Past Due [Line Items]    
Loans and leases 47,301 50,885
30-59 Days Past Due and Accruing | Commercial portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 31,597 34,668
30-59 Days Past Due and Accruing | Commercial portfolio | Commercial non-mortgage    
Financing Receivable, Past Due [Line Items]    
Loans and leases 14,902 3,949
30-59 Days Past Due and Accruing | Commercial portfolio | Asset-based    
Financing Receivable, Past Due [Line Items]    
Loans and leases 0 0
30-59 Days Past Due and Accruing | Commercial portfolio | Commercial real estate    
Financing Receivable, Past Due [Line Items]    
Loans and leases 6,267 22,115
30-59 Days Past Due and Accruing | Commercial portfolio | Multi-family    
Financing Receivable, Past Due [Line Items]    
Loans and leases 9,745 2,508
30-59 Days Past Due and Accruing | Commercial portfolio | Equipment financing    
Financing Receivable, Past Due [Line Items]    
Loans and leases 683 6,096
30-59 Days Past Due and Accruing | Consumer portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 15,704 16,217
30-59 Days Past Due and Accruing | Consumer portfolio | Residential    
Financing Receivable, Past Due [Line Items]    
Loans and leases 8,884 9,595
30-59 Days Past Due and Accruing | Consumer portfolio | Home equity    
Financing Receivable, Past Due [Line Items]    
Loans and leases 6,077 6,273
30-59 Days Past Due and Accruing | Consumer portfolio | Other consumer    
Financing Receivable, Past Due [Line Items]    
Loans and leases 743 349
60-89 Days Past Due and Accruing    
Financing Receivable, Past Due [Line Items]    
Loans and leases 7,651 62,697
60-89 Days Past Due and Accruing | Commercial portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,156 55,550
60-89 Days Past Due and Accruing | Commercial portfolio | Commercial non-mortgage    
Financing Receivable, Past Due [Line Items]    
Loans and leases 580 3,318
60-89 Days Past Due and Accruing | Commercial portfolio | Asset-based    
Financing Receivable, Past Due [Line Items]    
Loans and leases 0 21,997
60-89 Days Past Due and Accruing | Commercial portfolio | Commercial real estate    
Financing Receivable, Past Due [Line Items]    
Loans and leases 345 558
60-89 Days Past Due and Accruing | Commercial portfolio | Multi-family    
Financing Receivable, Past Due [Line Items]    
Loans and leases 0 26,377
60-89 Days Past Due and Accruing | Commercial portfolio | Equipment financing    
Financing Receivable, Past Due [Line Items]    
Loans and leases 231 3,300
60-89 Days Past Due and Accruing | Consumer portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 6,495 7,147
60-89 Days Past Due and Accruing | Consumer portfolio | Residential    
Financing Receivable, Past Due [Line Items]    
Loans and leases 3,769 4,604
60-89 Days Past Due and Accruing | Consumer portfolio | Home equity    
Financing Receivable, Past Due [Line Items]    
Loans and leases 2,339 2,381
60-89 Days Past Due and Accruing | Consumer portfolio | Other consumer    
Financing Receivable, Past Due [Line Items]    
Loans and leases 387 162
Current    
Financing Receivable, Past Due [Line Items]    
Loans and leases 53,082,852 51,930,861
Current | Commercial portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 42,119,824 41,551,357
Current | Commercial portfolio | Commercial non-mortgage    
Financing Receivable, Past Due [Line Items]    
Loans and leases 18,493,336 17,782,597
Current | Commercial portfolio | Asset-based    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,305,653 1,361,223
Current | Commercial portfolio | Commercial real estate    
Financing Receivable, Past Due [Line Items]    
Loans and leases 14,332,147 14,349,612
Current | Commercial portfolio | Multi-family    
Financing Receivable, Past Due [Line Items]    
Loans and leases 6,786,315 6,851,672
Current | Commercial portfolio | Equipment financing    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,202,373 1,206,253
Current | Consumer portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases 10,963,028 10,379,504
Current | Consumer portfolio | Residential    
Financing Receivable, Past Due [Line Items]    
Loans and leases 9,303,736 8,826,720
Current | Consumer portfolio | Home equity    
Financing Receivable, Past Due [Line Items]    
Loans and leases 1,358,909 1,397,613
Current | Consumer portfolio | Other consumer    
Financing Receivable, Past Due [Line Items]    
Loans and leases $ 300,383 155,171
In Process | Commercial portfolio    
Financing Receivable, Past Due [Line Items]    
Loans and leases   $ 32,700
v3.25.2
Loans and Leases - Allowance for Loan and Lease Losses by Portfolio Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]          
Balance, beginning of period $ 713,321 $ 641,442 $ 689,566 $ 635,737 $ 635,737
Provision (benefit) 45,126 61,041 123,838 104,235  
Charge-offs (41,238) (34,774) (97,856) (74,565)  
Recoveries 4,837 1,646 6,498 3,948  
Balance, end of period 722,046 669,355 722,046 669,355 689,566
Individually evaluated for credit losses 96,134 67,592 96,134 67,592  
Collectively evaluated for credit losses 625,912 601,763 625,912 601,763  
Increase in ACL on loans and leases     32,400    
Commercial portfolio          
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]          
Balance, beginning of period 649,450 589,109 635,871 577,663 577,663
Provision (benefit) 45,635 65,607 113,838 114,961  
Charge-offs (39,792) (33,356) (95,358) (71,817) (171,460)
Recoveries 3,250 360 4,192 913  
Balance, end of period 658,543 621,720 658,543 621,720 635,871
Individually evaluated for credit losses 95,323 66,943 95,323 66,943  
Collectively evaluated for credit losses 563,220 554,777 563,220 554,777  
Consumer portfolio          
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]          
Balance, beginning of period 63,871 52,333 53,695 58,074 58,074
Provision (benefit) (509) (4,566) 10,000 (10,726)  
Charge-offs (1,446) (1,418) (2,498) (2,748) (5,010)
Recoveries 1,587 1,286 2,306 3,035  
Balance, end of period 63,503 47,635 63,503 47,635 $ 53,695
Individually evaluated for credit losses 811 649 811 649  
Collectively evaluated for credit losses $ 62,692 $ 46,986 $ 62,692 $ 46,986  
v3.25.2
Loans and Leases - Amortized Cost Basis by Risk Rating (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Financing Receivable          
Loans and leases $ 53,671,959   $ 53,671,959   $ 52,505,168
Current period gross write-offs          
Total 41,238 $ 34,774 97,856 $ 74,565  
Commercial portfolio          
Financing Receivable          
Total financing receivable, Current fiscal year 3,059,938   3,059,938   5,840,676
Total financing receivable, Fiscal year before current fiscal year 5,669,924   5,669,924   6,270,657
Total financing receivable, Two years before current fiscal year 5,745,784   5,745,784   8,293,790
Total financing receivable, Three years before current fiscal year 7,489,096   7,489,096   3,916,614
Total financing receivable, Four years before current fiscal year 3,617,460   3,617,460   2,136,587
Total financing receivable, More than five years before current fiscal year 8,603,091   8,603,091   7,445,782
Revolving Loans Amortized Cost Basis 8,466,585   8,466,585   8,163,895
Loans and leases 42,651,878   42,651,878   42,068,001
Current period gross write-offs          
Current fiscal year     2,885   0
Fiscal year before current fiscal year     1,242   17,894
Two years before current fiscal year     21,726   48,257
Three years before current fiscal year     6,035   17,254
Four years before current fiscal year     1,781   25,583
More than five years before current fiscal year     27,423   41,212
Revolving Loans Amortized Cost Basis     34,266   21,260
Total 39,792 $ 33,356 95,358 $ 71,817 171,460
Commercial portfolio | Commercial non-mortgage          
Financing Receivable          
Total financing receivable, Current fiscal year 1,471,342   1,471,342   3,004,942
Total financing receivable, Fiscal year before current fiscal year 2,730,463   2,730,463   2,109,410
Total financing receivable, Two years before current fiscal year 1,869,270   1,869,270   3,212,637
Total financing receivable, Three years before current fiscal year 2,798,369   2,798,369   1,243,765
Total financing receivable, Four years before current fiscal year 1,251,864   1,251,864   609,387
Total financing receivable, More than five years before current fiscal year 1,674,103   1,674,103   1,279,538
Revolving Loans Amortized Cost Basis 6,929,410   6,929,410   6,578,263
Loans and leases 18,724,821   18,724,821   18,037,942
Current period gross write-offs          
Current fiscal year     1,317   0
Fiscal year before current fiscal year     1,242   11,894
Two years before current fiscal year     7,673   45,308
Three years before current fiscal year     5,780   10,668
Four years before current fiscal year     489   3,842
More than five years before current fiscal year     8,960   3,385
Revolving Loans Amortized Cost Basis     18,291   15,169
Total     43,752   90,266
Commercial portfolio | Asset-based          
Financing Receivable          
Total financing receivable, Current fiscal year 4,412   4,412   1,250
Total financing receivable, Fiscal year before current fiscal year 225   225   14,246
Total financing receivable, Two years before current fiscal year 12,819   12,819   0
Total financing receivable, Three years before current fiscal year 0   0   0
Total financing receivable, Four years before current fiscal year 0   0   0
Total financing receivable, More than five years before current fiscal year 23,070   23,070   26,720
Revolving Loans Amortized Cost Basis 1,309,480   1,309,480   1,361,791
Loans and leases 1,350,006   1,350,006   1,404,007
Current period gross write-offs          
Current fiscal year     0   0
Fiscal year before current fiscal year     0   0
Two years before current fiscal year     0   0
Three years before current fiscal year     0   0
Four years before current fiscal year     0   0
More than five years before current fiscal year     0   0
Revolving Loans Amortized Cost Basis     15,975   6,091
Total     15,975   6,091
Commercial portfolio | Commercial real estate          
Financing Receivable          
Total financing receivable, Current fiscal year 1,260,773   1,260,773   1,867,468
Total financing receivable, Fiscal year before current fiscal year 1,994,560   1,994,560   2,478,882
Total financing receivable, Two years before current fiscal year 2,281,549   2,281,549   3,431,179
Total financing receivable, Three years before current fiscal year 3,015,356   3,015,356   1,621,260
Total financing receivable, Four years before current fiscal year 1,360,029   1,360,029   1,094,418
Total financing receivable, More than five years before current fiscal year 4,416,741   4,416,741   3,792,379
Revolving Loans Amortized Cost Basis 210,698   210,698   206,850
Loans and leases 14,539,706   14,539,706   14,492,436
Current period gross write-offs          
Current fiscal year     0   0
Fiscal year before current fiscal year     0   854
Two years before current fiscal year     13,986   1,244
Three years before current fiscal year     255   1,579
Four years before current fiscal year     1,283   15,477
More than five years before current fiscal year     18,216   22,674
Revolving Loans Amortized Cost Basis     0   0
Total     33,740   41,828
Commercial portfolio | Multi-family          
Financing Receivable          
Total financing receivable, Current fiscal year 112,213   112,213   582,363
Total financing receivable, Fiscal year before current fiscal year 594,573   594,573   1,409,220
Total financing receivable, Two years before current fiscal year 1,363,942   1,363,942   1,424,552
Total financing receivable, Three years before current fiscal year 1,486,004   1,486,004   908,165
Total financing receivable, Four years before current fiscal year 905,560   905,560   343,430
Total financing receivable, More than five years before current fiscal year 2,339,780   2,339,780   2,213,879
Revolving Loans Amortized Cost Basis 16,997   16,997   16,991
Loans and leases 6,819,069   6,819,069   6,898,600
Current period gross write-offs          
Current fiscal year     0   0
Fiscal year before current fiscal year     0   0
Two years before current fiscal year     0   0
Three years before current fiscal year     0   4,955
Four years before current fiscal year     0   6,264
More than five years before current fiscal year     247   11,678
Revolving Loans Amortized Cost Basis     0   0
Total     247   22,897
Commercial portfolio | Equipment financing          
Financing Receivable          
Total financing receivable, Current fiscal year 211,198   211,198   384,653
Total financing receivable, Fiscal year before current fiscal year 350,103   350,103   258,899
Total financing receivable, Two years before current fiscal year 218,204   218,204   225,422
Total financing receivable, Three years before current fiscal year 189,367   189,367   143,424
Total financing receivable, Four years before current fiscal year 100,007   100,007   89,352
Total financing receivable, More than five years before current fiscal year 149,397   149,397   133,266
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 1,218,276   1,218,276   1,235,016
Current period gross write-offs          
Current fiscal year     1,568   0
Fiscal year before current fiscal year     0   5,146
Two years before current fiscal year     67   1,705
Three years before current fiscal year     0   52
Four years before current fiscal year     9   0
More than five years before current fiscal year     0   3,475
Revolving Loans Amortized Cost Basis     0   0
Total     1,644   10,378
Pass | Commercial portfolio | Commercial non-mortgage          
Financing Receivable          
Total financing receivable, Current fiscal year 1,426,513   1,426,513   2,917,048
Total financing receivable, Fiscal year before current fiscal year 2,647,354   2,647,354   1,916,905
Total financing receivable, Two years before current fiscal year 1,654,046   1,654,046   2,818,720
Total financing receivable, Three years before current fiscal year 2,464,246   2,464,246   1,100,575
Total financing receivable, Four years before current fiscal year 1,161,443   1,161,443   562,252
Total financing receivable, More than five years before current fiscal year 1,581,608   1,581,608   1,211,312
Revolving Loans Amortized Cost Basis 6,721,873   6,721,873   6,325,637
Loans and leases 17,657,083   17,657,083   16,852,449
Pass | Commercial portfolio | Asset-based          
Financing Receivable          
Total financing receivable, Current fiscal year 2,850   2,850   1,250
Total financing receivable, Fiscal year before current fiscal year 225   225   11,684
Total financing receivable, Two years before current fiscal year 10,311   10,311   0
Total financing receivable, Three years before current fiscal year 0   0   0
Total financing receivable, Four years before current fiscal year 0   0   0
Total financing receivable, More than five years before current fiscal year 18,246   18,246   20,255
Revolving Loans Amortized Cost Basis 1,078,602   1,078,602   1,132,901
Loans and leases 1,110,234   1,110,234   1,166,090
Pass | Commercial portfolio | Commercial real estate          
Financing Receivable          
Total financing receivable, Current fiscal year 1,260,773   1,260,773   1,867,468
Total financing receivable, Fiscal year before current fiscal year 1,991,259   1,991,259   2,334,965
Total financing receivable, Two years before current fiscal year 2,114,596   2,114,596   3,186,098
Total financing receivable, Three years before current fiscal year 2,801,954   2,801,954   1,462,814
Total financing receivable, Four years before current fiscal year 1,277,393   1,277,393   944,367
Total financing receivable, More than five years before current fiscal year 3,970,260   3,970,260   3,465,817
Revolving Loans Amortized Cost Basis 209,486   209,486   197,998
Loans and leases 13,625,721   13,625,721   13,459,527
Pass | Commercial portfolio | Multi-family          
Financing Receivable          
Total financing receivable, Current fiscal year 112,060   112,060   582,363
Total financing receivable, Fiscal year before current fiscal year 594,573   594,573   1,394,855
Total financing receivable, Two years before current fiscal year 1,349,648   1,349,648   1,314,395
Total financing receivable, Three years before current fiscal year 1,354,503   1,354,503   862,273
Total financing receivable, Four years before current fiscal year 855,885   855,885   245,802
Total financing receivable, More than five years before current fiscal year 2,164,313   2,164,313   2,179,207
Revolving Loans Amortized Cost Basis 16,997   16,997   16,991
Loans and leases 6,447,979   6,447,979   6,595,886
Pass | Commercial portfolio | Equipment financing          
Financing Receivable          
Total financing receivable, Current fiscal year 207,586   207,586   382,783
Total financing receivable, Fiscal year before current fiscal year 349,272   349,272   242,440
Total financing receivable, Two years before current fiscal year 202,534   202,534   207,081
Total financing receivable, Three years before current fiscal year 160,138   160,138   126,399
Total financing receivable, Four years before current fiscal year 88,827   88,827   83,838
Total financing receivable, More than five years before current fiscal year 140,480   140,480   124,910
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 1,148,837   1,148,837   1,167,451
Special mention | Commercial portfolio | Commercial non-mortgage          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   31,587
Total financing receivable, Fiscal year before current fiscal year 36,433   36,433   66,770
Total financing receivable, Two years before current fiscal year 59,114   59,114   156,555
Total financing receivable, Three years before current fiscal year 126,804   126,804   51,055
Total financing receivable, Four years before current fiscal year 91   91   30,669
Total financing receivable, More than five years before current fiscal year 0   0   4,203
Revolving Loans Amortized Cost Basis 34,158   34,158   44,017
Loans and leases 256,600   256,600   384,856
Special mention | Commercial portfolio | Asset-based          
Financing Receivable          
Total financing receivable, Current fiscal year 1,562   1,562   0
Total financing receivable, Fiscal year before current fiscal year 0   0   0
Total financing receivable, Two years before current fiscal year 0   0   0
Total financing receivable, Three years before current fiscal year 0   0   0
Total financing receivable, Four years before current fiscal year 0   0   0
Total financing receivable, More than five years before current fiscal year 4,818   4,818   5,226
Revolving Loans Amortized Cost Basis 40,524   40,524   90,372
Loans and leases 46,904   46,904   95,598
Special mention | Commercial portfolio | Commercial real estate          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   0
Total financing receivable, Fiscal year before current fiscal year 0   0   12,809
Total financing receivable, Two years before current fiscal year 32,092   32,092   175,252
Total financing receivable, Three years before current fiscal year 148,656   148,656   37,307
Total financing receivable, Four years before current fiscal year 0   0   37,469
Total financing receivable, More than five years before current fiscal year 82,073   82,073   64,483
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 262,821   262,821   327,320
Special mention | Commercial portfolio | Multi-family          
Financing Receivable          
Total financing receivable, Current fiscal year 153   153   0
Total financing receivable, Fiscal year before current fiscal year 0   0   14,365
Total financing receivable, Two years before current fiscal year 0   0   93,396
Total financing receivable, Three years before current fiscal year 114,867   114,867   18,790
Total financing receivable, Four years before current fiscal year 22,725   22,725   70,908
Total financing receivable, More than five years before current fiscal year 105,713   105,713   8,588
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 243,458   243,458   206,047
Special mention | Commercial portfolio | Equipment financing          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   1,298
Total financing receivable, Fiscal year before current fiscal year 0   0   231
Total financing receivable, Two years before current fiscal year 4,711   4,711   0
Total financing receivable, Three years before current fiscal year 13,511   13,511   55
Total financing receivable, Four years before current fiscal year 464   464   0
Total financing receivable, More than five years before current fiscal year 1,350   1,350   0
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 20,036   20,036   1,584
Substandard | Commercial portfolio | Commercial non-mortgage          
Financing Receivable          
Total financing receivable, Current fiscal year 44,829   44,829   56,307
Total financing receivable, Fiscal year before current fiscal year 46,676   46,676   125,735
Total financing receivable, Two years before current fiscal year 156,110   156,110   237,362
Total financing receivable, Three years before current fiscal year 207,319   207,319   92,134
Total financing receivable, Four years before current fiscal year 90,287   90,287   16,466
Total financing receivable, More than five years before current fiscal year 92,189   92,189   63,998
Revolving Loans Amortized Cost Basis 173,378   173,378   208,608
Loans and leases 810,788   810,788   800,610
Substandard | Commercial portfolio | Asset-based          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   0
Total financing receivable, Fiscal year before current fiscal year 0   0   2,562
Total financing receivable, Two years before current fiscal year 2,508   2,508   0
Total financing receivable, Three years before current fiscal year 0   0   0
Total financing receivable, Four years before current fiscal year 0   0   0
Total financing receivable, More than five years before current fiscal year 6   6   1,239
Revolving Loans Amortized Cost Basis 190,354   190,354   138,518
Loans and leases 192,868   192,868   142,319
Substandard | Commercial portfolio | Commercial real estate          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   0
Total financing receivable, Fiscal year before current fiscal year 3,301   3,301   131,108
Total financing receivable, Two years before current fiscal year 134,861   134,861   69,829
Total financing receivable, Three years before current fiscal year 64,746   64,746   121,139
Total financing receivable, Four years before current fiscal year 82,636   82,636   112,582
Total financing receivable, More than five years before current fiscal year 364,408   364,408   262,079
Revolving Loans Amortized Cost Basis 1,212   1,212   8,852
Loans and leases 651,164   651,164   705,589
Substandard | Commercial portfolio | Multi-family          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   0
Total financing receivable, Fiscal year before current fiscal year 0   0   0
Total financing receivable, Two years before current fiscal year 14,294   14,294   16,761
Total financing receivable, Three years before current fiscal year 16,634   16,634   27,102
Total financing receivable, Four years before current fiscal year 26,950   26,950   26,720
Total financing receivable, More than five years before current fiscal year 69,754   69,754   26,084
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 127,632   127,632   96,667
Substandard | Commercial portfolio | Equipment financing          
Financing Receivable          
Total financing receivable, Current fiscal year 3,612   3,612   572
Total financing receivable, Fiscal year before current fiscal year 831   831   16,228
Total financing receivable, Two years before current fiscal year 10,959   10,959   18,341
Total financing receivable, Three years before current fiscal year 15,718   15,718   16,970
Total financing receivable, Four years before current fiscal year 10,716   10,716   5,514
Total financing receivable, More than five years before current fiscal year 7,567   7,567   8,356
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 49,403   49,403   65,981
Doubtful | Commercial portfolio | Commercial non-mortgage          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   0
Total financing receivable, Fiscal year before current fiscal year 0   0   0
Total financing receivable, Two years before current fiscal year 0   0   0
Total financing receivable, Three years before current fiscal year 0   0   1
Total financing receivable, Four years before current fiscal year 43   43   0
Total financing receivable, More than five years before current fiscal year 306   306   25
Revolving Loans Amortized Cost Basis 1   1   1
Loans and leases $ 350   $ 350   $ 27
v3.25.2
Loans and Leases - Credit Quality Indicators (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Financing Receivable          
Loans and leases $ 53,671,959   $ 53,671,959   $ 52,505,168
Current period gross write-offs          
Total 41,238 $ 34,774 97,856 $ 74,565  
Consumer portfolio          
Financing Receivable          
Total financing receivable, Current fiscal year 805,747   805,747   1,298,754
Total financing receivable, Fiscal year before current fiscal year 1,437,747   1,437,747   763,519
Total financing receivable, Two years before current fiscal year 715,124   715,124   1,924,258
Total financing receivable, Three years before current fiscal year 1,875,637   1,875,637   2,156,856
Total financing receivable, Four years before current fiscal year 2,090,850   2,090,850   811,965
Total financing receivable, More than five years before current fiscal year 3,068,757   3,068,757   2,420,593
Revolving Loans Amortized Cost Basis 1,026,219   1,026,219   1,061,222
Loans and leases 11,020,081   11,020,081   10,437,167
Current period gross write-offs          
Current fiscal year     1,198   3,467
Fiscal year before current fiscal year     951   17
Two years before current fiscal year     8   34
Three years before current fiscal year     4   20
Four years before current fiscal year     8   115
More than five years before current fiscal year     71   784
Revolving Loans Amortized Cost Basis     258   573
Total 1,446 $ 1,418 2,498 $ 2,748 5,010
Consumer portfolio | Residential          
Financing Receivable          
Total financing receivable, Current fiscal year 696,779   696,779   1,151,655
Total financing receivable, Fiscal year before current fiscal year 1,232,744   1,232,744   697,121
Total financing receivable, Two years before current fiscal year 653,986   653,986   1,862,151
Total financing receivable, Three years before current fiscal year 1,817,633   1,817,633   2,082,332
Total financing receivable, Four years before current fiscal year 2,020,737   2,020,737   770,546
Total financing receivable, More than five years before current fiscal year 2,910,534   2,910,534   2,289,864
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 9,332,413   9,332,413   8,853,669
Current period gross write-offs          
Current fiscal year     0   0
Fiscal year before current fiscal year     0   0
Two years before current fiscal year     0   0
Three years before current fiscal year     0   0
Four years before current fiscal year     0   0
More than five years before current fiscal year     15   147
Revolving Loans Amortized Cost Basis     0   0
Total     15   147
Consumer portfolio | Home equity          
Financing Receivable          
Total financing receivable, Current fiscal year 19,741   19,741   37,780
Total financing receivable, Fiscal year before current fiscal year 35,971   35,971   64,724
Total financing receivable, Two years before current fiscal year 59,777   59,777   61,048
Total financing receivable, Three years before current fiscal year 57,225   57,225   72,184
Total financing receivable, Four years before current fiscal year 68,018   68,018   40,991
Total financing receivable, More than five years before current fiscal year 157,550   157,550   129,910
Revolving Loans Amortized Cost Basis 987,464   987,464   1,021,055
Loans and leases 1,385,746   1,385,746   1,427,692
Current period gross write-offs          
Current fiscal year     0   0
Fiscal year before current fiscal year     50   0
Two years before current fiscal year     0   0
Three years before current fiscal year     0   0
Four years before current fiscal year     0   2
More than five years before current fiscal year     29   444
Revolving Loans Amortized Cost Basis     161   351
Total     240   797
Consumer portfolio | Other consumer          
Financing Receivable          
Total financing receivable, Current fiscal year 89,227   89,227   109,319
Total financing receivable, Fiscal year before current fiscal year 169,032   169,032   1,674
Total financing receivable, Two years before current fiscal year 1,361   1,361   1,059
Total financing receivable, Three years before current fiscal year 779   779   2,340
Total financing receivable, Four years before current fiscal year 2,095   2,095   428
Total financing receivable, More than five years before current fiscal year 673   673   819
Revolving Loans Amortized Cost Basis 38,755   38,755   40,167
Loans and leases 301,922   301,922   155,806
Current period gross write-offs          
Current fiscal year     1,198   3,467
Fiscal year before current fiscal year     901   17
Two years before current fiscal year     8   34
Three years before current fiscal year     4   20
Four years before current fiscal year     8   113
More than five years before current fiscal year     27   193
Revolving Loans Amortized Cost Basis     97   222
Total     2,243   4,066
800+ | Consumer portfolio | Residential          
Financing Receivable          
Total financing receivable, Current fiscal year 191,796   191,796   312,771
Total financing receivable, Fiscal year before current fiscal year 501,827   501,827   299,006
Total financing receivable, Two years before current fiscal year 298,943   298,943   909,109
Total financing receivable, Three years before current fiscal year 919,014   919,014   1,097,807
Total financing receivable, Four years before current fiscal year 1,087,229   1,087,229   433,950
Total financing receivable, More than five years before current fiscal year 1,311,324   1,311,324   956,478
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 4,310,133   4,310,133   4,009,121
800+ | Consumer portfolio | Home equity          
Financing Receivable          
Total financing receivable, Current fiscal year 5,930   5,930   12,313
Total financing receivable, Fiscal year before current fiscal year 11,151   11,151   25,226
Total financing receivable, Two years before current fiscal year 25,589   25,589   23,512
Total financing receivable, Three years before current fiscal year 25,595   25,595   32,695
Total financing receivable, Four years before current fiscal year 30,833   30,833   22,705
Total financing receivable, More than five years before current fiscal year 70,449   70,449   53,844
Revolving Loans Amortized Cost Basis 349,518   349,518   365,741
Loans and leases 519,065   519,065   536,036
800+ | Consumer portfolio | Other consumer          
Financing Receivable          
Total financing receivable, Current fiscal year 3,318   3,318   4,920
Total financing receivable, Fiscal year before current fiscal year 7,264   7,264   312
Total financing receivable, Two years before current fiscal year 317   317   218
Total financing receivable, Three years before current fiscal year 141   141   1,765
Total financing receivable, Four years before current fiscal year 1,725   1,725   50
Total financing receivable, More than five years before current fiscal year 148   148   284
Revolving Loans Amortized Cost Basis 14,477   14,477   31,549
Loans and leases 27,390   27,390   39,098
740-799 | Consumer portfolio | Residential          
Financing Receivable          
Total financing receivable, Current fiscal year 401,252   401,252   649,118
Total financing receivable, Fiscal year before current fiscal year 546,890   546,890   258,699
Total financing receivable, Two years before current fiscal year 227,983   227,983   567,545
Total financing receivable, Three years before current fiscal year 531,523   531,523   656,599
Total financing receivable, Four years before current fiscal year 629,765   629,765   235,749
Total financing receivable, More than five years before current fiscal year 812,135   812,135   623,989
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 3,149,548   3,149,548   2,991,699
740-799 | Consumer portfolio | Home equity          
Financing Receivable          
Total financing receivable, Current fiscal year 7,838   7,838   12,238
Total financing receivable, Fiscal year before current fiscal year 12,907   12,907   21,831
Total financing receivable, Two years before current fiscal year 18,702   18,702   20,718
Total financing receivable, Three years before current fiscal year 16,799   16,799   23,517
Total financing receivable, Four years before current fiscal year 22,594   22,594   10,861
Total financing receivable, More than five years before current fiscal year 40,189   40,189   33,703
Revolving Loans Amortized Cost Basis 317,213   317,213   330,691
Loans and leases 436,242   436,242   453,559
740-799 | Consumer portfolio | Other consumer          
Financing Receivable          
Total financing receivable, Current fiscal year 34,320   34,320   45,001
Total financing receivable, Fiscal year before current fiscal year 66,461   66,461   721
Total financing receivable, Two years before current fiscal year 466   466   301
Total financing receivable, Three years before current fiscal year 241   241   165
Total financing receivable, Four years before current fiscal year 214   214   124
Total financing receivable, More than five years before current fiscal year 231   231   266
Revolving Loans Amortized Cost Basis 4,287   4,287   3,550
Loans and leases 106,220   106,220   50,128
670-739 | Consumer portfolio | Residential          
Financing Receivable          
Total financing receivable, Current fiscal year 97,051   97,051   172,886
Total financing receivable, Fiscal year before current fiscal year 162,365   162,365   123,354
Total financing receivable, Two years before current fiscal year 100,743   100,743   317,373
Total financing receivable, Three years before current fiscal year 297,619   297,619   271,247
Total financing receivable, Four years before current fiscal year 237,615   237,615   80,318
Total financing receivable, More than five years before current fiscal year 625,265   625,265   550,252
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 1,520,658   1,520,658   1,515,430
670-739 | Consumer portfolio | Home equity          
Financing Receivable          
Total financing receivable, Current fiscal year 5,352   5,352   11,416
Total financing receivable, Fiscal year before current fiscal year 10,143   10,143   14,298
Total financing receivable, Two years before current fiscal year 12,131   12,131   12,732
Total financing receivable, Three years before current fiscal year 9,648   9,648   13,074
Total financing receivable, Four years before current fiscal year 11,091   11,091   6,242
Total financing receivable, More than five years before current fiscal year 32,121   32,121   28,638
Revolving Loans Amortized Cost Basis 228,224   228,224   224,449
Loans and leases 308,710   308,710   310,849
670-739 | Consumer portfolio | Other consumer          
Financing Receivable          
Total financing receivable, Current fiscal year 50,326   50,326   57,952
Total financing receivable, Fiscal year before current fiscal year 93,010   93,010   432
Total financing receivable, Two years before current fiscal year 408   408   372
Total financing receivable, Three years before current fiscal year 236   236   313
Total financing receivable, Four years before current fiscal year 97   97   220
Total financing receivable, More than five years before current fiscal year 162   162   188
Revolving Loans Amortized Cost Basis 18,444   18,444   3,349
Loans and leases 162,683   162,683   62,826
580-669 | Consumer portfolio | Residential          
Financing Receivable          
Total financing receivable, Current fiscal year 6,680   6,680   16,643
Total financing receivable, Fiscal year before current fiscal year 20,747   20,747   13,382
Total financing receivable, Two years before current fiscal year 22,924   22,924   55,507
Total financing receivable, Three years before current fiscal year 53,824   53,824   35,292
Total financing receivable, Four years before current fiscal year 43,214   43,214   16,738
Total financing receivable, More than five years before current fiscal year 111,958   111,958   109,240
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 259,347   259,347   246,802
580-669 | Consumer portfolio | Home equity          
Financing Receivable          
Total financing receivable, Current fiscal year 469   469   1,755
Total financing receivable, Fiscal year before current fiscal year 1,555   1,555   2,570
Total financing receivable, Two years before current fiscal year 1,898   1,898   1,685
Total financing receivable, Three years before current fiscal year 2,864   2,864   2,172
Total financing receivable, Four years before current fiscal year 2,927   2,927   754
Total financing receivable, More than five years before current fiscal year 9,883   9,883   9,471
Revolving Loans Amortized Cost Basis 60,667   60,667   67,745
Loans and leases 80,263   80,263   86,152
580-669 | Consumer portfolio | Other consumer          
Financing Receivable          
Total financing receivable, Current fiscal year 1,261   1,261   1,417
Total financing receivable, Fiscal year before current fiscal year 2,242   2,242   116
Total financing receivable, Two years before current fiscal year 93   93   105
Total financing receivable, Three years before current fiscal year 115   115   69
Total financing receivable, Four years before current fiscal year 31   31   25
Total financing receivable, More than five years before current fiscal year 96   96   81
Revolving Loans Amortized Cost Basis 1,093   1,093   1,150
Loans and leases 4,931   4,931   2,963
579 and below | Consumer portfolio | Residential          
Financing Receivable          
Total financing receivable, Current fiscal year 0   0   237
Total financing receivable, Fiscal year before current fiscal year 915   915   2,680
Total financing receivable, Two years before current fiscal year 3,393   3,393   12,617
Total financing receivable, Three years before current fiscal year 15,653   15,653   21,387
Total financing receivable, Four years before current fiscal year 22,914   22,914   3,791
Total financing receivable, More than five years before current fiscal year 49,852   49,852   49,905
Revolving Loans Amortized Cost Basis 0   0   0
Loans and leases 92,727   92,727   90,617
579 and below | Consumer portfolio | Home equity          
Financing Receivable          
Total financing receivable, Current fiscal year 152   152   58
Total financing receivable, Fiscal year before current fiscal year 215   215   799
Total financing receivable, Two years before current fiscal year 1,457   1,457   2,401
Total financing receivable, Three years before current fiscal year 2,319   2,319   726
Total financing receivable, Four years before current fiscal year 573   573   429
Total financing receivable, More than five years before current fiscal year 4,908   4,908   4,254
Revolving Loans Amortized Cost Basis 31,842   31,842   32,429
Loans and leases 41,466   41,466   41,096
579 and below | Consumer portfolio | Other consumer          
Financing Receivable          
Total financing receivable, Current fiscal year 2   2   29
Total financing receivable, Fiscal year before current fiscal year 55   55   93
Total financing receivable, Two years before current fiscal year 77   77   63
Total financing receivable, Three years before current fiscal year 46   46   28
Total financing receivable, Four years before current fiscal year 28   28   9
Total financing receivable, More than five years before current fiscal year 36   36   0
Revolving Loans Amortized Cost Basis 454   454   569
Loans and leases $ 698   $ 698   $ 791
v3.25.2
Loans and Leases - Summary of Amortized Cost Basis (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 164,270 $ 120,016 $ 229,198 $ 193,799
% of Total Class 0.30% 0.20% 0.40% 0.40%
Accrued interest receivable $ 500 $ 300 $ 600 $ 400
Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 1,981   1,981 637
Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 84,072 119,351 147,450 148,457
Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 13,161 420 13,673 43,184
Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 425 245 1,463 1,521
Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 51,313   51,313  
Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 13,241   13,241  
Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 77   77  
Commercial non-mortgage        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 108,375 $ 69,432 $ 149,347 $ 130,253
% of Total Class 0.60% 0.40% 0.80% 0.80%
Commercial non-mortgage | Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0 $ 11
Commercial non-mortgage | Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 43,425 $ 69,182 $ 84,290 $ 86,150
Extended term by a weighted average 1 year 4 months 24 days 7 months 6 days 1 year 3 months 18 days 7 months 6 days
Commercial non-mortgage | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 13,161 $ 61 $ 13,161 $ 42,825
Extended term by a weighted average     2 years 4 months 24 days 6 months
Payment deferrals term 2 years 4 months 24 days      
Commercial non-mortgage | Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 399 189 $ 506 $ 1,267
Extended term by a weighted average 3 months 18 days      
Payment deferrals term 6 months      
Commercial non-mortgage | Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 51,313   $ 51,313  
Extended term by a weighted average     3 months 18 days  
Payment deferrals term     6 months  
Commercial non-mortgage | Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   $ 0  
Commercial non-mortgage | Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 77   77  
Asset-based        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 11,487 $ 6,150 $ 11,487 $ 7,817
% of Total Class 0.90% 0.40% 0.90% 0.50%
Asset-based | Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0 $ 0
Asset-based | Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 11,487 $ 6,150 $ 11,487 $ 7,817
Extended term by a weighted average 1 year 6 months 1 year 6 months
Asset-based | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0 $ 0 $ 0 $ 0
Asset-based | Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0 0 0 0
Asset-based | Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Asset-based | Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Asset-based | Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Commercial real estate        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 18,978 $ 44,333 $ 40,119 $ 44,833
% of Total Class 0.10% 0.30% 0.30% 0.30%
Commercial real estate | Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0 $ 0
Commercial real estate | Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 18,978 $ 43,974 $ 39,607 $ 44,474
Extended term by a weighted average 4 months 24 days 1 year 1 month 6 days 8 months 12 days 1 year 1 month 6 days
Commercial real estate | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0 $ 359 $ 512 $ 359
Commercial real estate | Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0 0 0 0
Commercial real estate | Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Commercial real estate | Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Commercial real estate | Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Multi-family        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 21,562   $ 23,256 $ 9,481
% of Total Class 0.30%   0.30% 0.10%
Multi-family | Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 1,981   $ 1,981 $ 0
Reduced weighted average interest rate 2.00%   2.00%  
Multi-family | Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 6,340   $ 8,034 $ 9,481
Extended term by a weighted average 3 years   2 years 6 months 1 year 4 months 24 days
Multi-family | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0 $ 0
Multi-family | Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0 0
Multi-family | Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Multi-family | Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 13,241   $ 13,241  
Reduced weighted average interest rate 2.00%   2.00%  
Payment deferrals term 9 months 18 days   9 months 18 days  
Multi-family | Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0  
Equipment financing        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 3,842   $ 4,032 $ 490
% of Total Class 0.30%   0.30% 0.00%
Equipment financing | Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0 $ 0
Equipment financing | Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 3,842   $ 4,032 490
Extended term by a weighted average 1 year 9 months 18 days   1 year 9 months 18 days  
Equipment financing | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0 0
Equipment financing | Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0 0
Equipment financing | Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Equipment financing | Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Equipment financing | Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Residential        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     $ 891 $ 759
% of Total Class     0.00% 0.00%
Residential | Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     $ 0 $ 626
Residential | Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     0 0
Residential | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     0 0
Residential | Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     891 133
Residential | Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     0  
Residential | Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     0  
Residential | Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total     0  
Home equity        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 26 $ 101 $ 66 $ 166
% of Total Class 0.00% 0.00% 0.00% 0.00%
Home equity | Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0 $ 0
Home equity | Term Extension        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0 $ 45 0 45
Home equity | Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0 0 0 0
Home equity | Combination - Term Extension & Interest Rate Reduction        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 26 $ 56 66 $ 121
Home equity | Term Extension & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Home equity | Interest Rate Reduction & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total 0   0  
Home equity | Term Extension, Interest Rate Reduction, & Payment Delay        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Total $ 0   $ 0  
v3.25.2
Loans and Leases - Aging of Loans Modified In Twelve Preceding Months (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Non-accrual $ 534,155 $ 460,725
Aging Loan Modifications    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 374,435 261,685
Non-accrual 169,991 155,196
Aging Loan Modifications | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 200,526 105,114
Aging Loan Modifications | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 3,819 1,375
Aging Loan Modifications | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 99 0
Aging Loan Modifications | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Commercial non-mortgage    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 225,191 175,306
Non-accrual 144,026 120,775
Aging Loan Modifications | Commercial non-mortgage | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 77,346 53,156
Aging Loan Modifications | Commercial non-mortgage | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 3,819 1,375
Aging Loan Modifications | Commercial non-mortgage | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Commercial non-mortgage | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Asset-based    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 26,487 12,817
Non-accrual 15,000 0
Aging Loan Modifications | Asset-based | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 11,487 12,817
Aging Loan Modifications | Asset-based | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Asset-based | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Asset-based | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Commercial real estate    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 92,798 61,940
Non-accrual 7,771 23,613
Aging Loan Modifications | Commercial real estate | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 85,027 38,327
Aging Loan Modifications | Commercial real estate | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Commercial real estate | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Commercial real estate | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Multi-family    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 23,256 9,481
Non-accrual 1,981 9,481
Aging Loan Modifications | Multi-family | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 21,275 0
Aging Loan Modifications | Multi-family | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Multi-family | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Multi-family | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Equipment financing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 4,131 777
Non-accrual 0 581
Aging Loan Modifications | Equipment financing | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 4,032 196
Aging Loan Modifications | Equipment financing | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Equipment financing | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 99 0
Aging Loan Modifications | Equipment financing | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Residential    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 1,774 894
Non-accrual 998 626
Aging Loan Modifications | Residential | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 776 268
Aging Loan Modifications | Residential | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Residential | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Residential | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Home equity    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 798 470
Non-accrual 215 120
Aging Loan Modifications | Home equity | Current    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 583 350
Aging Loan Modifications | Home equity | 30-59 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Home equity | 60-89 Days Past Due and Accruing    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total 0 0
Aging Loan Modifications | Home equity | 90 or More Days Past Due    
Financing Receivable, Troubled Debt Restructuring [Line Items]    
Total $ 0 $ 0
v3.25.2
Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jan. 24, 2024
Jun. 30, 2025
Dec. 31, 2024
Goodwill [Roll Forward]      
Balance, beginning of period   $ 2,868,068 $ 2,631,465
Balance, end of period   2,868,068 2,868,068
Ametros      
Goodwill [Roll Forward]      
Goodwill acquired   $ 0 $ 236,603
Balance, end of period $ 228,185    
Other adjustments $ 8,400    
v3.25.2
Goodwill and Other Intangible Assets - Gross Carrying Value and Accumulated Amortization of Other Intangible Assets (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 461,000 $ 461,000
Accumulated Amortization 145,029 126,699
Net Carrying Amount 315,971 334,301
Core deposits    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 328,837 328,837
Accumulated Amortization 87,585 76,795
Net Carrying Amount 241,252 252,042
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 122,063 122,063
Accumulated Amortization 53,716 47,186
Net Carrying Amount 68,347 74,877
Non-competition agreement    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 4,000 4,000
Accumulated Amortization 2,000 1,600
Net Carrying Amount 2,000 2,400
Trade name    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 6,100 6,100
Accumulated Amortization 1,728 1,118
Net Carrying Amount $ 4,372 $ 4,982
v3.25.2
Goodwill and Other Intangible Assets - Schedule of Expected Future Amortization Expense (Detail)
$ in Thousands
Jun. 30, 2025
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Remainder of 2025 $ 17,721
2026 34,083
2027 33,033
2028 30,162
2029 28,289
Thereafter $ 172,683
v3.25.2
Deposits - Summary of Deposits by Type (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Non-interest-bearing:    
Demand $ 10,345,761 $ 10,316,501
Interest-bearing:    
Health savings accounts 9,064,935 8,951,031
Checking 9,933,392 9,834,790
Money market 21,679,493 20,433,250
Savings 7,370,959 6,982,554
Time deposits 7,919,885 8,234,954
Total interest-bearing 55,968,664 54,436,579
Total deposits 66,314,425 64,753,080
Time deposits, money market, and interest-bearing checking obtained through brokers 2,624,835 3,181,298
Aggregate amount of time deposit accounts that exceeded the FDIC limit 1,465,572 1,407,077
Deposit overdrafts reclassified as loan balances 5,064 7,146
Money market sweep deposits received 8,700,000 7,300,000
Time deposit accounts at FDIC limit $ 19,300 $ 16,800
v3.25.2
Deposits - Scheduled Maturities of Time Deposits (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Deposit Liabilities [Abstract]    
Remainder of 2025 $ 5,946,812  
2026 1,876,195  
2027 38,286  
2028 20,127  
2029 17,969  
Thereafter 20,496  
Time deposits $ 7,919,885 $ 8,234,954
v3.25.2
Borrowings - Schedule of Repurchase Agreements (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets Sold under Agreements to Repurchase [Line Items]    
Securities sold under agreements to repurchase $ 372,806 $ 344,168
Securities sold under agreements to repurchase and federal funds purchased $ 372,806 $ 344,168
Securities sold under agreements to repurchase    
Assets Sold under Agreements to Repurchase [Line Items]    
Rate 3.66% 2.98%
Securities sold under agreements to repurchase and federal funds purchased    
Assets Sold under Agreements to Repurchase [Line Items]    
Rate 3.66% 2.98%
v3.25.2
Borrowings - Narrative (Details) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Debt Disclosure [Abstract]    
Market value pledged to repurchase agreements $ 389.4 $ 358.4
v3.25.2
Borrowings - Summary of Repurchase Agreement Offsetting (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets Sold under Agreements to Repurchase [Line Items]    
Gross Amounts of Recognized Liabilities $ 302,306 $ 209,961
Gross Amounts Offset in the Statement of Financial Position 0 0
Net Amounts of Liabilities Presented in the Statement of Financial Position 302,306 209,961
Gross Amounts Not Offset in the Statement of Financial position, Financial Instruments 302,306 209,961
Gross Amounts Not Offset in the Statement of Financial position, Cash Collateral Pledged 0 0
Net Amount 0 0
Market value pledged to repurchase agreements 389,400 358,400
Agency MBS    
Assets Sold under Agreements to Repurchase [Line Items]    
Market value pledged to repurchase agreements 315,100 220,600
Excess collateral $ 12,800 $ 10,600
v3.25.2
Borrowings - Summary of FHLB Advances (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Total Outstanding    
Maturing within 1 year $ 3,330,000 $ 2,100,000
After 1 but within 2 years 0 0
After 2 but within 3 years 417 218
After 3 but within 4 years 0 215
After 4 but within 5 years 629 642
After 5 years 8,868 9,033
Total FHLB advances $ 3,339,914 $ 2,110,108
Weighted- Average Contractual Coupon Rate    
Maturing within 1 year 4.49% 4.50%
After 1 but within 2 years 0.00% 0.00%
After 2 but within 3 years 1.37% 0.00%
After 3 but within 4 years 0.00% 2.75%
After 4 but within 5 years 1.75% 1.75%
After 5 years 2.02% 2.02%
Total FHLB advances 4.48% 4.49%
Aggregate market value of assets pledged as collateral $ 16,530,103 $ 16,581,133
Remaining borrowing capacity at FHLB $ 7,557,549 $ 8,670,348
v3.25.2
Borrowings - Schedule of Long-Term Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Debt Instrument [Line Items]    
Subordinated fixed-to-floating rate notes $ 896,394 $ 899,071
Debt issuance cost on 2029 senior notes (1,003) (1,137)
Long-term debt 905,634 909,185
Senior Notes    
Debt Instrument [Line Items]    
Discount on 2029 senior notes (373) (423)
Subordinated Debt    
Debt Instrument [Line Items]    
Premium on 2029 subordinated notes and 2030 subordinated notes 10,616 11,674
Junior Subordinated Debt    
Debt Instrument [Line Items]    
Subordinated fixed-to-floating rate notes $ 77,320 77,320
Senior Notes Due 2029 | Senior Notes    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate, percentage 4.10%  
Subordinated fixed-to-floating rate notes $ 320,074 322,751
Hedge basis adjustment 20,100 22,800
2029 subordinated notes | Subordinated Debt    
Debt Instrument [Line Items]    
Subordinated fixed-to-floating rate notes $ 274,000 $ 274,000
Interest rate spread of LIBOR plus (as a percent) 2.53%  
Variable interest rate 6.82% 6.84%
2030 subordinated notes | Subordinated Debt    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate, percentage 3.875%  
Subordinated fixed-to-floating rate notes $ 225,000 $ 225,000
Junior Subordinated Debt    
Debt Instrument [Line Items]    
Interest rate spread of LIBOR plus (as a percent) 2.95%  
Variable interest rate 7.52% 7.56%
v3.25.2
Stockholders' Equity - Schedule of Stock by Class (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common Stock Outstanding, beginning balance (in shares) 168,594,276 172,463,886 171,391,125 172,021,956
Employee stock compensation plan activity (in shares) 9,501 (87,634) 782,106 788,357
Common stock repurchase program (in shares) (1,520,514) (974,365) (5,089,968) (1,408,426)
Common Stock Outstanding, ending balance (in shares) 167,083,263 171,401,887 167,083,263 171,401,887
Common shares issued from treasury stock (in shares) 17,602 19,350 1,174,880 1,137,889
Employee Stock Compensation Plan        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock repurchase program (in shares) (8,101) (68,284) (392,774) (349,532)
Preferred Stock Series F Issued        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares, beginning balance (in shares) 6,000 6,000 6,000 6,000
Employee stock compensation plan activity (in shares) 0 0 0 0
Common stock repurchase program (in shares) 0 0 0 0
Shares, ending balance (in shares) 6,000 6,000 6,000 6,000
Preferred Stock Series G Issued        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares, beginning balance (in shares) 135,000 135,000 135,000 135,000
Employee stock compensation plan activity (in shares) 0 0 0 0
Common stock repurchase program (in shares) 0 0 0 0
Shares, ending balance (in shares) 135,000 135,000 135,000 135,000
Common Stock        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares, beginning balance (in shares) 182,778,045 182,778,045 182,778,045 182,778,045
Employee stock compensation plan activity (in shares) 0 0 0 0
Common stock repurchase program (in shares) 0 0 0 0
Shares, ending balance (in shares) 182,778,045 182,778,045 182,778,045 182,778,045
Treasury Stock Held        
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Treasury Stock Held, beginning balance (in shares) 14,183,769 10,314,159 11,386,920 10,756,089
Employee stock compensation plan activity (in shares) 9,501 (87,634) 782,106 788,357
Common stock repurchase program (in shares) (1,520,514) (974,365) (5,089,968) (1,408,426)
Treasury Stock Held, ending balance (in shares) 15,694,782 11,376,158 15,694,782 11,376,158
v3.25.2
Stockholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Apr. 30, 2025
Equity [Abstract]          
Share repurchase amount         $ 700,000
Common stock repurchase program (in shares) 1,520,514 974,365 5,089,968 1,408,426  
Treasury stock acquired, average cost per share (in usd per share) $ 51.70   $ 51.00    
Treasury stock acquired, value $ 78,600   $ 259,601 $ 65,402  
Share repurchase authority (in shares) $ 668,400   $ 668,400    
v3.25.2
Accumulated Other Comprehensive (Loss), Net of Tax - Schedule of Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period $ 9,204,154 $ 8,747,498 $ 9,133,214 $ 8,689,996
Other comprehensive income (loss) before reclassifications 8,902 (55,071) 113,620 (135,348)
Amounts reclassified from accumulated other comprehensive (loss) income 2,237 43,273 4,501 58,020
Total 11,139 (11,798) 118,121 (77,328)
Balance, end of period 9,337,617 8,809,268 9,337,617 8,809,268
Accumulated Other Comprehensive (Loss), Net of Tax        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period (449,401) (616,101) (556,383) (550,571)
Total 11,139 (11,798) 118,121 (77,328)
Balance, end of period (438,262) (627,899) (438,262) (627,899)
Investment Securities Available- for-Sale        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period (423,737) (553,721) (520,318) (517,450)
Other comprehensive income (loss) before reclassifications 8,858 (43,970) 105,824 (86,560)
Amounts reclassified from accumulated other comprehensive (loss) income 0 34,161 (385) 40,480
Total 8,858 (9,809) 105,439 (46,080)
Balance, end of period (414,879) (563,530) (414,879) (563,530)
Derivative Financial Instruments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period 524 (32,858) (9,600) (2,869)
Other comprehensive income (loss) before reclassifications 44 (10,243) 7,796 (48,181)
Amounts reclassified from accumulated other comprehensive (loss) income 1,960 8,633 4,332 16,582
Total 2,004 (1,610) 12,128 (31,599)
Balance, end of period 2,528 (34,468) 2,528 (34,468)
Defined Benefit Pension and Other Postretirement Benefit Plans        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance, beginning of period (26,188) (29,522) (26,465) (30,252)
Other comprehensive income (loss) before reclassifications 0 (858) 0 (607)
Amounts reclassified from accumulated other comprehensive (loss) income 277 479 554 958
Total 277 (379) 554 351
Balance, end of period $ (25,911) $ (29,901) $ (25,911) $ (29,901)
v3.25.2
Accumulated Other Comprehensive (Loss), Net of Tax - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Reclassification out of Accumulated Other Comprehensive Income [Line Items]        
Tax benefit $ (64,777) $ (47,941) $ (121,514) $ (117,287)
Interest payments 775,203 798,097 1,530,320 1,590,142
Premium amortization 1,000,587 976,286 1,974,074 1,928,136
Actuarial net loss amortization (32,796) (36,811) (63,524) (68,240)
Net income 258,848 181,633 485,765 397,956
Cash Flow Hedging        
Reclassification out of Accumulated Other Comprehensive Income [Line Items]        
Estimate of amount to be reclassified from AOCL 300   300  
Investment Securities Available- for-Sale | Reclassification out of accumulated comprehensive income        
Reclassification out of Accumulated Other Comprehensive Income [Line Items]        
Net unrealized gains (losses) 0 (46,496) 528 (55,183)
Tax benefit 0 12,335 (143) 14,703
Net income 0 (34,161) 385 (40,480)
Derivative Financial Instruments | Reclassification out of accumulated comprehensive income        
Reclassification out of Accumulated Other Comprehensive Income [Line Items]        
Tax benefit 729 3,214 1,612 6,063
Interest payments (2,689) (11,630) (5,944) (22,122)
Hedge terminations 0 0 0 (34)
Premium amortization 0 (217) 0 (489)
Net income (1,960) (8,633) (4,332) (16,582)
Defined benefit pension and other postretirement benefit plans: | Reclassification out of accumulated comprehensive income        
Reclassification out of Accumulated Other Comprehensive Income [Line Items]        
Tax benefit 103 179 206 357
Net income (277) (479) (554) (958)
Actuarial net loss amortization | Reclassification out of accumulated comprehensive income        
Reclassification out of Accumulated Other Comprehensive Income [Line Items]        
Actuarial net loss amortization $ (380) $ (658) $ (760) $ (1,315)
v3.25.2
Regulatory Capital and Restrictions - Schedule of Information on Capital Ratios (Detail)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Jun. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]      
Actual, CET1 Risk-Based Capital   $ 6,406,260 $ 6,318,876
Actual, Tier 1 Risk-Based Capital   6,690,239 6,602,855
Actual, Total Risk-Based Capital   7,927,728 7,800,717
Actual, Tier 1 Leverage Capital   $ 6,690,239 $ 6,602,855
Ratio, CET1 Risk-Based Capital   0.1135 0.1154
Actual, Ratio, Tier 1 Risk-Based Capital   0.1186 0.1206
Ratio, Total Risk-Based Capital   0.1405 0.1424
Actual, Ratio, Tier 1 Leverage Capital   0.0857 0.0870
Minimum Requirement, CET1 Risk-Based Capital   $ 2,539,270 $ 2,464,542
Minimum Requirement, Tier 1 Risk-Based Capital   3,385,694 3,286,057
Minimum Requirement, Total Risk-Based Capital   4,514,258 4,381,409
Minimum Requirement, Tier 1, Leverage Capital   $ 3,121,275 $ 3,034,369
Minimum Requirement, Ratio, Tier 1 Risk-Based Capital   0.060 0.060
Minimum Requirement, Ratio, Total Risk-Based Capital   0.080 0.080
Minimum Requirement, Ratio, Tier 1 Leverage Capital   0.040 0.040
Well Capitalized, CET1 Risk-Based Capital   $ 3,667,835 $ 3,559,895
Well Capitalized, Tier 1 Risk-Based Capital   4,514,258 4,381,409
Well Capitalized, Total Risk-Based Capital   5,642,823 5,476,761
Well Capitalized, Tier 1 Leverage Capital   $ 3,901,593 $ 3,792,961
Well Capitalized, Ratio, Tier 1 Risk-Based Capital   0.080 0.080
Well Capitalized, Ratio, Total Risk-Based Capital   0.100 0.100
Well Capitalized, Ratio, Tier 1 Leverage Capital   0.050 0.050
Transition regulatory capital percentage 25.00%    
Subsidiaries      
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]      
Actual, CET1 Risk-Based Capital   $ 7,076,737 $ 6,847,474
Actual, Tier 1 Risk-Based Capital   7,076,737 6,847,474
Actual, Total Risk-Based Capital   7,782,131 7,512,143
Actual, Tier 1 Leverage Capital   $ 7,076,737 $ 6,847,474
Ratio, CET1 Risk-Based Capital   0.1255 0.1253
Actual, Ratio, Tier 1 Risk-Based Capital   0.1255 0.1253
Ratio, Total Risk-Based Capital   0.1380 0.1374
Actual, Ratio, Tier 1 Leverage Capital   0.0908 0.0904
Minimum Requirement, CET1 Risk-Based Capital   $ 2,538,304 $ 2,460,031
Minimum Requirement, Tier 1 Risk-Based Capital   3,384,405 3,280,042
Minimum Requirement, Total Risk-Based Capital   4,512,540 4,373,389
Minimum Requirement, Tier 1, Leverage Capital   $ 3,118,568 $ 3,031,190
Minimum Requirement, Ratio, Tier 1 Risk-Based Capital   0.060 0.060
Minimum Requirement, Ratio, Total Risk-Based Capital   0.080 0.080
Minimum Requirement, Ratio, Tier 1 Leverage Capital   0.040 0.040
Well Capitalized, CET1 Risk-Based Capital   $ 3,666,439 $ 3,553,378
Well Capitalized, Tier 1 Risk-Based Capital   4,512,540 4,373,389
Well Capitalized, Total Risk-Based Capital   5,640,675 5,466,736
Well Capitalized, Tier 1 Leverage Capital   $ 3,898,210 $ 3,788,988
Well Capitalized, Ratio, Tier 1 Risk-Based Capital   0.080 0.080
Well Capitalized, Ratio, Total Risk-Based Capital   0.100 0.100
Well Capitalized, Ratio, Tier 1 Leverage Capital   0.050 0.050
Risk Based Capital Required for Capital Adequacy to Risk Weighted Assets      
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]      
Ratio, CET1 Risk-Based Capital   0.045 0.045
Risk Based Capital Required for Capital Adequacy to Risk Weighted Assets | Subsidiaries      
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]      
Ratio, CET1 Risk-Based Capital   0.045 0.045
Risk Based Capital Required to be Well Capitalized to Risk Weighted Assets      
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]      
Ratio, CET1 Risk-Based Capital   0.065 0.065
Risk Based Capital Required to be Well Capitalized to Risk Weighted Assets | Subsidiaries      
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]      
Ratio, CET1 Risk-Based Capital   0.065 0.065
v3.25.2
Regulatory Capital and Restrictions - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]        
Cash dividends paid to parent company $ 200.0 $ 125.0 $ 300.0 $ 300.0
v3.25.2
Variable Interest Entities - Narrative (Details) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Variable Interest Entity [Line Items]      
Percentage of outstanding equity interests 50.00%    
Maximum exposure to trusts     $ 36.4
Reimbursement obligation coverage percentage     12.00%
MW Advisor, LLC      
Variable Interest Entity [Line Items]      
Ownership percentage 50.00%    
Marathon Direct Lending SLP, LLC      
Variable Interest Entity [Line Items]      
Ownership percentage 50.00%    
Variable Interest Entity, Not Primary Beneficiary      
Variable Interest Entity [Line Items]      
Deposits assumed $ 99.1 $ 212.0  
Non-marketable investment carrying value 237.2   $ 216.5
Variable Interest Entity, Not Primary Beneficiary | Unfunded Loan Commitment      
Variable Interest Entity [Line Items]      
Maximum exposure to loss $ 352.7   $ 332.8
v3.25.2
Variable Interest Entities - Summary of LIHTC Investments and Commitments (Details) - Variable Interest Entity, Not Primary Beneficiary - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Variable Interest Entity [Line Items]    
Gross investment in LIHTC investments $ 1,538,516 $ 1,439,461
Accumulated amortization (288,773) (222,101)
Net investment in LIHTC investments 1,249,743 1,217,360
Unfunded commitments for LIHTC investments $ 700,153 $ 720,890
Investment, Proportional Amortization Method, Elected, Statement of Financial Position [Extensible Enumeration] Accrued interest receivable and other assets Accrued interest receivable and other assets
v3.25.2
Variable Interest Entities - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Income tax credits and other income tax benefits from LIHTC investments $ (40,093) $ (27,182) $ (81,799) $ (55,206)
Amortization of low-income housing tax credit investments $ 34,611 $ 21,836 $ 66,672 $ 42,249
v3.25.2
Earnings Per Common Share - Schedule of Earnings Per Share Basic and Diluted (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Earnings Per Share Reconciliation [Abstract]        
Net income $ 258,848 $ 181,633 $ 485,765 $ 397,956
Less: Preferred stock dividends 4,162 4,162 8,325 8,325
Income allocated to participating securities 2,991 1,977 5,361 4,090
Net income applicable to common stockholders $ 251,695 $ 175,494 $ 472,079 $ 385,541
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]        
Weighted-average common shares outstanding - basic (in shares) 165,884 169,675 167,524 170,061
Add: Effect of dilutive stock options and restricted stock (in shares) 247 262 329 290
Weighted-average common shares outstanding - diluted (in shares) 166,131 169,937 167,853 170,351
Earnings per common share:        
Basic (in dollars per share) $ 1.52 $ 1.03 $ 2.82 $ 2.27
Diluted (in dollars per share) $ 1.52 $ 1.03 $ 2.81 $ 2.26
v3.25.2
Earnings Per Common Share - Narrative (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Restricted Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 147,168 80,115 0 0
v3.25.2
Derivative Financial Instruments - Narrative (Detail) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Derivative Instruments, Gain (Loss) [Line Items]    
Cash collateral pledged $ 15,860 $ 80
Current net credit exposure 73,000  
Non-performance risk in fair value measurement 4,300 $ 7,600
Cash and Due from Banks    
Derivative Instruments, Gain (Loss) [Line Items]    
Cash collateral pledged 16,400  
CME Swaps Markets    
Derivative Instruments, Gain (Loss) [Line Items]    
Initial margin posted at clearing house 2,200  
Valuation, Cost Approach    
Derivative Instruments, Gain (Loss) [Line Items]    
Cash collateral pledged 121,600  
Valuation, Market Approach    
Derivative Instruments, Gain (Loss) [Line Items]    
Current net credit exposure $ 105,300  
Cash Flow Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Maximum time for forecasted transactions 2 years 4 months 24 days  
Estimate of amount to be reclassified from AOCL $ 300  
v3.25.2
Derivative Financial Instruments - Schedule of Notional Amounts and Fair Values (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Notional Amounts    
Asset Derivatives, Notional Amounts $ 12,275,167 $ 9,781,447
Liability Derivatives, Notional Amounts 11,944,662 13,812,216
Asset Derivatives    
Asset Derivatives, Fair Value 174,505 283,185
Gross derivative instruments, before netting 247,555 302,142
Gross Amounts Offset in the Statement of Financial Position 59,898 31,881
Cash collateral pledged 114,607 251,212
Total derivative instruments, after netting 73,050 19,049
Liability Derivatives    
Gross Amounts of Recognized Assets/Liabilities 76,369 32,218
Gross derivative instruments, before netting 243,787 311,561
Gross Amounts Offset in the Statement of Financial Position 59,898 31,881
Cash collateral pledged 15,860 80
Derivative Liability $ 168,029 $ 279,600
Derivative Asset Statement Of Financial Position Extensible Enumeration Not Disclosed Flag true true
Cross Currency Interest Rate Contract    
Notional Amounts    
Asset Derivatives, Notional Amounts $ 265,400 $ 294,500
Liability Derivatives, Notional Amounts 712,600 796,600
Designated as Hedging Instrument | Interest rate derivatives    
Notional Amounts    
Asset Derivatives, Notional Amounts 3,500,000 750,000
Liability Derivatives, Notional Amounts 1,750,000 4,250,000
Asset Derivatives    
Asset Derivatives, Fair Value 5,666 719
Liability Derivatives    
Gross Amounts of Recognized Assets/Liabilities 1,475 13,169
Not Designated as Hedging Instrument    
Notional Amounts    
Asset Derivatives, Notional Amounts 8,775,167 9,031,447
Liability Derivatives, Notional Amounts 10,194,662 9,562,216
Asset Derivatives    
Asset Derivatives, Fair Value 241,889 301,423
Liability Derivatives    
Gross Amounts of Recognized Assets/Liabilities 242,312 298,392
Not Designated as Hedging Instrument | Interest rate derivatives    
Notional Amounts    
Asset Derivatives, Notional Amounts 8,495,135 8,693,493
Liability Derivatives, Notional Amounts 9,406,550 8,728,767
Asset Derivatives    
Asset Derivatives, Fair Value 241,293 300,120
Liability Derivatives    
Gross Amounts of Recognized Assets/Liabilities 240,723 298,296
Not Designated as Hedging Instrument | Mortgage banking derivatives    
Notional Amounts    
Asset Derivatives, Notional Amounts 364 584
Liability Derivatives, Notional Amounts 0 0
Asset Derivatives    
Asset Derivatives, Fair Value 3 3
Liability Derivatives    
Gross Amounts of Recognized Assets/Liabilities 0 0
Not Designated as Hedging Instrument | Other    
Notional Amounts    
Asset Derivatives, Notional Amounts 279,668 337,370
Liability Derivatives, Notional Amounts 788,112 833,449
Asset Derivatives    
Asset Derivatives, Fair Value 593 1,300
Liability Derivatives    
Gross Amounts of Recognized Assets/Liabilities 1,589 96
Not Designated as Hedging Instrument | CME Swaps Markets    
Notional Amounts    
Asset Derivatives, Notional Amounts 68,100 71,100
Liability Derivatives, Notional Amounts $ 4,200 $ 0
v3.25.2
Derivative Financial Instruments - Schedule of Derivative Financial Instruments (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Asset Derivatives    
Gross Amounts of Recognized Assets/Liabilities $ 174,505 $ 283,185
Gross Amounts Offset in the Statement of Financial Position 59,898 31,881
Net Amounts of Assets/Liabilities Presented in the Statement of Financial Position 114,607 251,304
Gross Amounts Not Offset in the Statement of Financial position, Financial Instruments 0 0
Gross Amounts Not Offset in the Statement of Financial position, Cash Collateral Pledged 114,607 251,212
Net Amount 0 92
Liability Derivatives    
Gross Amounts of Recognized Assets/Liabilities 76,369 32,218
Gross Amounts Offset in the Statement of Financial Position 59,898 31,881
Net Amounts of Assets/Liabilities Presented in the Statement of Financial Position 16,471 337
Gross Amounts Not Offset in the Statement of Financial position, Financial Instruments 0 0
Gross Amounts Not Offset in the Statement of Financial position, Cash Collateral Pledged 15,860 80
Net Amount $ 611 $ 257
v3.25.2
Derivative Financial Instruments - Summary of Income Statement Effect of Derivatives Designated as Hedging Instruments (Details) - Designated as Hedging Instrument - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2023
Fair Value Hedging          
Derivative Instruments, Gain (Loss) [Line Items]          
Net recognized on cash flow hedges $ 0 $ 0 $ 0 $ 1,320  
Fair Value Hedging | Long-term Debt          
Derivative Instruments, Gain (Loss) [Line Items]          
Fair value hedging relationship         $ 400,000
Hedge basis adjustment         $ 1,300
Cash Flow Hedging          
Derivative Instruments, Gain (Loss) [Line Items]          
Net recognized on cash flow hedges (2,689) (11,847) (5,944) (22,645)  
Interest rate derivatives | Fair Value Hedging          
Derivative Instruments, Gain (Loss) [Line Items]          
Net recognized on cash flow hedges $ 0 $ 0 $ 0 $ (1,320)  
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Deposits Deposits Deposits Deposits  
Interest rate derivatives | Cash Flow Hedging | Operating Expense          
Derivative Instruments, Gain (Loss) [Line Items]          
Net recognized on cash flow hedges $ 0 $ 0 $ 0 $ 34  
Interest rate derivatives | Cash Flow Hedging | Other Income          
Derivative Instruments, Gain (Loss) [Line Items]          
Net recognized on cash flow hedges $ (2,689) $ (11,847) $ (5,944) $ (22,611)  
v3.25.2
Derivative Financial Instruments - Summary of Income Statement Effect of Derivatives Not Designated as Hedging Instruments (Detail) - Not Designated as Hedging Instrument - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Derivative Instruments, Gain (Loss) [Line Items]        
Total not designated as hedging instruments $ (3,138) $ (1,083) $ (6,936) $ 1,462
Interest rate derivatives | Operating Expense        
Derivative Instruments, Gain (Loss) [Line Items]        
Total not designated as hedging instruments 896 (1,734) (1,928) (444)
Mortgage banking derivatives | Operating Expense        
Derivative Instruments, Gain (Loss) [Line Items]        
Total not designated as hedging instruments (14) (8) (1) (30)
Other | Operating Expense        
Derivative Instruments, Gain (Loss) [Line Items]        
Total not designated as hedging instruments $ (4,020) $ 659 $ (5,007) $ 1,936
v3.25.2
Fair Value Measurements - Summary of Comparison to Loans Held-for-Sale (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Fair Value, Option, Quantitative Disclosures [Line Items]    
Fair Value $ 75 $ 297
UPB [1] 278,409 27,634
Difference 0 14
Originated loans held for sale    
Fair Value, Option, Quantitative Disclosures [Line Items]    
UPB $ 75 $ 283
[1] Total loans held for sale includes residential mortgage loans valued under the fair value option of $75 at June 30, 2025, and $297 at December 31, 2024.
v3.25.2
Fair Value Measurements - Narrative (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Broker dealer deposit program fair value   $ 2,500,000    
Total credit-related financial instruments with off-balance sheet risk   12,921,970   $ 12,237,964
Total write-ups   1,800    
Proceeds from sales of alternative investments   9,536 $ 0  
Gains on sale   5,748 $ 0  
Loans transferred to held-for-sale   278,300   27,300
Amortized cost of consumer loans   10,300    
Fair Value, Nonrecurring        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Investments held in Rabbi Trust   2,500   400
Carrying amount of alternative investments   3,800    
Proceeds from sales of alternative investments   9,500    
Gains on sale   5,700    
Rabbi Trust        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Investments held in Rabbi Trust   9,500   9,200
Alternative investments        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Investments held in Rabbi Trust   38,100   30,100
Readily determinable fair value proceeds $ 1,200      
Write-down of TDR's $ 300      
Equity investment, carrying amount   0   0
Alternative investments, carrying amount   50,500   43,400
Alternative investments | Fair Value, Nonrecurring        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Total credit-related financial instruments with off-balance sheet risk   70,800   61,500
Alternative investments measured at fair value   $ 8,200   $ 8,300
v3.25.2
Fair Value Measurements - Summary of Unobservable Inputs (Details)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2025
USD ($)
holding
Dec. 31, 2024
USD ($)
holding
Apr. 30, 2025
USD ($)
Fair Value, Option, Quantitative Disclosures [Line Items]      
Broker dealer deposit program fair value $ 2,500,000    
Re-sign broker dealers      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Contingent consideration 182 $ 182  
Re-sign broker dealers | Maximum      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Contingent consideration 207 207  
Deposit program growth      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Contingent consideration 12,500 11,568  
Change in consideration recognized in earnings $ 900    
Broker dealer deposit program fair value     $ 2,500,000
Deposit program growth | Maximum      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Contingent consideration   $ 12,500  
Probability of Achievement | Re-sign broker dealers      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Measurement input | holding 0.990 0.990  
Probability of Achievement | Deposit program growth      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Measurement input | holding   1.000  
Payment Term (in years) | Re-sign broker dealers      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Payment Term (in years) 4 months 17 days 10 months 17 days  
Payment Term (in years) | Deposit program growth      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Payment Term (in years)   6 months  
Discount Rate | Re-sign broker dealers      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Measurement input 0.0640 0.0640  
Discount Rate | Deposit program growth      
Fair Value, Option, Quantitative Disclosures [Line Items]      
Measurement input   0.0640  
v3.25.2
Fair Value Measurements - Summary of Fair Values of Assets and Liabilities Measured at Fair Value (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value [1] $ 9,620,354 $ 9,006,600
Total derivative instruments, after netting 73,050 19,049
Originated loans held for sale $ 75 $ 297
Derivative Liability Statement Of Financial Position Extensible Enumeration Not Disclosed Flag true true
Derivative Liability $ 168,029 $ 279,600
Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 9,620,354 9,006,600
Alternative investments measured at NAV 50,453 43,360
Total financial assets 9,931,337 9,365,837
Derivative Liability 243,787 311,561
Contingent consideration 182 11,750
Total financial liabilities 243,969 323,311
Fair Value, Recurring | Derivative instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total derivative instruments, after netting 247,555 302,142
Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Alternative investments measured at NAV 0 0
Total financial assets 13,435 14,701
Derivative Liability 1,515 43
Contingent consideration 0 0
Total financial liabilities 1,515 43
Fair Value, Recurring | Level 1 | Derivative instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total derivative instruments, after netting 535 1,263
Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 9,620,354 9,006,600
Alternative investments measured at NAV 0 0
Total financial assets 9,867,449 9,307,776
Derivative Liability 242,272 311,518
Contingent consideration 0 0
Total financial liabilities 242,272 311,518
Fair Value, Recurring | Level 2 | Derivative instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total derivative instruments, after netting 247,020 300,879
Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Alternative investments measured at NAV 0 0
Total financial assets 0 0
Derivative Liability 0 0
Contingent consideration 182 11,750
Total financial liabilities 182 11,750
Fair Value, Recurring | Level 3 | Derivative instruments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total derivative instruments, after netting 0 0
Originated loans held for sale | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Originated loans held for sale 75 297
Originated loans held for sale | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Originated loans held for sale 0 0
Originated loans held for sale | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Originated loans held for sale 75 297
Originated loans held for sale | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Originated loans held for sale 0 0
Investments held in Rabbi Trusts | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments held in Rabbi Trust 12,900 13,438
Investments held in Rabbi Trusts | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments held in Rabbi Trust 12,900 13,438
Investments held in Rabbi Trusts | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments held in Rabbi Trust 0 0
Investments held in Rabbi Trusts | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investments held in Rabbi Trust 0 0
Government agency debentures    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 192,436 186,426
Government agency debentures | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 192,436 186,426
Government agency debentures | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Government agency debentures | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 192,436 186,426
Government agency debentures | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Municipal bonds and notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 103,808 110,876
Municipal bonds and notes | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 103,808 110,876
Municipal bonds and notes | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Municipal bonds and notes | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 103,808 110,876
Municipal bonds and notes | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Agency CMO    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 27,113 29,043
Agency CMO | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 27,113 29,043
Agency CMO | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Agency CMO | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 27,113 29,043
Agency CMO | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Agency MBS    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 4,831,605 4,519,785
Agency MBS | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 4,831,605 4,519,785
Agency MBS | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Agency MBS | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 4,831,605 4,519,785
Agency MBS | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Agency CMBS    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 3,224,198 3,034,392
Agency CMBS | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 3,224,198 3,034,392
Agency CMBS | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Agency CMBS | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 3,224,198 3,034,392
Agency CMBS | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
CMBS    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 790,132 625,388
CMBS | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 790,132 625,388
CMBS | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
CMBS | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 790,132 625,388
CMBS | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Corporate debt    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 403,373 452,266
Corporate debt | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 403,373 452,266
Corporate debt | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Corporate debt | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 403,373 452,266
Corporate debt | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Private label MBS    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 38,364 39,219
Private label MBS | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 38,364 39,219
Private label MBS | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Private label MBS | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 38,364 39,219
Private label MBS | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Other    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 9,325 9,205
Other | Fair Value, Recurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 9,325 9,205
Other | Fair Value, Recurring | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 0 0
Other | Fair Value, Recurring | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value 9,325 9,205
Other | Fair Value, Recurring | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Investment securities available-for-sale, at fair value $ 0 $ 0
[1] Investment securities available-for-sale had an amortized cost basis of $10,189,481 at June 30, 2025, and $9,720,415 at December 31, 2024.
v3.25.2
Fair Value Measurements - Summary of Estimated Fair Values of Significant Financial Instruments (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Held-to-maturity investment securities, Fair Value $ 7,291,244 $ 7,453,123
Carrying Amount | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 2,993,919 2,074,434
Held-to-maturity investment securities, Carrying Amount 8,192,720 8,444,191
Loans and leases, net 52,949,913 51,815,602
Securities sold under agreements to repurchase and federal funds purchased 372,806 344,168
FHLB advances 3,339,914 2,110,108
Long-term debt 905,634 909,185
Carrying Amount | Fair Value, Nonrecurring | Deposit liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Deposits 58,394,540 56,518,126
Carrying Amount | Fair Value, Nonrecurring | Time deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Deposits 7,919,885 8,234,954
Level 1 | Fair Value | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash and cash equivalents 2,993,919 2,074,434
Level 2 | Fair Value | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Held-to-maturity investment securities, Fair Value 7,291,244 7,453,123
Securities sold under agreements to repurchase and federal funds purchased 372,858 344,166
FHLB advances 3,337,057 2,107,790
Long-term debt 909,945 860,200
Level 2 | Fair Value | Fair Value, Nonrecurring | Deposit liabilities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Deposits 58,394,540 56,518,126
Level 2 | Fair Value | Fair Value, Nonrecurring | Time deposits    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Deposits 7,895,161 8,211,582
Level 3 | Fair Value | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loans and leases, net $ 51,416,732 $ 50,245,305
v3.25.2
Segment Reporting - Narrative (Details)
 6 Months Ended
Jun. 30, 2025
banking_center
Segment
Segment Reporting [Abstract]  
Number of reportable segments | Segment 3
Number of banking centers | banking_center 196
Provision for credit losses period 3 years
v3.25.2
Segment Reporting - Summary of Balance Sheet Information by Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Segment Reporting Information [Line Items]            
Goodwill $ 2,868,068   $ 2,868,068   $ 2,868,068 $ 2,631,465
Total assets 81,914,270   81,914,270   79,025,073  
Net interest income 621,182 $ 572,297 1,233,374 $ 1,140,036    
Non-interest income 94,657 42,298 187,263 141,651    
Total segment revenues 715,839 614,595 1,420,637 1,281,687    
Compensation and benefits 199,930 186,850 398,575 375,390    
Occupancy 19,337 15,103 39,054 34,542    
Technology and equipment 45,932 45,303 93,651 91,139    
Marketing 5,171 4,107 9,198 8,388    
Segment pre-tax, pre-provision net revenue 370,125 288,574 731,279 619,743    
Provision for credit losses 46,500 59,000 124,000 104,500    
Total consolidated income before income taxes 323,625 229,574 607,279 515,243    
Intangible assets amortization 9,093 8,716 18,330 17,910    
Operating Segments            
Segment Reporting Information [Line Items]            
Net interest income 628,815 631,931 1,246,363 1,265,788    
Non-interest income 83,906 86,367 168,458 185,686    
Total segment revenues 712,721 718,298 1,414,821 1,451,474    
Segment pre-tax, pre-provision net revenue 425,852 446,538 842,994 901,241    
Operating Segments | Commercial Banking            
Segment Reporting Information [Line Items]            
Goodwill 1,960,363   1,960,363   1,960,363  
Total assets 43,908,431   43,908,431   43,010,580  
Net interest income 318,518 337,588 637,641 679,530    
Non-interest income 30,628 34,510 59,586 68,790    
Total segment revenues 349,146 372,098 697,227 748,320    
Compensation and benefits 50,807 49,904 102,916 100,662    
Occupancy 0 0 0 0    
Technology and equipment 2,336 2,051 4,447 4,009    
Marketing 0 0 0 0    
Other segment items 55,229 52,633 107,591 106,142    
Segment pre-tax, pre-provision net revenue 240,774 267,510 482,273 537,507    
Occupancy and technology depreciation 100 100 100 100    
Intangible assets amortization 2,700 1,700 5,500 4,700    
Operating Segments | Healthcare Financial Services            
Segment Reporting Information [Line Items]            
Goodwill 285,670   285,670   285,670  
Total assets 477,234   477,234   488,194  
Net interest income 97,625 91,664 193,986 177,802    
Non-interest income 28,687 27,465 58,077 58,526    
Total segment revenues 126,312 119,129 252,063 236,328    
Compensation and benefits 24,171 22,915 47,508 44,277    
Occupancy 0 0 0 0    
Technology and equipment 7,524 8,092 16,288 16,098    
Marketing 0 0 0 0    
Other segment items 23,758 20,260 47,377 43,019    
Segment pre-tax, pre-provision net revenue 70,859 67,862 140,890 132,934    
Occupancy and technology depreciation 1,500 1,300 2,900 2,600    
Intangible assets amortization 3,400 3,600 6,900 6,300    
Operating Segments | Consumer Banking            
Segment Reporting Information [Line Items]            
Goodwill 622,035   622,035   622,035  
Total assets 13,499,277   13,499,277   12,932,260  
Net interest income 212,672 202,679 414,736 408,456    
Non-interest income 24,591 24,392 50,795 58,370    
Total segment revenues 237,263 227,071 465,531 466,826    
Compensation and benefits 37,285 36,526 74,569 73,421    
Occupancy 13,835 13,683 28,183 28,221    
Technology and equipment 2,917 2,331 5,966 4,759    
Marketing 2,043 1,714 4,025 3,561    
Other segment items 66,964 61,651 132,957 126,064    
Segment pre-tax, pre-provision net revenue 114,219 111,166 219,831 230,800    
Occupancy and technology depreciation 2,400 2,300 5,000 4,600    
Intangible assets amortization 1,800 2,100 3,600 4,300    
Segment Reporting, Reconciling Item, Corporate Nonsegment            
Segment Reporting Information [Line Items]            
Goodwill 0   0   0  
Total assets 24,029,328   24,029,328   $ 22,594,039  
Non-interest income 10,751 (44,069) 18,805 (44,035)    
Total segment revenues 3,118 (103,703) 5,816 (169,787)    
Segment pre-tax, pre-provision net revenue $ (55,727) $ (157,964) $ (111,715) $ (281,498)    
v3.25.2
Revenue from Contracts with Customers - Summary of Revenues From Contracts With Customers (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue from External Customer [Line Items]        
Revenue from contracts with customers $ 59,430 $ 61,834 $ 120,208 $ 125,839
Non-interest income 94,657 42,298 187,263 141,651
Deposit service fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 40,934 41,027 79,829 83,616
Loan and lease related fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 2,520 3,943 4,745 7,565
Wealth and investment services        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 7,779 8,556 15,568 16,480
Other        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 8,197 8,308 20,066 18,178
Other sources of non-interest income        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 35,227      
Non-interest income   (19,536) 67,055 15,812
Operating Segments        
Revenue from External Customer [Line Items]        
Non-interest income 83,906 86,367 168,458 185,686
Operating Segments | Commercial Banking        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 10,423 12,311 20,703 24,953
Non-interest income 30,628 34,510 59,586 68,790
Operating Segments | Commercial Banking | Deposit service fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 4,550 5,160 9,289 11,002
Operating Segments | Commercial Banking | Loan and lease related fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 2,520 3,943 4,745 7,565
Operating Segments | Commercial Banking | Wealth and investment services        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 3,353 3,208 6,669 6,386
Operating Segments | Commercial Banking | Other        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 0 0 0 0
Operating Segments | Commercial Banking | Other sources of non-interest income        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 20,205      
Non-interest income   22,199 38,883 43,837
Operating Segments | Healthcare Financial Services        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 28,359 27,465 57,728 58,526
Non-interest income 28,687 27,465 58,077 58,526
Operating Segments | Healthcare Financial Services | Deposit service fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 20,282 20,460 39,351 42,512
Operating Segments | Healthcare Financial Services | Loan and lease related fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 0 0 0 0
Operating Segments | Healthcare Financial Services | Wealth and investment services        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 0 0 0 0
Operating Segments | Healthcare Financial Services | Other        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 8,077 7,005 18,377 16,014
Operating Segments | Healthcare Financial Services | Other sources of non-interest income        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 328      
Non-interest income   0 349 0
Operating Segments | Consumer Banking        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 21,116 21,322 41,305 40,686
Non-interest income 24,591 24,392 50,795 58,370
Operating Segments | Consumer Banking | Deposit service fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 16,268 15,552 31,562 30,348
Operating Segments | Consumer Banking | Loan and lease related fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 0 0 0 0
Operating Segments | Consumer Banking | Wealth and investment services        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 4,432 5,354 8,910 10,105
Operating Segments | Consumer Banking | Other        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 416 416 833 233
Operating Segments | Consumer Banking | Other sources of non-interest income        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 3,475      
Non-interest income   3,070 9,490 17,684
Segment Reporting, Reconciling Item, Corporate Nonsegment        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers (468) 736 472 1,674
Non-interest income 10,751 (44,069) 18,805 (44,035)
Segment Reporting, Reconciling Item, Corporate Nonsegment | Deposit service fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers (166) (145) (373) (246)
Segment Reporting, Reconciling Item, Corporate Nonsegment | Loan and lease related fees        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers 0 0 0 0
Segment Reporting, Reconciling Item, Corporate Nonsegment | Wealth and investment services        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers (6) (6) (11) (11)
Segment Reporting, Reconciling Item, Corporate Nonsegment | Other        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers (296) 887 856 1,931
Segment Reporting, Reconciling Item, Corporate Nonsegment | Other sources of non-interest income        
Revenue from External Customer [Line Items]        
Revenue from contracts with customers $ 11,219      
Non-interest income   $ (44,805) $ 18,333 $ (45,709)
v3.25.2
Revenue from Contracts with Customers - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]          
Deferred revenue recognized in other income $ 0.5 $ 0.4 $ 0.9 $ 0.7  
Contracts with customers accounts receivable 3.6   3.6   $ 2.7
Contracts with customers deferred costs 4.6   4.6   3.0
Contracts with customers deferred revenue $ 24.0   $ 24.0   $ 22.8
v3.25.2
Commitments and Contingencies - Summary of Credit Related Financial Instruments With Off-Balance Sheet Risk (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Loss Contingencies [Line Items]    
Total credit-related financial instruments with off-balance sheet risk $ 12,921,970 $ 12,237,964
Standby letters of credit    
Loss Contingencies [Line Items]    
Total credit-related financial instruments with off-balance sheet risk 608,752 578,912
Commercial letters of credit    
Loss Contingencies [Line Items]    
Total credit-related financial instruments with off-balance sheet risk 27,842 28,287
Commitments to extend credit    
Loss Contingencies [Line Items]    
Total credit-related financial instruments with off-balance sheet risk $ 12,285,376 $ 11,630,765
v3.25.2
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Jun. 30, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Accrual for special assessment charge   $ 39.8 $ 28.0
SEC Schedule, 12-09, Allowance, Credit Loss      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
ACL on unfunded loan commitments $ 22.8 $ 22.6